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Preface .
During the past twenty years the formulation of many biological
concepts have been greatly influenced by the growth to prominence of
new branches of mathematics, physics and biology concerned with the
analysis and control of complex structures.
It has become axiomatic that structures displaying a certain degree
of autonomous directive activity may profitably be considered as systems
with certain inherent constraints upon their activities. These systems
may in turn be subject to further constraints that determine the behaviour
of other interacting systems. Such constraints may, for example, be
considered as determining, by feedback control mechanisms, the size or
complexity of a self-regulating system, or maintaining its physical or
homeostatic stability in the face of conflicts in the external environ¬
ment.
It is now evident that the immune system may be considered as part
of a general system composed of discrete but often interacting entities
each with inherent controls in addition to those imposed 'from above*.
One of the properties of such closely interrelated systems is that
a change in one of the parameters may affect the values of others. The
effects induced by changes in the variables studied do not necessarily
prove a direct cause-effect relationship. The possibility exists that
alterations in variables other than those under study could be responsible
for the effect observed. The converse is also true. Evidence of
activation or even involvement of a particular system does not necessarily
imply that it is required in the production of a particular phenomenon,
nor does it validate further generalisation to the involvement of this
system under any conditions except those identical to the conditions
under which it was initially observed.
The steps leading to the induction of antibody must involve a
morass of infinitely elaborate, interdependant processes each, to a
greater or lesser extent, determining the final result.
It was with due regard to the complexity of biological systems
that this study was undertaken and its tentative conclusions reached.
Its main concerns are the mechanisms of humoral antibody formation and
tolerance induction and the effect upon these of certain bacterial
adjuvants.
The work was undertaken in the Immunology laboratory, Bacteriology
Department, University of Edinburgh.
The author is grateful to Dr. D.M. Weir, not only for his help and
guidance, but also for the spirit in which this assistance was given.
I am also indebted to the members of this laboratory and many of
the other numerous immunologiats resident in Hdinburgh for useful criti¬
cism and discussions.
I am extremely grateful to the staff of the Edinburgh Regional
Computing Centre, and the KDF9 and 360/50 oomputers, for alleviating much
of the tedious effort involved in calculating many of the results expressed
in this thesis. In particular I would like to thank Mrs. J. Snashall,
formerly of the Department of Computer Science, for her help in writing
the programs and Mr. W. Lutz, Department of Social Medicine, for statis¬
tical advice.
Finally I would like to thank my wife Jana for her patience, help
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One of the main aims of this thesis was to investigate the relation¬
ship between tolerance and immunity. In order to do so the response of
CBA mice to bovine serum albumin (BSA) was examined and a reproducible
model system derived for the induction of tolerance to a single low dose
of the antigen. The tolerant state so induced was examined with respect
to the quantity, quality and class of antibodies formed.
The effect of the physical state of the antigen upon the dose
threshold for tolerance induction and immunity was investigated. Attempts
were made to correlate the response induced with the localisation of the
antigen preparations within the lymphoreticular tissues.
The examination of the effect of the genetic background of the
animals upon the response to BSA and upon the threshold for tolerance
induction employed four inbred strains of mice and their hybrids.
Included among these strains were NZB mice which were of particular
interest in view of their lymphoreticular abnormalities and their tendency
to develop various autoimmune phenomena.
The relationship between tolerance and immunity was further investi¬
gated by the use of adjuvants, in particular C.parvum. The ability of
these adjuvants to prevent the induction of tolerance to centrifuged BSA
was examined as was the effect of C.parvum upon the lymphoreticular
tissues. The findings are discussed with relation to the adjuvant effect
of C.parvum and also to the haematological changes it induces, including
transitory immune reactivity directed against autologous red cells.
GENERAL INTRODUCTION
It is only since the 1950*s that the biological system for the
production of antibodies has come to be viewed as an integrated whole.
Prior to this, the gross biochemical characteristics of this class of
proteins had been defined and the nature of their specificity been shown
to depend upon specific chemical groupings on the antigen. It was a
main concern of early theories of antibody formation to relate this
information to the in vivo morphological and cellular changes that were
known to be brought about as a result of introduction into the body of a
wide variety of foreign materials, and that were shown to correlate with
the appearance of specific antibody in the serum.
There is now overwhelming evidence that, despite its limitations,
the scheme for protein synthesis developed for relatively simple bacterial
cells, is also essentially correct for the mammalian cell. Enzymic and
sequential amino acid analysis of antibody molecules has supported the
concept that the sequence of the amino acids, and hence the structure of
the antibody molecule, has an equivalent pattern coded for in the form of
relatively stable genetic material. The data which emerged has removed
from general consideration those theories of antibody formation that do
not have a strict genetical basis, and in addition has given new insight
into the concept of antibody specificity.
In spite of these advances, one of the most elusive and least
understood factors in the immune response continues to be the self-evld«nt
role of antigen in its initiation and probably also its control. It
would thus seem pertinent to study the sequential fate of antigen within
the body as an initial step towards understanding the processes involved
in the production of antibody which are the subject of this thesis.
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1* The reticuloendothelial system and the fate of antigen.
a. Historical.
The vital role of phagocytes in removing foreign substances from
the tissue fluids has been appreciated since the classical studies of
Metchnikoff (1905). Even before this time the phenomenon of phago¬
cytosis had been observed by Wyssokowitach (1886). The cells, both free
and fixed in tissue that were pre-eminant in their capacity to take up
vital dyes, were grouped together by Aschoff (1924) into the reticulo¬
endothelial system, or RES. This classification has survived until
recently when a new proposal was made that only the very highly phago¬
cytic mononuclear cells and their precursors should be considered as a
system, under the term mononuclear phagocytic system, or MPS (Langevoort
jit al., 1970). This new classification takes into better account the
differences between vital dyes and suspensoids in the rapidity of their
uptake and their final microscopic distribution (see Cappel, 1929)* As
well as being a functionally related system, the MPS includes only those
cell types related to, or thought to be related to, the blood monocyte.
This definition excludes dendritic, reticular, endothelial, and fibrocytic
cells which were included by Aschoff in his broadest classification of
the RES. As this system is not yet universally accepted, reference will
be made only to the reticuloendothelial system, in spite of the fact that
in certain instances only actively phagocytic cells may be involved in
the processes described.
The first attempts to follow the fate of a soluble antigen in the
body appears to come from Metchnikoff (1897)• He used toxicity as a
tracer and studied the fixation of tetanus toxin in the tissues of the
chicken. He noted, however, that organs rich in blood could not be
quantitated properly for their antigen content. By doing careful
toxicity assays on washed organ minces, Wolf-Eisner (1908) helped to
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overcome this obstacle. Rabbits were shown to concentrate tetanus
antigen in the spleen, liver, bone marrow, kidney and lungs? findings
later to be confirmed using a variety of techniques.
Microscopic location of antigen within the cells of the RHS was
first described by Sabin (1939)• Injecting R-salt-azo-benzidene-azo-
egg^-albumin into rabbits, she used the evidence of the dye as an in vivo
marker for the presence of antigen. The dark red colour was detected
in the vacuoles of fixed tissue macrophages, TCupffer cells, polymorpho¬
nuclear leucocytes, monocytes, and cells lining the lymphatic vessels.
Sabin also described 'shedding1 of cytoplasm by dye-containing cells,
which appeared to coincide with the appearance of demonstrable serum
antibodies.
Of the many methods used since to investigate the fate and localis¬
ation of antigens in vivo , radioactively-labelled antigens have yielded
the most complete data. This method was first used by Libby and Madison
Op
(1947) to study the distribution of P-labelled tobacco mosaic virus
injected into mice. Since then, workers in this field have tended to
use radioiodinated soluble antigens. The justification for supposing
that the presence of label reflects the presence of undegraded or
partially degraded antigen has been expounded by Campbell and Oarvey
(1963) and Humphrey et &1.(1967).
b. Localization of antigen in vivo.
The most complete studies on the characteristics of this process
come from Nossal and his co-workers in Melbourne. They used, as antigen,
IPC 1^1
microgram quantities of ^1- or I-labelled S.adelaide flagella, either
in its natural form or as purified monomeric or polymeric flagellin.
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After injection into the foot pad of the rat, moat of the antigen
was found to pass through the draining lymph node. As little as 1-2$
of the injected antigen was found at any time to be retained in the
lymphoid system, the majority of antigen being excreted within the first
24 hours (Nossal et al., 19^3? Ada et al., 1964). These findings are
in good agreement with those of other workers in a variety of other
systems (see Campbell and Garvey, 1963).
Autoradiography on the draining lymph node of the injected rats
showed the majority of retained antigen to be within the medullary
macrophages. A smaller quantity was associated with dendritic cells in
the follicles. After a few days the label in the medullary regions was
found to disappear whereas the label in the follicles diminished more
gradually over a period of several weeks.
The majority of label in the medullary macrophages was enclosed
within vacuoles and phagolysosomes, as judged by electron microscopy
(Nossal et al., 1968 ). The much smaller quantity of antigen free in
the cytoplasm of these cells was considered to be rapidly incorporated
into membrane bound inclusions.
In contrast, the label in the follicles was thought to be, in the
main, on the surfaces of dendritic cell processes which lay in close
proximity to lymphocyte membranes. Very few labelled lymphocytes per se
were found in these studies, nor was label seen associated with areas of
plasmacytosis (Nossal et al», 1968a).
Although injected substances vary amongst themselves in the sites
they occupy within the body, and the rate at which they are taken up,
the sequence of events described above, with only a few qualitative
differences, ha3 been established as occuring after the injection of a
N- K
wide variety of soluble protein antigenB.
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Uptake of antigens in the lymph node medulla and at the border
of the red and white pulp of the epleen is a recurrent event, which is
often followed by digestion of the antigen and rapid loss of label from
these areas. Localization of particulate antigens and non-antigens
also occurs in these areas.
follicular localization on the other hand, appears, at least
quantitatively, to show a certain specificity for antigens only. In
addition, there are differences between antigens with regard to the time
after injection at which follicular localization is most prominent.
The majority of antigens require 3-7 days before significant levels of
label are found in the follicles (McDevitt al., 1966; Balfour and
Humphrey, 1967? White etal., 1967)* More rapid follicular localization
has been shown to occur with homologous and heterologous IgG, homologous
IgM, and with antigen-antibody complexes (Hanna et al., 1968)} Herd and
Ada, 1969)* Localization of immunoglobulin molecules appears dependant
upon the presence of an intact P region (Herd and Ada, 1969)- The
o
conflicting time sequences have been resolved by the accumulation of a
body of evidence suggesting that participation of specific antibody is
required for the follicular localization of antigen.
In both actively and passively immunised animals it has been
repeatedly shown that there is an antigen specific increase in the rate
and degree of both medullary and follicular uptake although the effect
is most marked with respect to the latter. By contrast, in fully
tolerant animals only medullary uptake is found (Balfour and Humphrey*
1967J White et al., 1967)* In addition, where antibody formation ie
depressed by X-irradiation (Jaroslow and Nossal, 1966), anti-lymphocytio
treatment (Barth et al., 1969)> thoracic duct drainage (Williams and
Nossal, 1966), or in germ-free and neonatal animals (Williams and
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Nossal, 1966) there is a marked decrease in the efficiency of follicular
uptake. A more direct approach, by Balfour and Humphrey (1967) and
White et al. (1967)» was to examine by fluorescent techniques the distri¬
bution of antibody around and in the germinal centres of primed animals.
The site and pattern of localization of antibody in the centres was found
to be similar to that already described for the antigen. The presence
of antibody, capable of attaching by the Fq portion to the surface of
the processes of dendritic cells, seems a likely mechanism whereby the
uptake of antigen onto these cells is potentiated, either before or after
antigen-antibody complexes are formed.
2. Follicular uptake of antigen and the immune response.
Lack of knowledge on the precise role of follicles in the production
of antibody has hindered attempts to explain the role of antigen specifi¬
cally trapped in them. In 1930, Hellman and White noted the appearance
of Fleming's 'germinal centres' in the lymph node follicles of animals
injected with foreign or toxic materials. These centres, which Hellman
called 'reaction centres', also appeared in the Malphigian nodules of
the spleen. Since then there has been much support based on pbylogenetic,
ontogenetic and kinetic evidence for the contention that these areas of
the lymphoid tissue are important in the production of large quantities
of antibodies.
Germinal centres are not formed in tolerant animals in response to
test antigen (Cohn and Thorbecke, 1964)# nor are they present in germ-free
animals (Gilmstedt, 1936). In normal animals there is an appropriate
time relationship between the rapid expansion of primary follicles to
give germinal centres and the appearance of high titres of serum antibody
(Hanna, 19651 1966). Furthermore, specific intracellular and inter-
oellular immunoglobulins have been found in a number of rabbit germinal
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centres following diphtheria toxoid and ovalbumin injection (Leduc et al,,
1955)* Under given conditions, the secondary responses to these antigens
could be limited to that lymph node draining the site of the primary
injection (White et al.t 1955)* It is of interest that besides being
antibody-producing sites, Uhrich (1946) considered germinal centres to be
also in part the place where lymphocytes returned from the blood to the
lymph nodes. Follicular stimulation however, does not appear to be the
first histological change associated with antibody formation. Antibody
forming cells are first found in lymph node medulla and/or at the border
of the red and white pulp of the spleen (Leduc et d., 1955)* On the
basis of this morphological evidence, it seems unlikely that specific
localization of antigen in the form of antigen-antibody complexes is a
prerequisite for the initiation of primary immune responses. Recent
findings of IgO complexed to antigen a few hours after its injection may
correct this viewpoint (Ivanyi, 1970} Tuan et _al., 1970) although other
roles for follicular trapping have been proposed.
Whiteet al. (1967) have suggested that antigen on dendritic cells
may act as a focus for germinal centre proliferation in the chicken spleen.
After antibody forming cell3 had disappeared from the medulla, clusters
of such cells were found in germinal centres. Ada and Parish (1968)
suggested that follicular localization may have a role in the promotion
of tolerance and/or immunological memory, and in addition it may have an
inhibitory or regulating role to play in the immune response (Jerne, 1967}
ff
Uhr and LJoller, 1968). Mitchison (1969a)has suggested a role for
follicular localization in increasing the effective local concentration
of antigen in an area where cell migration is likely to occur.
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3. Phagocytosis in the immune response.
a. Introduction.
Antibody formation has been shown in the main to be a property of
cells of the lymphocytic and plasmacytic series (Attardi eit jal., 1959?
Leduc jet ail., 1955)» although there are a few reports that other cell
types may also be involved.
Noltenius and Chahin (19^9) demonstrated cells of macrophage morpho¬
logy and function forming 'direct' plaques by a modification of Jerne's
technique. These cells, supposedly secreting specific antibody, were
found in the spleens of mice immunised against sheep red blood cells and
were capable of phagocytosing india ink particles and red blood cells.
In this and other similar studies (Mitsuhashi et al., 19^7) the proportion
of such cells was small in comparison with the number of antibody forming
cells of lymphocytic character. Furthermore, the relationship of this
cell type to the classical macrophage is uncertain (see p.14).
Although not generally considered as antibody forming cells macro¬
phages are often thought to be concerned in the induction of immune
responses. A priori one might expect phagocytes within the lymphoid
organs in close apposition to the antibody forming cells, to be involved
in first steps towards antibody production. The sinus lining macrophages
of the spleen seem exquisitely situated to contact lymphocytes recircul¬
ating through this organ (Ooldschneider and McGregor, 19&9)- Several
experimental systems have demonstrated that contact of antigen with
macrophages may enhance its immunogenicity. Whether or not the processes
involved have any relevance to the final immune response can be considered
only in relation to evidence from in vivo experiments.
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b. The role of the macrophage In vivo and in vitro.
Frei et al., (1968) argued that the primary response of the rabbit
to bovine serum albumin requires the intervention of the macrophage.
BSA ^filtered' by passage in vivo, was found to lose its inaaunogenicity.
The more particulate and hence more readily phagocytosed material seems
to be removed by the passage through an animal leaving only monomeric
form of the antigen which is tolerogenic. The conclusion drawn from
these experiments must be taken in light of the fact that commercial B.'5A
has often been shown to contain pyrogenic contaminants (Dvorak and Bast,
1970j Philip et al., 1966).
Gallily and Feldman (1967), amongst others, derived similar views
on the role of macrophages from experiments based upon the different
sensitivities of macrophages and lymphocytes to X-irradiation. Mouse
peritoneal macrophages, incubated with Shigella in vitro and washed, were
found capable of restoring agglutinin production in 550r X-irradiated
hosts. Similar mice receiving bacteria alone and/or lymph node cells
were found to be unreactive. Macrophages from irradiated donors were
ailso ineffective. Mltchison (1969) showed live macrophages containing
bovine serum albumin and other protein antigens to be highly immunogenic
in mice. Similar transfer experiments have shown macrophages capable
of conferring responsiveness to red blood cells upon neonates(Argyris,
1968). It is also of interest that macrophages of foetal or newborn
animals appear capable of ingesting bacteria but not of killing them
(Reade, 1968).
That macrophages may concentrate antigen and present it in a
suitable form to the reactive cells is a hypothesis supported by the fact
that they appear to be required for an in vitro immune response (Hoffman,
1970). Clusters of macrophages around presumably 'reacting' lymphocytes
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hare been observed in vitro (Flshaan et al.t 1963? Sharp and Burwell,
i960). In contrast, the presence of too many macrophages can inhibit
in vitro transformation and antibody production by mouse spleen cells
(Hoffman, 1970? Parkhouse and Button, 1966).
Opposed to the positive role of macrophages in immunogenesis,
there are numerous reports in accord with the older ooncepts that
macrophages simply destroy antigen In vivo, perhaps in doing so protecting
the lymphoid cells from excessive exposure. Perkins and Makinodan
(1965) showed that the ability of macrophages, which had ingested sheep
red blood cells, to stimulate primed spleen cells, decreased with time
after ingestion. Furthermore, in vivo stimulation of peritoneal macro¬
phages with gelatin led to a decrease in the immune response to sheep
red blood cells and aggregated human gamma globulin if these were given
by the intraperitoneal route (Perkins, 1970).
c. Persistence of antigen and phagocytosis.
Protagonists for the role of the macrophage in immunogenesis have
gathered a considerable amount of evidence on the intracellular fate of
antigen, that suggests ways in which these cells could help to initiate
an immune response.
As long ago aa 1928 Wells stated that "antigenic activity is in some
way related to digestive proteolysis." It is now generally accepted
that the majority of materials both phagocytosed and pinocytosed by
macrophages are taken up within vesicles. These move towards the nuclear
region and fuse with Golgi vesicles containing hydrolases. It is within
the dense granules or secondary lysosomes so formed, that digestion of
the engulfed materials takes place, and only molecules of very small
molecular weight appear to be released (Ehrenreich and Cohn, 1969? Cohn,
1968). What has been of interest to immunologists, however, is that
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soma antigen appears to remain in the macrophage, seemingly resisting
degradation*
In 1951 McMaster and Kruse injected azodye conjugated to bovine
gamma globulin into mice. Although most of the dye was rapidly excreted,
a blue colour was evident within phagocytic cells for up to 100 days in
the case of BOG and 40 days in the case H3A. This persistence of dye
correlated roughly with the presence of antigenic determinants in the
blood, liver, spleen and lymph nodes, as judged by the ability of extracts
of these organs to induce vascular changes in the ear by the reversed
passive anaphylaxis technique. Haurowitz and Crarapton (1952) found
radioactive label, and hence presumably antigen, associated with micro¬
somal and mitochondrial extracts of reticuloendothelial organs (see
Haurowitz, i960). More recently, Askonas et al. (1968) showed the
majority of ^*I-labelled haemocyanin from Llaia squinado to be digested
by mouse peritoneal cells within 3-4 Hours. During breakdown the
label was in the main associated with phagosomes. A smaller quantity
of membrane associated label, however was also found which was shown
to persist for a much longer length of time.
In 1956, Oarvey and Campbell isolated residual antigen from the
35
livers of mice injected with S-labelled sulfanilo-bovine-serum-albumin.
They used antibody to precipitate the antigen from liver cell homo-
genates, and discovered the precipitate to also contain RNA. The
quantity of RNA correlated with the amount of latel in the precipitates.
Furthermore, antigen-RNA complexes thus obtained were 100-200 times
more immunogenic thar, the free form of the antigen. Similar complexes
could also be isolated from the animals* circulation and urine. The
low molecular weight and abnormal base composition of at least certain
of these RNAs has since been interpreted as precluding an informational
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function (jfuan _et _al., 1970). Many instances have been since cited
where RNA-antigen complexes, extracted from cells which have taken up
the antigen, have been shown to be exceptionally immunogenic in com¬
parison with the free form of the antigen (Askonas and Rhodes, 1965).
By contrast, a decrease in the izmounogenicity of keyhole limpet
haemocyanin after macrophage processing has been described (Unanue,
1969a). In fact, KLH was shown to be more immunogenic in its free form
than when macrophage bound. Similar experiments, had previously shown
the reverse situation to hold for Maia squinado haemocyanin which is a
poorer immunogen (Unanue and Askonas, 1968a).
Recent studies by Kolsch and Mitchison (1968) have concentrated
upon residual heterologous serum albumin which escapes digestion and
localizes near the macrophage nucleus. This antigen, when macrophage
associated, was shown to be far superior to native antigen in eliciting
a primary immune response (Mitchison, 1969). The relationship between
this intracellular antigen, membrane associated antigen and the antigen
found complexed to RNA is unclear. Their possible role in vivo will be
discussed later.
d. The role of macrophage-derived RHA.
As already indicated, the role of the RNA complexed to antigen has
been taken by many workers to be non-informational in nature (see also
Gottlieb ert al., 1967). There is, however, evidence that an informat¬
ional form of RHA may be produced by a cell in response to antigen i.e.
RHA capable of transferring specific responsiveness to virgin lymphoid
dells.
Fishraan and colleagues in 1961 extracted RNA from peritoneal cells






indue* in non-sensitised homologous lymph nods cells the in vitro
production of specific anti-phage antibody (Fishraan, 1961} Piahman
and Adler, 1963). From enzymic digestion studies these workers
concluded that antigen was not an important constituent in their
preparation. Similar experiments further emphasising the role of
RNA were performed by Adler et al. (1966), but using peritoneal cells
and lymph node cells from donor rabbits which differed in their allo¬
typic expression. In these experiments IgM anti-phage antibody was
found with the allotypic character of the peritoneal cell donor whereas
the allotype of the IgO was that of the lymph node cell donor. As
many workers failed to repeat this observation, it is fair to point
to the difficulties involved in the antibody assay systems as well as
the possible requirement for cell penetration by the RNA (see Jureziz
et al., 1970). Bell and Bray (19<>9)» however, did succeed in support¬
ing Adler's work. RNA extracts cf peritoneal exudate or lymph node
cells from animals immunised against sheep red blood cells could induce
lymphoid cells from non-immunised animals to produce IgM antibodies
bearing the light chain genetic determinants peculiar to the RNA donor.
®* The role of macrophages in the immune response.
To cope with the body of conflicting results and conclusions drawn
on the basis of both the in vivo and the in vitro experiments mentioned,
it appears necessary to Judge each experimental situation on its own
merits.
The most obvious and most fundamental aspect of macrophage function
is universally agreed to be its role as Scavenger*. Other roles are
less well agreed upon.
The investigation of highly immunogenic 'processed' antigen may
lack relevance to the main inductive pathways for antibody formation.
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It is difficult to validly compare the immunogenicity of cell-associated
antigen or antigen-RNA complexes with that of the free native antigen.
The alterations in the spatial location of antigen brought about by its
altered physical form, protection from intravascular degradation, and
slower excretion, as well as non-specific adjuvant effects, could all
possibly give increased imraunogenicity.
That antigen can persist for a considerable period within macro¬
phages may simply be due to the inefficiency of macrophage digestion
and/or heterogeneity of lysosomes or cells.
Functional heterogeneity of cell populations may in part explain
the puzaling experiments of Fishman and Adler (1963). Fishman noted
that only one phage particle per 1000 macrophages was necessary to
induce production of an informational RNA capable of inducing a transient
IgM anti-phage response in cultures of non sensitized cells. This
might suggest that only a minor population of cells was responding.
Within a conventional ideology it is difficult to suggest how a
messenger RNA might be produced by antigen without the participation of
an antibody-like mediator. Although macrophages are thought on the
whole not to be antibody producers there is evidence for cells which
are functionally both macrophages and lymphocytes.
Mouse thoracic duct cells, under extreme provocation, have been
demonstrated to transform into phagocytic liver cells (Boak et al.» 1968).
Blast transformed cells which are not susceptible to anti-macrophage
serum, have been shown to stick to glass and to bind cytophilic antibody
(Unanue, 1968). Established human immunoglobulin-producing cell lines
contain a small percentage of actively phagocytic cells (Kammermeyer
et ail., 1968), as do 'mixed lymphocyte' cultures (Coulson ert al«» 1967 )•
These highly phagocytic 'activated' cells may be an important population
in the experiments of Fishman and Adler and may also account for the
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reports of small numbers of •macrophages* from primed animals which
have been shown to produce •antibody* plaques to sheep red blood cells
and anti-Salmonella IgM antibody (Noltenius and Ruhl, 19^9; Mitsuhashi
at al., 1967)*
While the role of •informational1 RNA as messenger or derepressor,
acting to direct the synthesis of antibody or effector molecule, remains
a possibility, it remains to be shown that the main pathways to antibody
synthesis in vivo utilise these or any other special attributes of the
macrophage population*
Experimentally, the role of the macrophages fixed in lymphoid
organs is often simulated by the use of the peritoneal exudate cells.
The justification for this lies in the seeming similarities between the
two cell populations with respect to the uptake and degradation of
antigen (Askonas et al., 1968) as well as the preferential localization
of peritoneal macrophages in the medullary areas of the lymph node after
intravenous injection (Roser, 19&5? Rusael and Roser, 1966). In view
of the observed differences between alveolar and peritoneal macrophages
(Cohn, 1968) with respect to both enzyme content and antibactericidal
activity, functional differences between populations of cells and/or
lysosomes may exist which would negate the use of the peritoneal macro¬
phages as a model system. Extremely little is known about the functional
attributes of the macrophage population fixed in the lymphoid organs.
In conclusion there can be no dogmatic statement concerning the
function of macrophages other than that they are in the final analysis
important in vivo in determining the outcome of an antigenic challenge.
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4. The antibody-producing cells.
a. Introduction*
It is now clearly established that antibody producing cells belong
mainly to the lymphocytic and plasoacytic series and that they arise
by differentiation and proliferation of precursor cells, which in most
instances appear to be small lymphocytes. This process of differen¬
tiation can be simulated in vitro. Small lymphocytes can transform
into blast cells following antigenic (Abdou and Richter, 1969? Dutton,
1966) and mitogenic (Marshall and Roberts, 1963; 1965) challenge. A
similar process has been described to occur when adoptively transferred
small lymphocytes are challenged in vivo (Gowans, 1966? Ford et al.,
1966).
Highly differentiated cells, committed to antibody synthesis, appear
restricted with respect to the class, light chain type, allotype and
idiotype they produce (see Cebra, 1968; Pernis, 1967? Oell and Sell,
1965). Whether or not their antigen sensitive precursor cell also
produces antibody which is of limited genie expression, is a question
of great importance for the complete understanding of imraunogenesis.
The presence of immunoglobulin determinants on the surface of a
proportion of lymphocytes (Pernis et al., 1970), as well as the predil¬
ection of radioactively-labelled antigen for a small number of normal
cells of this type (Sulitzeanu, 1968), has added strength to the hypoth¬
esis that there may exist precommitted antigen sensitive entities. This
has also been suggested by the limiting dilution technique (Pericins et al.,
1961) and the findings of Kennedy et al. (1966). For the production
of a mouse anti-SRBC response there is a cell type in the mouse spleen
which exists in limiting frequency of approximately 10 . A similar
number of human peripheral cells have been shown to react with
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fluorescent antisera raised against the idiotypic determinants of a
myeloma protein (Pernis, 19^7)• It seems therefore possible that there
exists a population of cells that are predetermined to produce humoral
antibody of one specificity against an antigen.
In a graft versus host situation, however, Simonsen (1967) found
cells sensitive for the B isoantigen of chicken to exist in limiting
frequency of 10"~*. While not necessarily contradictory, these findings
require resolution.
There is a simple hypothesis that direct interaction could occur
between intact or 'processed* antigen and its specific antigen-sensitive
cell, triggering it to proliferation and differentiation into a mature
antibody forming cell. However, it has recently been conclusively
shown that the immune response to an antigen may depend upon interaction
between more than one population of lymphocytes, leading to the concept
of the antigen-sensitive 'unit*. This concept of immunogenesis will
be examined by reviewing in brief what is known about the functional
aspects of the heterogeneity of lymphocytes.
b. The heterogeneity of small lymphocytes.
The developmental and functional capabilities of lymphocytes,
within, and from different, sites have recently been found to show
variable degrees of heterogeneity. Lymphocytes are known to differ in
ft
size, volume, electrophoretic mobility (Rubenstroth-Bauer and Lucke-Huhle,
1968) as well as cellular infrastructure and content of histocompatibility
antigens (Raff, 1969? Raff and Wortis, 1970). Further divisions have
also been made which, while not absolute, can divide the lymphocyte
population with respect to their involvement in certain i®nune responses
and which can be correlated in part with differences in their origin
and life span.
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o. The origins of lymphocytes and their competence.
There seems to be little doubt that, at least in mice, the earliest
precursors of lymphocytes are derived from mesenchymal cells of the bone
marrow and liver and that stem cells from the marrow continue to seed
other lymphoid organs throughout the animals' life (Tyan and Cole, 1965??
Zaalberg and Van der Meul, 1966} Wilier, 1964} McGregor, 1968). Such
conclusions are based mainly upon recolonisation of X-irradiated animals
with lymphoid cells which can be traced by their chromosomal markers or
by autoradiography.
During recolonisation of X-irradiated mice with mixtures of syngeneic
lymphoid cells from various organs, Micklem_et _al. (1966) showed that donor
bone marrow cells could eventually replace other cell types in the thymus,
lymph nodes, spleen and bone marrow of the recipients. This property may
be linked to their multipotency with regard to developing into the many
cell types of the reticular system.
X-irradiated, bone marrow-reconstituted mice show complete haema¬
topoietic recovery by 14 days and the immune system is complete by 25-30
days. Complete immune reconstitution of these mice, however, is dependent
upon the presence of an intact thymus (Osoba, 1968). It appears that a
certain number of bone marrow cells sequester and differentiate within
this primary lymphoid organ before being released into the circulation
(Ford and Micklem, 1963} Dukor et al., 1965)* These 'thymus derived*
cells are found in high numbers in the blood, lymph and within certain
'thymus dependant' compartments in the spleen and lymph nodes (Leuchars
et al., 1966} Davies et al., 1966} Raff, 1970). Neonatal thymectomy, as
might be predicted, has been shown to deplete this population of cells but
leave bone marrow derived cells functional (Parrott at al., 1966). These
two populations of cells, different with regard to origin, also seem to
differ in their life span and their involvement in immune responses.
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d. The life span of lymphocytes.
The existence of two populations of lymphocytes, differing in their
life span was first suggested by Ottensen (1954)* He found a biphasic
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fall off in the numbers of P-labelled circulating lymphocytes over an
extended period of time following injections of the label into humans.
Everett and others have extended this concept in the rat. Studying the
uptake of radioactive markers and their disappearance in small lymphocyte
populations taken from different tissues, the concept of at least two sub-
populations with differing half lives was firmly established (Little et al.,
1962} Caffrey et al., 1962} Everett et al., 1964» 1964a} Everett and Tyler,
1967). Despite the problems of radiation damage and label reutilisation
brought about by the often necessarily long label infusion time (see
Robinson et al., 19^5) it became generally confirmed that the ratio of
long- to short-lived lymphocytes was greater in the thoracic duct lymph
than in the mesenteric node and in the spleen, with thymus and bone marrow
containing but few of the long-lived variety. This rank order also parall¬
els the ability of these populations to give a graft-versus-host reaction.
e. Recirculation of lymphoid cells.
A satisfactory explanation for the varying ratios of short- to long-
lived lymphocytes in different tissues has been derived in part from studies
on the recirculation of lymphocytes (Gowans, 1959? Cowans and Knight, 1964)*
Thoracic duct small lymphocytes, labelled in vitro with ^H-adenosine and
injected into rats, were found to whow a predilection for the mid- to deep-
cortex of the lymph nodes and Peyers patches, and for the splenic white
pulp. The passage of such cells, with no or little evident mitosis,
through the post-capillary venules of the lymph node into the lymph occured
within 2-4 hours after injection.
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Transport of recirculating cells through the spleen has also heen
ai^-
described (Ford, 1969? Ford-^ 1966; Goldschneider and McGregor, 1968;
Gowans and Knight, 1964). At present, autoradiographic studies suggest
passage of cells from the marginal zone to the periarteriolar sheath via
the endothelial cells of the sinus wall. The pathway from the white pulp
to the blood is as yet uncertain.
Other pathways of lymphocyte travel are less well known although
it seems likely that the peripheral lymph is contributed to by cells which
drift through the connective tissues. The composition of the blood 13
also a reflection of cell types other than those derived from the thoracic
duct (Yoffey, 1964).
The recirculating lymphocyte population appears to a large extent to
be identical to the thymus-derived, long-lived population already described.
Such a concept can be supported by the evidence that thymocytes, macrophages,
large lymphocytes, bone marrow cells, Kupffer cells and generally cells with
a 3hort life span are not found,to any great extent,capable of recirculating
through the transport areas of the lymph nodes and spleen, areas which
correspond closely to the thymus-dependent areas already mentioned on p.18
(Goldschneider and McGregor, 1968). Furthermore, neonatal thymectomy leads
to a depletion of the transport areas, a decrease in thoracic duct output
and a loss of the long-lived lymphocytes, a situation which will be shown
to be mimiced by other treatments.
At present it is not known to what extent the life span and behaviour
of lymphocytes are linked to their origin. Neither is it known whether
the phenomena described in the last two paragraphs are applicable to species
other than rodents in which the majority of the experiments were performed.
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f. Funotional and cooperative aspects of lymphocyte subpopulatlons.
Clarification of the roles of subpopulations of lymphocytes has been
achieved, at least in part, by work on thymectomised and bursectomised
animals and on states of congenital thymic aplasia and agammaglobulinemia.
Cellular and certain humoral immune responses appear to be under the
influence of the thymus ami to require its intact functional presence.
In a similar manner, treatments which mimic neonatal thymectomy e.g.
antilymphocytic serum treatment or thoracic duct drainage (Shellam, 1969a;
Turk and Willoughby, 1967), leading to depression of the recirculating
lymphocyte pool and depletion of the transport areas of the spleen and
lymph nodes, also seem to depress cellular and certain humoral immune
responses (Lance and Batchelor, 1968; Miller and Osoba, 1967)* The
restocking of thyinus-dependent areas following such treatments appears to
be a slow process dependant upon the presence of an intact thymus, but full
responsiveness can be rapidly restored by the adoptive transfer of thymo¬
cytes (Martin and Miller, 1968).
It is unclear why certain immune responses appear to depend upon
thymus-derived lymphocytes while others do not, but it has been further
accentuated by studies initiated by Claman (1J66) on immune reconstitution
of unresponsive mice with various lymphoid populations.
Kennedy et al. (1965) and others found that the anti-SRBC response is
not restored by the injection of thymocytes into lethally X-irradiated
mice, although this was possible in neonatally thymectomised animals
(Miller and Mitchell, 1968). However, when syngeneic bone marrow cells
were injected along with thymus cells into the X-irradiated hosts, the
response could be restored and, furthermore, the two populations acted
synergistically. The ensuing haemolysin response to sheep red blood cells
was rapid and often higher than the sum of the responses when either
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population was used alone (Claman et al., 1966} Mitchell and Miller,
1968). A. similar synergistic cooperation has been described between
thymus and spleen cells for the response to bovine serum albumin in an
•inert' thymectomised-irradiated host (Taylor, 1969), between thymus and
spleen in the anti-SRBC system (Claman et^ al., 1966a) and between bone
marrow and spleen (Radovitch et al>, 1968) using the same antigen.
In experiments showing cooperation between formative tissue cells,
the bulk of evidence suggests that a humoral response, at least in the
context of the cell transfer system, is dependent upon the presence of
the bone marrow cells for the provision of the precursors of the antibody
forming cells. The direct plaque-forming cells against sheep red blood
cells were of this origin (Mitchell and Miller, 1968a) and the experiments
of Taylor et al. (1966) suggest that Ig^a *s a*so produced by marrow
cells in reconstituted animals.
The specificity of the thymus cells responses in these experiments
is as yet uncertain. Taylor (1969) has shown that thymus cells taken
from animals previously injected with soluble BSA, are unable to synergist
effectively with bone marrow cells in reconstitutlon experiments. The
suggestion that the thymus cells had become tolerant was weakened by the
finding that the synergistic response to human serum albumin was also
affected. Although thymus cells are not generally thought of as antibody
forming and releasing cells, rabbit thymus cells transplanted across an
allotypic barrier into a newborn animal can, in certain instances, lead
to appearance of globulins of the donor expression in the serum of the
recipient (Chou et al., 1967)#
In graft-veraus-host reactions the specific antigen sensitive cells
appear to be purely thymus-dependant. X-irradiated recipients receiving
thymus and bone marrow cells together produce a splenomegaly which in
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part is th® result of synergistic action between the two populations.
However the bone marrow seems to play essentially a non-immunologic
proliferative role (Hilgard, 1970)•
Cooperation between thymus-depsndent and non-thymus-dependent lympho¬
cytes has been taken as an explanation for puzzling results obtained in
hapten-carrier systems. Under given experimental conditions, anti-hapten
secondary responses can often be shown to be best elicited if the host
is primed both against the hapten and the carrier (Ovary and Benacerraf,
1963). Both cell populations are required to be normally responsive
('Banl et jil.» 1970). Within the confines of a one cell - one antibody
hypothesis such a result could be accommodated only by the cooperation of
two discrete cell populations or their products of stimulation. It has
been suggested that the carrier specificity resides in the thymus-derived
cells (Rajewsky et al.t 19*>9) although direct evidence is lacking.
The induction of an anti- SRBC response in vitro in spleen cells taken
from at least certain strains of sice, has been shown to require at least
e
three distinct cell types which can be separated by velocity, centrifug-
ation, size, radiosensitivity and their ability to bind antigen (Haaklllet al..
1970? L'osier and Coppleson, 1968} Osoba, 1970). It has been repeatedly
suggested that one of these cell typ«3 may be a thyous-derived population
though direct evidence is lacking.
Further evidence for the interaction between cells within an existing
lymphoid organ comes from experiments involving transfer of spleen cells
to X-irradiated histooorapatible recipients or the growth of lymphoid cells
in diffusion chamber cultures. The relationship between the dose of
lymphoid cells (and hence antigen-sensitive cells) and the number of
antibody forming cells, has been shown to be linear over most dose ranges,
although when the lymphoid cells are limiting a parabolic relationship
has been demonstrated. A parabolic relationship is consistent with the
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interpretation that the number of antibody-forming cells produced is
dependant upon the interaction of two or more cells. The linear
relationship could represent a saturation effect (Groves et al.t 1969;
Celeda, 1967; Bosma et al., 1968). The cell types involved in these
responses are unfortunately unknown.
Such experiments support the implication derived from other indirect
sources that even in fully formed lymphoid tissues there are classes of
cells of varying functional involvement.
5. The composite immune response.
In recent years it has become clear that there are many different
ways, rather than one essential pathway, by which contact between antigen
and antigen sensitive cell may be established.
Marked diminution in the antibody response to certain antigens is
caused by procedures which selectively depress the thyous-derived cell
population. For example whilst the responses of mice to antigens such
as horse ferritin and pneumococcal polysaccharide appear to be independent
of such procedures (Humphrey et al., 1964; Fahey et al., 1965) the
response to bovine serum albumin is very thymus-dependant (Taylor, 1969)*
This distinction between antigens does not necessarily cross the species
barriers. A corollary to this distinction may be the dependance of
certain responses upon recirculation of cells through the lymphoid organs
(Hall and Morris, 1964; Taliaferro and Taliaferro 1956; Ford and Gowans,
1967; Ford, 1968).
Further distinctions between responses to different antigens lie
in their dependance upon interaction with macrophages, in differences in
physicochemlcal nature, in the amount of natural opsonins present and
other less well known variables.
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As a unifying concept Mitchison (1968b)suggested that the final
immune response is dependant upon the triggering of antigen-sensitive
lymphocytes which bear a receptor with affinity equal to or greater than
the molar concentration of the immunogen. To localise antigen,with
resulting stimulation of lymphocytes, may be the main effective role of
the processes just described. Under this theory there is no strict
requirement for cell interaction as an essential step in an immune
response but they may act as methods whereby the response can be amplified
or regulated. A similar action could be envisaged to occur via released
soluble factors.
It is inevitable from what has been said that each antigen, each
animal, each assay must be considered to exist within each experimental
system separately.
6. Immunological tolerance
The injection of antigen under certain circumstances, instead of
leading to an immune response, may lead to an antigen specific defect in
responsiveness. The lack of that particular response is usually judged
by challenge with the same antigen under conditions which favour its
immunogenicity. The terms tolerance, paralysis and specific unresponsive¬
ness have been used to cover these states, their usage depending on the
experimental design involved. Never the less, it has recently become
popular to oonsider these terms synonomous, implying common basic mechan¬
isms. In order that unjustified parallels are not drawn between the
different experimental models, they shall be differentiated from one another
in the introduction, although stress will be laid upon the induction of
unresponsiveness to heterologous serum protein in adult animals, a basic
concern of this thesis.
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I. Historical*
Ths phenomenon now known as acquired immunological tolerance was
known many years before the realisation of its bearing on fundamental
immunological mechanisms*
Wells and Osbourne (1911) and many others, in varying experimental
conditions, presented results dealing with the specific suppression of
an immune response by prior exposure to antigen (Olenny and Hopkins,
1924; Sulzberger, 1929? Traub, 1936? Pelton and Ottinger, 1942).
The concept achieved scientific respectability as a result of Owen's
(1945) study on dizygotic cattle twins. The majority of such twins are
synchorial. He demonstrated some of the twins to be permanent erythro¬
cyte chimaeras whose red cell populations were mixtures of two distinct
antigenic types. Apart from an animal's own erythrocytes, genetically
foreign circulating red cells could be demonstrated, often in a consid¬
erable proportion. The phenotype of these foreign cells was that of
the other twin* It was suggested that the mosaicism was due to in utero
exchange of primordial haematopoietic cells, which occured via placental
vascular anastomosis? the normal rejection processes being inoperative
(Owen, 1945)*
This suggestion was later confirmed by showing that pinch grafts
between dizygotic cattle displayed anomalous behaviour (Anderson et al.,
1951? Billingham et al., 1953). Only in a minority of instances were
the true genetic differences between the twins revealed? in the majority
of cases the grafts survived as though the animals were monozygotic.
TSven in those cases showing rejection the reaction was rather variable
and weak.
In 1949 Burnet and Fanner advanced their hypothesis of tolerance to
self. Their concept was that the immunological system becomes non-
reactive to antigens with which it comes into contact in embryonic life,
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the function of such a mechanism being to ensure nonresponsiveness to
self components. Although not dealing with examples where suppression
had been demonstrated in adult animals, it proved an excellent working
hypothesis for neonatal tolerance induction, capable of being tested by
the experimental introduction of antigens into animals in ovo or in utero.
II. Tolerance induction in the neonate.
a. Introduction.
Burnet's early attempts to support his hypothesis by the inoculation
of chick embryos with flu virus, bacteriophage and human red blood cells
met with little success (Burnet at ail., 1950)« No differences were
observed in haemagglutinin or inactivation titres when treated and control
chicken were challenged with the corresponding antigens at 5-8 weeks of
age.
Blllingham et al. (1953), using a system more analogous to Owen's
bovine twins experiment, did however demonstrate what they referred to as
"actively acquired tolerance." This was defined as the inability of an
animal to react immunologically against foreign homologous tissues if it
had been exposed to them during an early period of neonatal life. They
demonstrated facilitation of skin graft survival and inhibition of specific
antibody formation in mice and chicken injected jLn utero or ijn ovo with a
variety of foreign tissue cells. Injection of specifically primed spleen
cells led to a loss of the tolerated grafts. The phenomenon was thus
shown not to depend upon antigenic transformation of the graft, to be
antigen specific, and in addition the effect was demonstrated to be non-
heritable.
Outside the sphere of cellular isoantigens, Buxton (1954) reported
a decrease in antibody formation to Salmonella pullarum in chickens that
had previously been treated with the bacteria at 15 days of age. These
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experiments, however, were unconvincing due to the lack of appropriate
controls. Similar results were obtained by Kerr and Robertson (1954)
in calves receiving Trichomonas, although their conclusions are uncon¬
vincing due to small number of animals used. Other reports on experi¬
ments dealing with more complex and phylogenetically remote antigens were
et fll., /
on the whole negative. Bauer/(1956) and Owen (1957) both failed to
induce tolerance in rats to sheep red blood cells and Nossal's (1957)
attempts to make foetal mice tolerant to flu virus were unsuccessful.
Nossal in fact gave data suggesting priming of the mice.
b. Tolerance to protein antigens.
Hanan and Oyama (1954), however, did obtain results with protein
antigens that were interpreted by the authors as examples of immune
tolerance as predicted by Burnet. They injected 0.1 - 1.0 mg doses of
alum-precipitated bovine serum albumin three times weekly, intraperiton-
eally, into newborn rabbits. The antigen was administered in this fashion
for the first month of the experimental animals* life. After that they
received intravenous injections for 114 or 186 days. When challenged
with immunogenic doses of BSA and egg albumin the animals failed to produce
anti-B3A precipitins and anti-B3A sensitizing antibodies for the passive
anaphylaxis test or Arthus reaction. Littermate controls, which received
the challenge routine only, responded positively. While most tolerant
animals showed antibody responses to egg albumin the response was dimin¬
ished in comparison to controls.
It has since been adequately documented that heterologous serum
proteins can readily induce this form of unresponsiveness (see review by
Smith, 1961). The majority of experiments have, for practical reasons,
been done in rabbits although other species have proved equally amenable.
The parameters involved in tolerance induction have been extensively
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surveyed and include ontogenic age of animals, dose of an antigen and
the immunisation schedule (Smith, 1961). The duration of the tolerant
state was found to correlate positively with the dosage when a single
injection was employed and the state could be prolonged by further doses
of relatively small amounts. Doses greater than 0.2 mg/dav of bovine
3erum albumin over the first five days of a rabbits life were found to
establish unresponsiveness (Dubert and Paraf, 1957) whereas as little as
10^/ug can significantly prolong the state (Smith and Bridges, 1958)*
In spite of the success of these experiments, difficulties have
still been encountered with more complex antigens. Smith and Bridges
(1958) found no evidence of tolerance to a variety of bacterial antigens
and Oowland (1965) failed to demonstrate neonatal tolerance to Pseudomonas
in rabbits injected when 1-7 days old.
c. Tolerance to self-replicating antigens.
It has, however, been suggested that where a virus is transmitted via
the egg, tolerance may be induced. Rubin et al.t (1962) studying avian
leukaemia virus, and Traub (193651939) examining the spread of lympho-
chorio-meningitis endemic in a small stock of mice, both suggested that
if infection takes place jLn ovo or in utero, then the disease often took
hold. If the infection took place shortly after birth the animals often
became resistant. Larson (1969) showed it possible to induce tolerance
to lympho-chorio-meningitis virus by experimentally infecting neonatal
mice within the first 18 hours of life. When the infection treatment
was postponed until 2-9 days after birth the outcome varied between
complete tolerance and antibody formation with low viraemia. Solomon
(1968) produced a state of partial tolerance to Salmonella g^llinarum in
1-7 day old chickens as measured by agglutination test. In addition,he
demonstrated that small numbers of virulent bacteria could be as effective
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as large numbers of avirulent ones in inducing tolerance.
It seems possible that the ease with which tolerance could be
induced in the experiments described above could be a result of the self-
replicating nature of the antigens used. Differences between antigens
in their tolerogenicity may possibly be due to differences in the
"effective dose" of antigen or differences in their handling. A further
complication is, however, that although neonates appear to be relatively
poor antibody producers, they are not absolutely incompetent.
d. Immunity and tolerance in neonates.
Nossal (1959) found that foetal rats exposed to sublethal pulmonary
infection with flu virus or intraperitoneal presentation of high titre
flu vaccines gave evidence of immunisation. Silverstein _et _al. (1963)
showed foetal sheep capable of responding to bacteriophage, ferritin and
ovalbumin after 10 days of a 150 day gestation period. Similarly, there
is evidence that newborn mice can give an immune response to allogeneic
cells when these are given in doses lower than that required for tolerance
induction (Howard and Vichie, 1969).
The dose dependence curve of the immunological reaction for neonatal
Wistar rats injected with Salmonella adelaide flagellin was described in
detail by Shellam and Rossal (1968) and is of interest. Two zones of
—7
tolerance were induced by injections in the region of 10 ^ig /g body
weight/day and 10 /ug/g body weight/day. 7'ithin this range a zone of
/
immunity was detected. Shellam (1969) also showed that <10 * pg/g
body weight/day for two weeks and 1 /ug-100rag both led to tolerance
induction to polymerised flagellin, whereas dose3 of 10pg-lyug under the
same injection regime led to immunity. Throughout these studies partial
tolerance only was demonstrated. Quantitative comparison was performed
by the bacterial immobilisation test and although no antibody was produced
by the neonates, they could be primed.
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e. Mechanisms of neonatal tolerance.
In spite of the difficulties encountered in attempts to induce
tolerance to certain antigens, and in spite of the early ontogenic
maturation of responsiveness to certain antigens, it is nevertheless
fair to conclude that tolerance may be more readily induced in neonates
than in adult animals.
Freund (1930) first suggested that the ease of neonatal tolerance
induction may be due to the relative lack of responsiveness of young
animals. Mitchison (1968) found no systemic difference between neonates
and adults in the dose of antigen required to produce tolerance to bovine
serum albumin and lysozyme, provided that the antigen was administered to
both under non-immunizing conditions. Such experiments led Dresser and
Mitchison (19^8) to the conclusion that the lack of an immune response in
young animals, due to deficiencies of the immunologically competent cells,
could account for differences between neonates and adults with regard to
tolerance induction.
Other workers have suggested that defects in the immune function of
reticuloendothelial cells may account, at least in part, for the ease of
tolerance induction in neonates (Mitchell and Nossal, 1966). Newborn
animals tend to lack well organised phagocytic structures and although
phagocytosis may occur, there still appear to be a deficiency in the
processing and localisation of antigen (Reade, 19685 Williams and Nossal,
1966).
It is appealing to think that the lack of an immune response of the
neonates to certain antigens may allow the display of or even facilitate
tolerance induction. There is evidence for a similar situation in the
adult; a parallel that has been taken to argue in favour of a common basic
mechanism for tolerance induction.
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III. Tolerance in mature animals.
a. Historical.
Adult animals were first shown to display immune negativity with
symptoms resembling those found in neonatal tolerance by Glenny and
Hopkins in 1924. Studying the rate of elimination of horse anti-
diphteria toxoid serum from rabbits, they showed in two animals previously
exposed to 18 or 21 ml of normal or antitoxic serum, a delay in the rapid
phase of immune elimination. They suggested that the outcome might be
dependent upon the ratio of antigen to antibody either present or produced,
but did not rule out the possibility that "excessive stimulation might
have crippled the antibody response."
Pelton and Ottinger (1942) and Felton (1949) displayed the phenomenon
they called paralysis which again had features resembling neonatal toler¬
ance. They injected 0.005 - 0.5 mg of pneumococcal polysaccharide or
whole pneumococci into adult white mice. In most instances a specific
failure to respond to a normally immunogenic dose of 0.005 mg was reported.
The polysaccharide persisted in the tissues for at least 52 weeks.
Differences in the nature of antigens, easily degradable or persist¬
ing, led to distinctions being drawn between paralysis and specifically
induced unresponsiveness, in particular to natural protein antigens. At
present it is advisable to consider this distinction to be of relevance
to at least the kinetics if not the mechanism of tolerance induction.
b. Specific unresponsiveness to protein antigens.
Although Glenny and Hopkins (I924) described the induction of an
unresponsive state to serum proteins, it was not until 1955 that their
original observations derived support. Dixon and Kaurer (1955 5 1955®)
injected rabbits for 37 days with 500mg/kg body weight/day of whole human
plasma or purified bovine serum albumin. The animals were unable to
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give immune elimination of the predominant antigens when challenged
later. Trace amounts of antibody could, however, be detected against
certain minor components of human plasma. It is of additional interest
that in spite of the large dosage, the animals recovered responsiveness
within six months.
Subsequent examples of selective unresponsiveness induced by large
doses of protein antigens are numerous (see reviews by Smith, I96I5
Dresser and Uitchison, 1968). Impetus for studies of this kind came
from the work of Dresser in providing an easily reproducible model system
amenable to manipulation. High speed ultra-centrifugation (Dresser,
1962a'1 and in vivo screening (Dresser, 1963) of bovine gamma globulin was
found to remove its ability to elicit an antibody response if given to
mice in soluble form. Such material «as also found to readily induce
tolerance, the alteration being the removal of a minor but powerful anti¬
genic fraction that Dresser presumed to be IgA.
Using this system in CBA mice, Dresser (l962a)demonstrated that
relatively low single doses of antigen, i.e. 5^ - 200/ug, were capable
of giving rise to an unresponsive state. The animals were unable to
respond by immune clearance to challenge with BOO in Freund*s complete
adjuvant. Ultracentrifuged human gamma globulin was found to be effective
in C57B1/6 mice over a wide dose range of 0.05 - 10 mg (Dietrich and Daigle,
1964). With bovine serum albumin, however, these workers found that
"complete tolerance could be induced only in a small proportion of animals.
The degree of tolerance was not clearly related to the do3e of BSA."
-3 2
Close examination of the data over the dose range 10 to 10 mg does,
howrever, reveal a tendency towards partial unresponsiveness at the extremes
of antigen dosage.
In this and other test systems, 3mall doses as well as high doses of
certain antigens have been described as giving rise to an unresponsive
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state} additional variables are the number of injections, the form of
the antigens, the route of application and the species and strain of
animals used.
Mitchison showed that BSA was capable of displaying two zones of
tolerance separated by a zone of immunity (Mitchison, 1964). In his
model experiments for investigating the relationship between immunity
and unresponsiveness he used adult CBA mice. Employing multiple
injections of BSA and varying the dosage and the time, the response of
treated animals and controls to challenge was measured and fitted to a
double cubic surface. Pour zones of dosage in time could be distin¬
guished. More than 1 rag of BSA three times weekly led, after initial
immunisation, to an unresponsive state; 0.04 - 1.0 tag led to immunis¬
ation; 1.0 - 10.0 rag also led to tolerance; less than 0.1 rag had no
effect.
Further verification of the two dosage effect was later provided and
attempts at similar experiments were performed using lysozyme, ovalbumin
and diphteria toxoid (Mitchison, 1968). While none of these antigens
gave the low zone phenomenon, lysozyme displayed a tendency to produce
unresponsiveness when given in the high dose ( > 100yug three times
weekly). Such dose dependant responses may be compared to those derived
for the response of neonates to flagellar antigens (Shellam and Nossal,
1968; Shellam, 1969).
The type of antigen used is of relevance in considering the kinetics
of induction of the unresponsive state. Serum albumins and gamma
globulins have been extensively used. These are found to be poor anti¬
gens in the majority of species, and techniques which reduce their
immunogenic!ty tend to allow their tolerance inducing capacities to be
observed. Ultracentrifugation and in vivo screening of bovine gamma
globulin has already been mentioned. These techniques have also been
exploited for the study of the responses of rabbits to BSA. It was
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found that the injection of large doses of BSA into rabbits, followed
by removal of their serum and injection of this BSA-containing semra
into other rabbits, made tolerance induction in the latter more feas¬
ible. This was attributed to the removal of aggregated BSA by the
reticulo-endothelial system of the 'filter' animals. BSA was found
to give two main peaks on Sephadex G150 filtration. The first peak
was presumed to be a diaer and was immunogenic while the second, pre¬
sumably the monomer, readily induced unresponsiveness. Unfortunately
no details were given of further biochemical characterisation of the
antigens or their contaminants (Frei et al., 1965; Prei, 196? ),
Injection of bovine gamma globulin into the mesenteric vein of
guinea-pigs has also been used as a method of selecting for a tolero¬
genic population of molecules. It wa3 found that 5» 50 and
injected by this route regularly inhibited the normal delayed hyper-
circulating antibody response was also diminished (Battisto and Miller,
Other procedures that reduce the immune response to antigen, tend
to facilitate tolerance induction. Thoracic duct drainage prior to
antigenic stimulus had this effect in rats as did pretreatment with anti-
lymphocytic serum in rats and mice (Shellam, 1969 a). Following thoracic
drainage only a slight non-significant depression in primary response
to an optimally immunogenic dose of flagellin or polymerised flagellin
was noted. However, with both treatments, the response to 100yUg/g
body weight given three times weekly for ten weeks, was suppressed.
Unresponsiveness was demonstrated by the lack of response to a booster
of 10yUg polymerised flagellin two weeks after the last injection. Both
treatments thus lowered thethreshold for high zone tolerance induction.
Results obtained in the low zone regions were equivocal due to inherent
variation in the random bred Wistar rats.
sensitivity injected into a foot pad. The
1962)
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IV. The mechanism of tolerance Induction.
a. The cells involved.
In 1956 Billingham et al. postulated three possible routes leading
to specific unresponsiveness. "Central" failure of reactivity could
lead to a defect in the restricted line of normally responsive cells)
"afferent" interference could affect the access of antigen to the cells)
"efferent" interference could be brought about by antibody already
produced.
♦Central' failure of the immune response has been repeatedly
suggested as the most common cause of the phenomena described above.
This conclusion has been drawn mainly from adoptive transfer studies.
Cells transferred from normal to tolerant animals have often been shown
to be capable of an antibody response to the antigen previously used to
paralyse the recipients (Mtchison, 1962a; Penman et al., 196?) but see
McCullagh, 1970). Thoracic duct cells from donors made tolerant to
sheep red blood cells by cyclophosphamide treatment were shown to be
specifically incapable of restoring the response in neonatally thymecto-
mised hosts (Miller and Mitchell, 1968). Forbes (1969) added normal
macrophages to lymphoid cells from mice tolerant to sheep red blood
cells and found no i_n vitro antibody formation.
Further evidence has been derived from studies of the recovery of
animals from tolerance as follows.
b. Recovery of adults from an unresponsive state.
Early studies on the persistence of unresponsive states held
suggestions that the phenomenon might be a stable condition. Such
inferences, however, came from studies upon tolerance induction in
neonates using pneumococcal polysaccharide
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tation antigens (Bllllngham et al., 1956). Studies using antigens
which are more susceptible to degradation, suggest that recovery
usually takes place over a period of a few months.
Smith (1961) argued that recovery occurs when the antigen
disappears from the circulation. Such a conclusion was derived from
the finding that continuous repeated injections of small doses of
antigen could prolong the state seemingly indefinitely. Such a
hypothesis is however no longer tenable in view of the findings of
Humphrey (1964a) and others (Mitchison, 1965 J Dixon and Weigle, 1963).
These authors all found that tolerance persisted for at least a short
time after antigen could be reasonably presumed to have disappeared
from the animal. These experiments tend to support the concept that,
rather than maintaining cells in their unresponsive state, further
antigen injections in fact operate upon new maturing cells.
More support for this hypothesis comes from the finding that the
duration of the unresponsive state increases markedly with the age of
the animal (Mitchison, 1965). The influence of thymectomy upon the
duration of tolerance also argues for the recovery of responsiveness
as being due to the appearance of a new ♦virgin' population of lympho¬
cytes.
When mice are made neonatally tolerant to bovine serum albumin,
their recovery can be slowed by adult thymectomy (Taylor, 1964*
Pierpaoli, 1967)* The response that does occur, has been ascribed to
a reaction of marrow-derived cells, acting without the cooperation of
thymus-derived cells (Taylor, 1969). Further evidence for a defect
induced in the thyraus-derived cell population during tolerance to
serum proteins comes from Isakovic et al. (1965). Thymus grafts from
animals tolerant to bovine gamma globulin were found to be specifically
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incapable of restoring responsiveness in thymectomised and irradiated
recipients. In addition, one of the best methods of producing a
profound tolerant state to either normal or heated bovine gamma
globulin is to inject the antigens into the thymuses of irradiated
rats (Staples et al., 1966; Horiuchi and Waksman, 1968). In a coop¬
erative system of bone marrow and thymus cells Taylor (19^9) showed
that irradiated (900r) and reconstituted mice had a depressed ability
to respond if either of the two reconstituting populations were derived
from donors given 10 rag of bovine serum albumin one day prior to transfer.
The phenomenon was especially striking when thymus cells were from the
injected donor.
Although it seems likely that thyraus-derived cells can become
tolerant with a resulting lack of responsiveness in the whole animal,
tolerance of the bone marrow-derived cell3 also may occur. •Thyinus-
independent' antigens can induce tolerance, and inability of normal
thymocytes to break tolerance to 3heep red blood cells has been reported
(Penman et al.« 1967)* although the thymic inoculum was unfortunately
not shown to be active in non-tolerant animals. The recovery from
tolerance in the bone marrow-derived population might be expected to be
relatively rapid in the absence of antigen, but at present there is
little evidence available to support the idea that the duration of the
tolerant state might depend upon the particular cell population involved.
c. Antigens and tolerance.
The ease with which certain serum proteins and cellular isoantigens
induce tolerance in both neonatal and adult animals is striking. The
reasons for this may be multiple.
It has been suggested that the final immune response of an animal
may depend upon the differences between autologous structures and the
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antigen. Presumably where the antigen has many determinants in cooxnon
with host components, or where there are structural similarities between
corresponding epitopes, the response may be weak. As already mentioned
tolerance is easier to induce to 'weak' antigens (Dresser and Kitchison,
19685 Gowland, 1965)* Partial support for this concept comes from a
finding that smaller amounts of serum or gamma globulins were nedded to
induce tolerance in the chicken when turkey antigens were used rather
than the phylogenetically more remote goose (Tempdis, 1964). Similarly
mice become more readily tolerant to rat serum albumin than to guinea-
pig, chicken or bovine albumin, as judged by immune elimination of the
antigens (Dietrich, 1968).
A further reason why certain antigens appear to produce tolerance
readily may lie in those physico-ohemical characteristics of the antigen
that allow diffusion through the body. The kinetics of tolerance
induction tend to favour a hypothesis involving direct interaction of
antigen with the lymphooyte. The best evidence for this comes from
yitchison (1968a). Although many reports suggested that toleranoe
induction within lymphoid organs may take several days ('.Veigle and Gfolub
1967), Mitchison showed by adoptive transfer that non-responsiveness
of the peripheral white blood cell pool could occur within two hours,
although the problems of redistribution of 'responsive' cells following
antigen injection were not explored. The lack of an immune response
due to the lack of phagocytosis of antigen with resulting tolerance
induction has already been discussed (see Frei et al., 1968 ).
The relationship between the number, spatial distribution and the
siae of antigenic determinants as regards binding to, and perhaps
perturbation of, the membrane of the antigen-sensitive cell is a
relatively unknown factor in tolerance induction as, indeed, it is in
antibody formation. As in antibody formation, monovalent antigens
40
380S to be incapable of tolerance induction, suggesting that tolerance
induction is an active process with similar thermodynamic requirements
to antibody formation. This aspect of tolerance induction will be
discussed later.
d. The relation between tolerance and immunisation.
The relationship between specific unresponsiveness and responsive¬
ness has often been said to hold the key to the problem of the mechanism
of tolerance induction.
Mitchison (1964$ 1968) demonstrated that mice receiving an extended
course of multiple injections of high doses of BSA or lysozyme went
through an initial phase of immunisation before passing to an unrespon¬
sive state. It seemed that no matter how high the dose above a high
zone tolerancetlreshoId, the initial steps were those of immunisation.
There have been many reports that it is possible to render animals
primed to a certain antigen,tolerant to it by further injection of large
doses of that antigen (Dresser, 1965). It has been argued that such
experiments do not differ essentially from the induction of high zone
tolerance (Dresser and Mitchison, 1968} Mitchison, 1968). The differ¬
ence between high and low zone tolerance may, in a similar manner, be
considered functional rather than fundamental, the high doses of antigen
being required to combat that antigen 'lost* by binding to antibody.
It was demonstrated that concomitant immunisation occurs even in the
presence of vast antigen excess (Day and Farr, 1966). Rabbits receiving
500 mg BSA daily were found capable of antibody production which could
be detected only after fractionation of the serum to detect non-absorbed
anti-BSA antibodies. Such an exercise displays the difficulties in
demonstrating true inhibition in the high zone as compared to "mopping up"
of antibodies by excess antigen. This would be especially true in
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experiments where in vivo techniques e.g. antigen clearance are used
as measures of immune reactivity.
It is an attractive proposition that the requirements for tolerance
induction are similar to those for Immunisation. It is of some interest
that the only reports of tolerance induced jLn vitro (to thymus dependent
antigens) were done under conditions where a primary immune response
can also be induced (Deiner and Armstrong, 1967I Armstrong et al., 1969 j
Scott and Waksaan, 1969). Similarly D aminoacid polymers which are
nonimmunogenic, are also incapable of producing tolerance although they
can combine with antibodies produced against L aminoacid polymers
(Collottiand Leskowitz, 19*>9)»
Supra-optimal stimulation of an animal with many antigens may result
in a sub-optimal response. The relationship of this phenomenon to
classical tolerance is not known. It has been suggested that when the
dose is above the optimal there may be restricted proliferation with
ensuing exhaustive differentiation (sterzl, 1967)« The hypothesis,
that the response of antigen-sensitive cells may depend upon the dose
and type of antigen, receives some support from the experiments of Byers
and Sercarz (1970)• There was a delay in the in vitro antibody response
of rabbit lymph node fragmentsto BSA when the cells were cultured in the
presence of the antigen for three days instead of two hours. There was
also a delay in the wave of proliferation of antibody-forming cells
precursors. This is similar to the dose - response relationship found
in the in vitro transformation of primed cells by antigen. In vivo,
large doses of antigen were also shown to prolong the initial lag phase
before antibody production (Modabbsrand Sercarz, 1970). While the
relation of these phenomena to tolerance is uncertain, they suggest the
need to consider tolerance as possibly involving differentiation and
proliferation of antigen-sensitive cells regulated by antigen in a
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manner not conducive to the production of large quantity of antibody
over a long time period.
Such hypotheses suggest a reversibility of paralysis at the cellular
level. There is some 3cant evidence to support this idea. Thoracic
duct cells from normal, or tolerant, allogeneic animals can induce a
high haemolysin response in host rats tolerant to sheep red blood cells*
The response is brought about by host cells (McCullagh, 1970)• An
alternative explanation, however, in this case could be that a small
newly generated population undergoes rapid multiplication.
It is obvious that the relationship between tolerance and immunis¬
ation requires further examination at the cellular level in order that
the factors involved in immunogenesis be fully understood.
V, Factors influencing tolerance and immunity.
The number of parameters that may be involved in dictating the end
result of an animal's response to an antigen, appear limitless. The
size of the problem may be judged by the problem of "the animal that ruins
the statistics."
The influence of psychosocial factors upon various immune responses
has been studied in length. Unfortunately, although such factors aB
•shock', handling, 'crowding' of animals etc. have been shown to have an
influence, the outcome of such manipulations is not easily predictable,
being dependant upon the type of manipulation used, the stage of the
animals* life when it occurs, the dosage and intensity of the insult, the
phenomenon under investigation and the means by which it is studied (see
Friedman et al., 1969)* The difficulties inherent in 3uch studies mean
that little basic knowledge is available on the effects of psychosocial
factors although their existence is of extreme importance in experimental
design.
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There are, however, numerous factors which have been shown to have
a reasonably predictable effect upon immune responses. Certain factors
which tend to have an inhibitory effect have been mentioned in passing.
It is of more relevance to this particular thesis to examine in more
detail factors that enhance immune responses, in particular the non¬
specific influence of bacteria and bacterial products upon antibody
production.
7. Non-specific stimulators of antibody formation.
a. Introduction.
An enormous list of substances is now available whose administration
enhances the recipient's ability to respond to a non cross-reacting
antigenic challenge (see White, 19^3? Munoz, 1964? Herbert, 1964). The
spectrum of substances, defined as adjuvants, is so great as to take the
majority outside the scope of this thesis. In justification, it is
sufficient to point to the wide range of physical characteristics attrib¬
utable to these substances, their varying effects, and the likelihood that
more than one mechanism of action is involved, possibly even where only a
single substance is being investigated. Extrapolation between adjuvants
with regard to their mechanisms of action, is also complicated by the
finding that the effects noted are often dependant upon the variables
involved in each particular experimental system.
For these reasons, special attention shall be reserved for those
bacteria or bacterial products that act as adjuvants, and of these only
the Corynebacteriaceae shall be considered in detail.
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b. Historical.
Since the turn of the century, many physicians have remarked upon
the apparent correlation between the presence of certain bacterial
infections and an enhanced resistance of their patients to other non-
related infectious agents and to neoplasms (see Fowler, 19^9)* The
recent interest in non-specific immunotherapy for the treatment of
patients with leukemia (Mathe, 1969? Hathe et al., 1969) is derived from
these observations and receives considerable support from animal experi¬
ments.
Lewis and Loomis (1924) were among the first workers to suggest on
the basis of experimental evidence that bacteria could non-specifically
enhance the immune response to an antigen. The injection of sheep red
blood cells into tuberculous leisons of guinea-pigs resulted in a supra-
normal agglutinin tltre. This work was later extended to antigens such
as egg white, and horse serum with similar results (Dienes, 1927? 1936).
Freund began his classic experiments bearing in mind the above
mentioned observations and the reports that petroleum jelly with lanolin
(Le Moignic and Pinoy,1916,19l6a),paraffin (Coulaude, 1935) and vaseline oil
(Saenz, 1935? 1937) were all able to elevate antibody and/or hypersens¬
itivity responses. Freund's studies on the delayed hypersensitivity to
tuberculin using killed tubercle bacilli and on the adjuvant effect of
water-in-oil emulsions containing these bacilli, laid the basis for the
most common experimental adjuvants in use to-day (see Freund, 1956).
Although administration of a mixture of an aqueous antigen solution with
light mineral oil and emulsifier leads to an enhanced immune response,
the addition of killed mycobacteria not only further increases the anti¬
body and sensitisation responses but also in some way changes the
characteristics of sensitisation away from an immediate type of response
to a delayed one.
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A wide variety of bacteria and their products have been shown
capable of adjuvant action either on their own or as substitutes for
mycobacteria in Preund's complete adjuvant.
Various gram-negative bacilli possess activity on their own which
is believed to be associated with their endotoxin content (Stuart and
Windel, 1951* Johnson at al., 1956)# Khanolkar (1924) showed that
Escherichia colit Salmonella paratyphi B and pyocaneus bacillus (Pseudo-
monas pyocyanaa /aeruginosa/) enhance antibody formation against
Oaemtner's bacillus (S.enterltidis). Since then Bacillus abortus,
Haemophilus influenzae. H.pertussis and certain Salmonella, Shigella and
Serratla have also been shown capable of enhancing responses to a variety
of immunological challenges (see ?&moz, 1964),
Gram-po3itive cocci wore first shown to enhance agglutinin formation
to S.typhosa when given simultaneously to human volunteers (Clark et al.,
1922). Ramon (1925) demonstrated that horses developing abscesses at
the injection site of diphtheria toxoid developed higher anti-toxin titree
upon hyperimmunisation than those without them. The same result could
be obtained by experimental infection of the injection site with
Streptococci and Staphylococci.
Gram-positive bacilli, in particular Listeria and Corynebacterla,
which will be dealt separately, have also been shown, under certain
conditions, to possess adjuvant activity.
c. Postulated mechanisms of adjuvant action.
The postulated mechanisms suggested for adjuvant action are numerous.
As it is impossible to cover all of these in detail, only a few of the
more commonly suggested mechanisms will be dealt with in relation to the
adjuvant concerned. A few basic points, however, should be borne in mind.
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The parameters involved in the study of adjuvant action are super¬
ficially similar} at least in number, to those dictating a normal immune
response. The dose and the type of antigen and adjuvant as well as the
route and 'timetable' of their injections have been shown to be important
(Weigle, I960; Shaw et al., 1962; Farthing and Holt, 1962; Lipton and
Freund, 1933). The sex, age and nutritional status of animals are
possible variables (Miles and Pirie, 1939} Axelrod and Pruzansky, 1955)»
as well as the species (Rice, 1947) and strain of animals used (Lewis
and Loomis, 1925; Schneider, 1959)• The mode of action of adjuvant is
hence difficult to determine except, perhaps, within the operating
experimental conditions. However, there seem to be two, mutually non
exclusive, mechanisms by which adjuvants may be distinguished in accordance
with their main effects.
The first involves the protection of antigen by adjuvant and its
slow release. This view was first presented by Glenny et al. (1926; 193l)
in their studies on alum-absorbed toxoids and was also later taken to
incorporate the 'depot* action of Freund's adjuvant (Freund, 1956; White
et al., 1955,1955a ).
The second mechanism includes the more physiological rather than
physical effects of adjuvants as first described by Ramon (19^5) (Vide
infra). Since then many inorganic and organic substances, often not
chemically related, have been shown to possess adjuvant activity that
is associated with the appearance of local reactions, with cell destruct¬
ion, cell proliferation and often granuloma formation. The relationship
of these phenomena to the stimulation of antibody forming cells within
lymphoid organs and also within the granulomatous site has been discussed
in detail (White et al., 1955,1955a ).
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The stimulatory and/or toxic effect of certain bacteria or bacterial
products upon cells has been suggested as a possible common pathway of
their adjuvant action. Hepatosplenoaegaly and/or increased reticulo¬
endothelial activity has often been taken as a means of screening for
%
adjuvant materials based upon this concept.
Besides increasing reticuloendothelial activity, endotoxin may
alter vascular permeability (Condie _et al., 1955)* Endotoxin also affects
liver lysosomes causing release of ^-glucuronidase and cathepsin (Weissman
and Thomas, 1962). lysosomes from rabbits made tolerant to endotoxin or
given hydrocortisone did not show this effect. These treatments also
affect the ability of endotoxin to act as an adjuvant (Golub and Weigle,
1967). A further explanation for the action of endotoxin as an adjuvant
related the action of Salmonella typhosa lipopolysaccharide to the 'stress
symptoms' which it produced in rabbits. The responses of mice and guinea-
pigs, which were fairly resistant to the endotoxin, were little affected
by its adjuvant action (Kind and Johnson , 1959)•
One of the most important practical and theoretical points to be
considered when dealing with those adjuvants that do not have the antigen
incorporated, is the timing of their administration with respect to that
of the antigen. This was highlighted for endotoxin (Kind and Johnson,
1959f Taliaferro and Taliaferro, 1954). The adjuvant was found active
only if given within a critical time period, at or around the time of
antigen administration. This led to a suggestion that adjuvants act
upon the early period of the immunisation, cutting down the induction
time of antibody production. This would be consistent with the ability
of many adjuvants to affect only the primary immune response to an antigen.
A further mechanism of adjuvant action postulated for B.pertussis,
is based upon its well documented effects of leucocytosis and lymphocytosis
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in mice (Mora#, 19651 Morse and Reister, 1967)* The main effect on the
lymphocyte population was redistribution of these cells rather than an
increased rate of multiplication* This was taken to account for the
observed enlargement and hypercellullarity of the paracortical areas of
lymph nodes, and the hypocellularlty of thymus. Neonatally thymectomised
animals do not give this response (Kalpakstoglou et al.« 1969)*
Little is known about the physical and chemical requirements than
confer upon bacterial substances the ability to act as adjuvants. The
essential active constituent in mycobacteria appears to be a cell wall
peptido-glycolipid (White and Marshall, 1958f White etal., 1964). The
mycobacterial cell wall possesses a complex superficial netwoik of inter¬
lacing filaments of a uniform width that are similar in form to purified
peptido-glycolipids(white,1967a,b). Ho such structures were found when
a wide variety of other bacteria were examined, with the possible exception
of Nocardia. The presence and the number of such filaments may be related
to an ability of these bacteria to resist digestion by host enzymes.
It seems rather parodoxical that many substances which suppress
antibody formation have been shown also capable under certain conditions
of enhancing it. Dixon and ScConahey (1963) found that whole body X-
irradiation (400-600r), given 2-3 hours after antigen, enhanced antibody
titres. Colchicine augmented antibody responses in X-irradiated and
normal animals (Taliaferro and Jaroslow, i960). Chanooughan and Schwartz
(1966) showed that 6-iaercaptopurine treatment five days before antigen
led to an enhanced immune response.
Such experiments can be taken in conjunction with others that suggest
DNA,RNA or nucleotides could enhance antibody production. Taliaferro
and Jaroolow (i960) restored the haemolysin response in X-irradiated
rabbits by injecting antigen with DNA or RNA digests 24 hours after
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irradiation. Braun (1965) reported that injection of oligonucleotides
from calf thymus led to an increase in number of plaque forming cells
against sheep erythrocytes. These findings support another hypothesis
that certain adjuvants may act by providing substances necessary for the
control of the initial stimulatory events that lead to antibody production.
8. Corynebacteria as adjuvants with special reference to C.parvus.
The Corynebacteriaceae are habitual saprophytes of the natural
cavities in man and animals. Under certain conditions they may become
pathogenic. While studying this pathogenicity in man, Prevot noted an
intense reciprocal affinity of these bacteria to the reticuloendothelial
system. Further, he noted in uncured patients a tendency to develop
malignant tumors and haemopathies, features which, unlike the cases of
lymphadenitis, purulence, septicaemia and metastasis, tended to distinguish
the corynebacterial infections from those caused by other endogenous flora
( 'r£vot, 1968). Although experimental injection of animals with these
organisms did not induce tumors, Levaditi et al, (1965) show live
C.anaeroblua to bring about a characteristic histioreticulosis associated
with the accumulation of PAS + ve material in plasmodes and monocytes.
Since heat-killed, enzyme-digested and ultrasonicated material could give
a similar response, it was suggested that there was an interaction between
bacteria and the reticuloendothelial system which was not a result of
the infection (Tr6vot, 1963). Many strains of Corynebacteria were in
varying degrees able to stimulate the reticuloendothelial system of mice
(revet and Iran Van Phi, 1964).
Attempts to isolate the "reticulostimulin" have so far proved
unsuccessful. It seems to be, however, dependant upon the external
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topology of the cell wall (Prevot et al.» 1968). It may be of Interest
to follow up the reports that petroleum ether extract of C.ovie lipids
given intradermally lead to an intense local reaction and cause death
si
of phagocytes when administered on carbon (Came< 1956). The virulence
of C.ovis seems to be related to its lipid content (Jolly, 1966) and
the most powerful reticuloendothelial stimulators also appear the most
pathogenic (Pr^vot, 1968).
With regard to the adjuvant effects of C.parvum, Amiel et al. (1969)
showed its protective effect in mice challenged intraperitoneally with
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lCr isogeneic leukemia cells. C.parvum in this experiment was given
intravenously four days before challenge. Tumor growth in mice could
also be significantly inhibited if animals were given C.parvum within
two days after the sarcoma cells transfer, but protection against Shrlich
ascites tumor was established only when C.parvum was given on the same
day by the same route as the tumor cells (Halpern et al., 1966). A
significant delay in the onset of mammary carcinoma was found when C.parvum
was given either at day -2 or between days 8-12 (Woodruff and Boak, 1966).
In experiments on the resistance of syngeneic ot F^ mice to AKR leukemia
graft after C.parvum application, it was shown that the effect was best
when it was given at day -7 but only by the same route as the cell inoculum
(Lamensans et al., 1968). It is obvious that the protective effect of
C.parvum is dependant upon the nature of the stimulus, as well as the
route and timing of the injections and in all probability, the source
of the used C.parvum preparation.
It has often been found that C.parvum is most (or only) effective
when given at or near the time of tumor challenge. From a clinical
view-point this is an obvious drawback. Currie and Bagshawe (1970),
however, have reported favourable results in fibrosarcoma bearing mice
when cyclophosphamide was administered prior to C.parvum although the
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timing of the injection appeared cruoial. In spite of the difficulties
involved several fairly successful treatments of humans have been reported.
In these cases C.parvum was used in conjunction with more conventional
methods of tumor therapy (Mathe, 1969).
While there are few other reports on adjuvant activity associated
with corynebacteria, C.parvua has been shown capable of substituting
for mycobacteria in complete Freund's adjuvant and enhancing levels of
circulating antibodies and delayed hypersensitivity to picrylated
albumins in guinea-pigs (Meveu et al., 1964). Similar substitution with
C.rubrun, its chloroform extracts and residues was also successful
(Faronetto, 1968). The last preparation could also induce adjuvant
arthritis in rats but not in mice nor in guinea-pigs (Paronetto, 1970).
The effect of C.parvua on the celullar kinetics of the response to
sheep red blood cells in mice has been studied in some detail. An
increase in the number of direct plaque forming cells was found if the
adjuvant was given at the same time, or better four days before the
antigenic challenge (Amiel et al., 1969). An increased rosette formation
was demonstrated in similar experiments by Becreusefond et al., (1970).
They noted that the enhanced response in C.parvum treated mice was marked
by an increase in all specific rosette-forming cell types although there
was an especially large increase in plasmacytes.
Associated with the injection of C.parvum into mice, various haema-
tological sequelae have been reported. In particular it was a fall in
haemoglobin level (Halpem et al., 1964), an increase in reticulocyte count
(Nussenweig, 1967) and a decrease in circulating erythrocytes (Halpern and
Pray, 1969), The relationship between the immunological and haematolog-
lcal effects of the bacteria is as yet unknown although there has been a
recent report that the autoimmune manifestation of the NZB mice disease
could be brought on by the administration of C.parvum ( Ilalpern and Fray,1969).
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9. Proposed objectives of researoh In this thesis.
The basic objective of the work reported In this thesis was to
elucidate the relationship between immunological unresponsiveness and
immunological reactivity. It was hoped that a study of factors influen¬
cing the decisive initial phases of the immune response might further
elucidate the mechanisms involved in initiation of these phenomena.
Furthermore, such study may throw light upon the relationship of altered
activity of cells to autoimmune manifestations.
In order to study the initial phases of immune responsiveness three
approaches were employed. The first was chemical and physical modifi¬
cation of antigen resulting in alterations in its initial mode of local¬
isation. The degree of aggregation of a protein has previously been
shown to have dramatic effeots upon antibody production (Dresser, 1962aj
Claman, 1963 J Biro and Garcia, 19^5). The role of the physical state
of antigen in determining unresponsiveness or reactivity appears basio
to the understanding of the different mechanisms underlying these two
phenomena.
The second approach involved the use of various reticulostimulating
agents. C.parvum strain 10387 had previously been shown capable of
preventing the induotion of tolerance tc bovine serum albumin in rabbits
with the induction of immune responsiveness (Pinckard .fli ,al.» 1967,1967aj
1968). It was hoped to study this effect in more detail with regard to
the localisation of the antigen within the lymphoid organs and the cellular
disturbances caused by this and other adjuvants. In order to do this it
was necessary to utilise inbred CBA mice rather than rabbits which enable
the use of a larger and more uniform population.
The third approach to the study lies in the observed reticulocytosis
(Nussenweig, 1967) and lowered haemoglobin level (Halpern nl &1., 1964)
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and the increase in the number of spleen cells with reactivity directed
against 'self' red blood cells (McCraken et al. 197l)» that has been
observed in mice treated with C.parvum. It was hoped that it would
prove possible to differentiate or link the haematological disorders
with the adjuvant offsots of the organisms.
In order to study the antibody responses to antigens care was
taken in the choice of technique. It is well established that many
classical serological tests measure the secondary effects of antigen-
antibody interactions. Such tests may bias their sensitivity in favour
of one or more classes of antibodies. It is of particular importance
in the study of adjuvants where alterations in the class of antibody
has been noted (White, 19&7) to use tests which are dependant upon the
primary binding of antigen with antibody, and whenever possible to have





a. Breeding? and stock mice.
CBA strain inbred mice were bred by the 'traffic light* system of
cousin mating from nuclei obtained from the Animals Division, Institute
for Medical Research,Mill Hill, London. Three generations only were
bred from each nucleus. The first generation, the progeny of the first
generation and the second generation were used as stock animals or
further mating pairs as the situation demanded. All other progeny were
used for stock and experimental purposes only.
Mice of the New Zealand Black (NZB) strain were of stock originating
from Otago Medical School, New Zealand and maintained in the Department
of Surgical Science, Edinburgh, or from the progeny of breeding pairs
derived from this source but bred in the Bacteriology Department Animal
House. The inbred nature of this strain has been maintained by brother-
sister matings for over 72 generations.
Other inbred lines of mice used - C57BL, CBA, DBA/2, and NZB x CBA,
C57BL x CBA hybrids - were obtained from the Department of Surgical
Science, Edinburgh.
b. Care of mice.
All mice were handled and cared for in accordance with the recommen¬
dations of the U.F.A.W. Handbook. Breeding mice were fed 'Oxoid'
autoclaved breeding di&t supplemented by bran twice weekly. Weanling
mice (3-5 weeks of age) were fed a Isl mixture of the breeding diet and
'Oxoid* B41 experimental diet. All stock and experimental mice received
the standard B41 pellet food. At all times the animals were allowed to
feed and drink ad libitum.
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°* Experimental groups.
Unless specifically stated to the contrary, mice of 12 - 41 weeks
of age (17 to 27g body weight) were used and within any given experiment,
the weight range was < 3g and the age range < 6 weeks.
At all times different groups within an experiment were carefully
matched as to sex, weight, age and number of animals per cage and mice
from different litters and generations randomised.
Wherever possible animals of one sex only wero used in any given
experiment and further experiments to show up the Influences of sex
variation performed. In particular, where peripheral cell counts were
performed and alterations of in vivo phagocytosis and pinocytosis were
being studied, animals of only one sex were used. These phenomena are
known to show quantitative differences linked to sex (Dunn, 1954)•
d. Collection of mouse sera.
Unless otherwise stated, mice were bled from the retro-orbital
plexus. A hand drawn glass pipette made from tubing 4 mm external
diameter and 2 mm internal diameter was used. Before use the pipette
was rinsed in sterile saline containing 400 i.u. of heparin per ml and
blotted dry. The blood was clotted at room temperature for 1 hour.
This prevented haemolysis which tended to occur at 37° C. Following
overnight incubation at 4°C the clotted blood was spun for 20,000g.min
and the sera removed and stored (-20°C) till used.
2. Antigens.
Bovine serum albumin (B5A).
Immunologists have often considered serum proteins such as albumins
to consist of a pure or homogeneous population of molecules. For this
reason they are often preferred to more complex antigens for investigations
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into the mechanics of antibody formation. Recent evidence has, however,
suggested a marked degree of biochemical heterogeneity within albumin
preparations (Peeters et al., 1970). Furthermore, it is now recognised
that the different physical forms present in purified preparations of
antigens, may vary in their immunogenic potential and in their capacity
to act as test antigens for the in vitro detection of antibody. It is
therefore necessary to define, to some extent, the BSA preparations used
in this thesis.
a. Native BSA (BSA).
Two batches of Cohn fraction V (*Armour* - lot nos. MM2071 and NM2072)
were the main sources of the BSA used in this thesis. Stock solutions
were prepared in O.85# sterile saline and stored in aliquots at -20°C
for periods of less than three months. All solutions were standardised
for protein content by their absorbance at 280 i^u in a Unicara spectro¬
photometer, as compared to standard BSA solutions of known nitrogen
content determined by the micro-Kjeldhal method (Kabat and Mayer, 1961).
This BSA is approximately 90$ pure with less than 5$ aggregated
material. Five lines were found by immunodiffusion and immunoelectro-
phoresis when the preparations were tested against a potent rabbit anti-
bovine serum. The main contaminant migrated as though it was a trans¬
ferrin. The other contaminants were one (X-globulin and two >#-globulins.
b* Centrifuged BSA (c.BSA).
c.BSA was prepared by the method of Pinckard jet ad. (19^7)• Three
4 ml quantities of BSA were spun in the cold for 8.2 x lO^g.min in a
MSE 'Superspeed 40* using a swing out rotor and with the brake off. The
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top &a1 of each tube were carefully removed and used fresh. The
contaminants in this preparation were qualitatively similar to those
in BSA.
c. Monomer BSA (m.B3A).
Monomer BSA was prepared by filtration through Sephadex G150. The
only contaminant detected by Immunoelectrophoresis was the Ot-globulin
component.
d. Heated BSA (h.BSA).
Heated BSA was prepared by incubating a stock solution of BSA at
60°C for 1 hour in a water bath.
e. BSA heated at low pH (p.BSA).
The pH of a stock solution of monomer BSA (50-100 mg/ml) was lowered
to 3.8 by the addition of 0.1 N HC1. After one hour at 60°C the solution
was allowed to stand at 4°C for two days. The aggregates were removed
by oentrifugation for 5000 g.min and wahhed in sterile saline until the
supematants showed no visible precipitation on the addition of 10$ TCA.
The precipitates were then dissolved in sterile saline and the pH adjusted
to 7*0. These preparations show a considerable degree of aggregation
as judged by 3ephadex GI50 gel filtration, although 'monomer1 is also
present.
f. Alum-precipitated BSA (a.BSA).
Alum-precipitated BSA was prepared using the aluminium hydroxide
gel 'Alhydrogel* (Seravac Labs., Maidenhead). This is a viscous homo¬
geneous gel containing 2$ A1 (OH)^ corresponding to 1.3$ kl2°y 1,1:18
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gel hau a high absorption capacity for proteins, is supplied sterile and
is pyrogen-free. It also has a stable uniform form (Neubetft and Bethke,
1968).
A given volume of *Alby<Ir°gel• was added to the same or a smaller
volume of stock BSA solution of concentration < 25 mg/ml. After immediate
mixing adsorption of the protein was continued by incubation at room
temperature for one hour and overnight at 4°C. .After spinning for
20,000g.min at 4°C the supernatant was discarded and the precipitate
resuspended in sterile saline so that the final volume was identical to
the original volume of 'Alhydrogel' used. Large aggregates were dispersed
by repeated passage through a 19 gauge and than a 23 gauge needle.
This procedure leads to a very stable complex in which 95-l°0$ of
the BSA is bound. Repeated washing in saline leads to only an extremely
small loss of bound BSA. Even with eight daily washes with 10$ normal
rabbit serum, over 50$ of the BSA added is still bound (Pinckard, 1967 \
McBride - unpublished results).
g. BSA in Preund's complete adjuvant.
•Difco* Preund's complete adjuvant containing 0.05 mg Mycobacterium
per ml was used. Equal volumes of BSA at the appropriate concentration
and adjuvant were mixed using two syringes connected by a needle with a
Luer attachment at both ends. The milky emulsion formed was tested for
stability by placing a drop on the surface of water (Herbert, 1967)*
3. Radioactive iodination of BSA.
In all instances iodination of BSA was performed by the method of
Hunter and Greenwood (1962) and Hunter (1967).
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a. Theory.
The chemistry of radio iodination of proteins is basically that of
substitution of iodine into tyrosine residues (Hughes, 1957)» although
under certain circumstances iodine may react with sulphydryl groups or
with tryptophan. The type and dose of substitution will therefore
depend upon the availability and number of tyrosine groups in the protein.
Substitution occurs when iodide is oxidised to elemental iodine in the
presence of the protein.
For this oxidation the chloramine+T method of radio iodination uses
a sodium salt of the N-monochloro-derivative of p-toluene sulphonamide
which in aqueous solution yields hypoohlorous acid. At or around the
pH optimum of 7»5> cationic iodine (l+) is formed, the reaction then going
to completion. The method is rapid, efficient and involves minimal
handling risks as well as giving a high yield ($ utilization of iodine)
which can be 100$ if the concentration of protein is sufficiently high
( > 1 ag/ol) (Hunter, 1967)*
As with any other labelling procedure, it is of extreme importance
that the protein is altered as little as possible during iodination and
that it will behave in an identical fashion to native protein in the test
system. Denaturatlon of the protein caused by the labelling procedure,
and alterations in the structure of the protein due to irradiation damage,
or due to the substitution of hydrogen by iodine, must all be considered
as possibly giving rise to altered biological activity. In view of the
fact that 'trace labelling* of a relatively large molecular weight compound
was used, such alterations in structure are probably insignificant.
However, whenever it was considered to be important, the biological activity
of the radioiodinated BSA was compared with that of the native form.
b. Explanatory notes.
The following procedure leads to a calculated substitution of one
atom of per 15 - 5° molecules of BSA or one atom of par 200
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molecules. Unless otherwise stated trace labelled BSA was prepared
with these degrees of substitution.
Borate buffer (pH 8.4,^ « 0.1) was employed for labelling only when
the end product was to be used in the Parr technique. Otherwise phosphate
buffered saline was used (pH 7*2). Both and radionuclides
were used. Their relative merits have been discussed in detail (Hunter,
1967). was the radionuclide most commonly used in this thesis
because of its greater half life, the better resolution obtained when
using it in autoradiographic studies and the lower external radiation
risks. Although the specific activity of is lower than for *
this is in part compensated for by the higher counting efficiency for the
weak gamma emiter.
c. Materials.
I. Borate buffer pH 8.4} - 0.1
or Phosphate buffered saline pH 7-2; yu - 0.2
II. 3mCi IMS/3 125I in iodide form (98/ iodide):
carrier free in dilute NaOH solution pH 7—91 free from reducing
agent; 80-120 mCi/ml; specific activity of 4-12 Ci/mg iodine;
probable isotopic abundance 25$.
or 3mc IBS/3 in iodide form; carrier free in dilute NaOH
solution pH 8-10; free from reducing agent; 200 mCi/ml;
specific activity of 20 Ci/mg iodine; isotopic abundance of
about 155k.
Data and material supplied by The Radiochemical centre, Amershaa,
Buckinghamshire.
III. Chloramine-T (BDH) 0.5 nig/ml aliquots in distilled water, stored
at -20°C till used.
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IV. BSA Stock solution 20 mg/ml were prepared as described
earlier.
d. Procedure.
Normal safety precautions for the handling of high activity samples
were adhered to throughout. 0.25 ml of the appropriate buffer was
added to the solution containing the radionuclide. With continuous
stirring, to this was added 0.25 Ql of 2% BSA solution (5 rag) immediately
mixture and washings were transferred to a 1" dialysis sack, the final
volume being approximately 4 ml. All additions and manipulations were
performed using 1 ml sterile disposable syringes and needles. Dialysis
the appropriate buffer.
After this period of time chloraraine-T and unreacted iodine were
to a large extent removed, the preparation being approximately 98-99$
precipitable by 10$ TCA.
The yield ($ utilization of iodine) using this method was over 80$
with borate buffer and over 90$ when phosphate buffered saline was used.
Chloramine-T is an oxidising agent and a small excess of sodium
metabisulphite is often added to bring the reaction to a close, reducing
both the Chloramine-T and also any unreacted iodine to iodide. The
small quantities of Chloramine-T and the degree of substitution required
as well as the fact that unwanted materials were removed by dialysis
made a reducing agent unnecessary.
Chloramine-T. After 1-2 min the reaction





The passage of a charged particle across a solid or liquid phosphor
leads to a transfer of the energy of the particle to the phosphor in
the form of molecular excitation or ionlaation. A portion of this
energy will be re-emitted, naturally as small flashes of visible or
ultra-violet light i.e. scintillations. Scintillation counters can
utilise either solid or liquid phosphors. Soft B emitters (e.g. ^H»
14 IS
C, ?S) use liquid or gel phosphors and the source is brought into
intimate contact with the detector, usually organic phosphors in
suitable solvents. In this way the geometrical efficiency of the
arrangement is at a maximum and self absorption within the source reduced
to a minimum. In gamma ray spectrometry the phosphor of choice ia
normally an alkali metal iodide activated with a trace of thallium.
The scintillations produced in the phosphor as the charged particles
traverse it, are absorbed by the photocathode of a photomultipller tube
that then emits electrons, the flow of which is amplified after passing
through many anodes, finally emerging as a single pulse that can be
recorded on a scaler.
Radionuclides produce characteristically different energies of
radiation. As each photon may produce a pulse, these also will vary
in magnitude. Discrimination between pulses of different magnitudes
or *heighta* can be achieved by means of a pulse height analyser. This
device can be adjusted by raeans of 'threshold* and 'window voltage
settings' to accept only pulses within a selected 'channel*. Through
this channel only pulses emanating from photons with a given energy
will flow and be recorded. This enables pulses specific for the radio¬
nuclide being used to be selected for at the expense of extraneous
♦noise*.
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The efficiency in counting a radioactive preparation is measured
by the number of counts recorded per number of disintegrations times
100. This figure often falls short of 100$ for a variety of reasons
dependant on the source* the detector and their relationship, as well
as the operating conditions.
The distribution of the recorded pulses, like that of the disinte¬
grations of the radioactive nuclide, naturally follows a Poisson form.
The error in a single determination is thus the square root of the
total number of counts collected (n). The standard proportional error
^ 2 ^
being /n or /n, a measurement which can be easily reduced to any
required dimensions by counting for a sufficient length of time.
However, the number of pulses determined has at least two components.
One is specific for a given nuclide and the other contributed to by
'background noise'. Since two count rate determinations must be made
to arrive at the net count rate, the standard errors of the differences
will be compounded of the individual errors. If the total counts and
time corresponding to count rate A, are represented by N and t respect-
Si &
ively, and of B, and t^, with standard errors of a and b them
(A — a) — (B — b) - A - B - (a2 + b2)
or
/ + . + / + .\ . + _ + A B(A - a) — (B — b) " A — B — + t—
a b
b. Equipment.
A Nuclear Enterprises "Gamma-Matic" Marie 1-A Scintillation Spectro¬




The S.H.T. voltage and the amplifiers were set in order to minimise
fluctuations due to changes in ambient temperature and minor voltage
fluctuations, and to minimise photooultiplier''noise'.
The pulse height analyser was adjusted so as to include the main
energy peaks of the radionuclide to be counted with minimal background
noise. In practical terms a background of 1-3 c/sec was sufficiently
easy to obtain with any of the nuclides used.
All samples were counted such that the probable counting error was
less than 10/, and normally less than 1%.
All samples for comparison, were counted with the same geometry.
Care was taken that the activity of all samples were within the
e
resolving limits of the counter i.e. 'dead' time. ( < 5 i 10 c/sec).
5» The ammonium sulphate method for the detection of antl-BSA antibodies.
This technique was performed by the method of Farr (1958) and Minden
and Farr (1967) •
a. Theory.
The Farr technique gives a measure of the capacity of an antisera to
combine with those macromolecular antigens soluble in 50/ saturated
ammonium sulphate (3AS/2), the method being capable of detecting both
precipitating and non-precipitating antigen-antibody complexes.
The te3t is based upon the principle that radioiodinated BSA is
soluble in SAS/2 whereas gamma globulin is not; any antigen bound to
antibody will therefore be precipitated. *Antigen not bound will remain
in the supernatant. When measured in antigen excess, soluble antigen-
antibody complexes are precipitated by 3A3/2 and the amount of antigen
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bound per ml of serum can be calculated. This amount is known as the
antigen binding capacity (ABC) of the serum at the particular antigen
concentration used. The formation and dissociation of antigen-antibody
complexes is markedly inhibited once the SAS has been added, the results
therefore are likely to be a true reflection of the amount of bound
antigen at a given point in time.
By measuring the ABC values at more than one antigen concentration
it is possible to derive a figure based on qualitative differences
between antibody populations. This manoeuver detects $iie presence or
absence of unoccupied antibody combining sites when antigen is in exoess.
If most of the available antibody combining sites are bound, am increase
of antigen concentration does not increase the ABC value of the antiserum.
In practise, as the antigen concentration Increases, the ABC value also
tends to increase to a maximum value, but never decreases. As a general
rule, a marked discrepancy in ABC values at two given antigen concentrat¬
ions indicates the presence of 'non-avid* antibody, normally a population
with a rapid dissociation rate (Mlnden and Farr, 1967).
It can be seen that the Farr technique is one of the few primary
techniques capable of quantitating the direct binding of antigen with
antibody. Techniques which rely on secondary or tertiary features of
the combination of antigen and antibody have long been criticised as
being possibly misleading. The results are dependent upon a series of
events which often, if not always, solely involve, or are more efficiently
performed by, one particular class of antibody; a result of biological
capacities of immuniglobullns other than antigen binding. Results
obtained from these techniques can thus be easily biased by the presence
of a minority population of antibodies.
b. Reagents.
I. Borate buffer pH 8.3 - 8.5, yu ■ 0.1
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6.184 g boric acid
9.536 g borax (sodium tetraborate)
4*384 g sodium chloride
HgO to 1000 ml
After the addition of SA3 this buffer maintains pH of 7«9»
II. Normal rabbit serum (NRS)
A one in ten dilution in borate buffer for antisera dilution.
A one in 100 dilution in borate buffer for I-BSA dilution.
III. Saturated ammonium sulphate - (SAS), Mayand Baker Ltd.
Specific gravity 1.233 to 1.248.
Stored at 4°C with crystals remaining to prevent supersaturation.
Kept at 4°C before and after addition.
IV. 50$ saturated ammonium sulphate (3AS/2) in borate buffer.
SAS diluted 111 with borate buffer.
Kept at 4°C throughout.
V. #I—BSA
The concentration of stock I-BSA was carefully measured by
reading in an SP500 Unlearn spectrophotometer at 280 m/u. and
compared with a stock BSA preparation of approximately the same
concentration which had previously been standardised by the
micro-Kjeldhal method for nitrogen determination. An aliquot
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of the stock I-BSA solution was diluted volumetrically with
It 100 NRS in borate buffer to the required dilution for the test.
The normal rabbit serum is necessary to minimise adsorption of
the *I-BSA to the glass and also to prevent denaturation of the
antigen by the effects of dilution. The antigen concentrations
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most commonly employed were 0.1yug N and O.Ol^ig N added in
equal volumes to 0.5 ml antiserum (see note 1, p.7l ).
VI. Trichloracetic acid (TCA) - 20% (w/v) aqueous solution.
c. Procedure.
Unless otherwise stated volumetric procedures were used as well sis
standard procedures to eliminate carry over during diluting.
I. Antiserum dilutions.
All antisera were initially diluted 1»10 in borate buffer to give
a convenient standard volume. Prom this four-fold serial dilutions
were made employing normal rabbit sera (is 10) as diluent (see
note II, p.71 ).
II. Experimental tubes.
For each antigen concentration 0.5 ml aliquots of the antisera
dilutions were transferred in duplicate to 75 * 12 ram glass tubes.
III. Control tubes.
For each antigen dilution the following control were usedt
a) 4 "control" tubes received 0.5 ml of Is 10 NHS instead of the
antiserum.
b) 4 "TCA" control tubes received 0.5 ml of the same Is 10 NHS.
c) 4 "AgAdd" tubes which receive only the antigen.
IV. Addition of the *I-BSA.
#
I-BSA at the appropriate antigen concentration was added to all
control and experimental tubes. Each tube received 0.5 - 0.01 ml
from an automatic syringe with valve and cannula attachment (Turner
& Co. Ltd. London).
V. .After shaking, all tubes were incubated at 4°C overnight.
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VI. With all reagents kept at 4°C all experimental tubes and the
4 "control" tubes (Procedurellla)received 1.0 ml of SAS and were
immediately shaken by a rotating mixer. The SAS was added by
means of an automatic syringe, carefully tested for accuracy of
delivery. Control tubes labelled "TCA" controls received 1.0 ml
of 2<yi TCA instead of SAS and the contents were immediately mixed.
VII. After incubation at 4°C for 30 min all tubes were spun for 4,500
g.rain in an USE refrigerated (4°C ) centrifuge.
VIII. After centrifugation the supernatants were discarded and the tubes,
containing white precipitates, blotted by inversion onto absorbent
paper.
IX. The "TCA" control tubes are ready for counting.
X. All other tubes received 3 ml SAS/2 by automatic syringe and the
precipitates well resuspended. The tubes were again incubated at
4°C for 30 rain before recentrifugation (4°C), removal of supernat¬
ants and blotting (see note III, p.71 ).
XI. Counting!
All tubes were counted as described elsewhere (p.62 ).
d. Calculations.
The "Ag Add" control tubes are a measure of the amount of radio¬
activity added to all tubes. The "TCA" control tubes give a measure
of the amount of this radioactivity bound to protein and hence
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precipitable by antibody. In all cases the antigen was not used
whenever the "TCA" control was less than 98# of the "Ag Add" value.
In fact, in the majority of cases '"PCA" control values were greater
than "Ag Add" values owing to the different geometry of the two samples.
Because the geometry of the experimental tubes and "control" tubes
are equivalent to those of the "TCA" controls, and because these tubes
give a better estimate of the radioactivity bound to the antigen the
average of these tubes was taken a3 the amount of radioactivity capable
of precipitation by anti-B3A antibody.
In calculating the antigen binding capacity of an antiserum, account
must be taken of the small quantity of non-antibody bound, non-specifically
trapped radioactivity present in the precipitates. Correction for this
value is obtained from the "control" control tubes. The number of
counts in these tubes are normally about 5""10# of those found in the
"TCA" control tubes. The amount of radioactivity bound specifically to
antibody in experimental tubes (exp) can be calculated as a percentage
of that capable of being bound by the formula:-
# antigen bound » ~ x 100 (see note IV, p.7I )
This value was calculated for the average of each pair of experimental
tubes. Within the limits of 30# to 80# this value of percentage of
antigen bound by antibody is directly proportional to the log reciprocal
of the antiserum dilution. Furthermore, between 10# and 30# there is
almost direct proportionality with the reciprocal of the antiserum
dilution. These values are approximate and vary slightly between anti-
sera. Quantitative comparison of antisera is therefore not easy nor
#
very meaningful using purely the percent of antigen bound. Instead
comparisons are made in the region of antigen excess. Where two points
lie in the region of 30-80# bound, the dilution of antiserum is calcul¬
ated which would bind 33# of the total available antigen. Where there
TO
is direct proportionality the antigen binding capacity can be calcul¬
ated directly. For comparative purposes the antigen-binding capacity
(ABC) is expressed as yug N BSA bound per ml of undiluted serum.
Where it was possible to measure ABC values by both methods good agree¬
ment was found in nearly all cases. Calculations of per cent bindings
and ABC values were carried out using the Edinburgh Regional Computing
Centre's KDF9 or 360/50 computers (see appendix l).
e. Statistical analysis of results.
Initial Inspection of data from animals given the same treatment
showed that the ABC values do not follow a normal distribution making
comparison of treatments difficult. A near normal distribution was
however, derived by logarithmic transformation of the data. Sera
showing no antigen binding capacity were treated as positive with an ABC
value of 0.01. This manoeuvre led to little or no alteration in the
geometric mean of the majority of groups. Results for groups of mice
with different treatments were compared by the 'student's' t—test.
Before doing this thfcir variances were tested for equality by the
variance-ratio (f) test. Where it was decided that the true variances
of the two samples were probably the same, then the t-test was performed.
Where a significant difference was found in their variances a modified
test was performed (Bailey, 1959)• Initial calculations were carried
out with the assistance of the personnel and PDP9 computer in the
Department of Social Medicine, Edinburgh.
f. The effect of antigen dilution.
The effect of alterations in antigen concentration upon the ABC
values has been taken as a measure of qualitative differences in the
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antilody binding. This dilution effect can be conveniently expressed
as a ratio of the ABC values at two antigen concentrations, i.e. ABC
at low antigen concentration divided by ABC at high antigen concentrat¬
ion times 100. In this work:, unless otherwise stated, the antigen
concentrations used were O.lyug N and O.OlyUg N added.
g. Kotes on the Farr technique.
I. The low antigen concentrations, O.lyug N and O.Olyug N, most
commonly used in the work reported have been 3hown extremely sensitive
in the detection of low levels of antibody (Pinckard et al., 1968), and
are hence very valuable in studies involving tolerance.
II. It is desirable to dilute the test sera in autologous serum, but
with mice this is impractical. Preliminary experiments showed that
the use of normal rabbit sera caused only a very slight loss in accuracy
when compared to autologous sera.
III. Washing of precipitates in SAS/2 may be omitted from the procedure
(Mitchison, 19&4). Washing does lead to a lowered 'control' and
experimental value and a slightly lower ABC value although the resulting
slight increase in sensitivity of the technique is probably compensated
for by the loss in time and increase in variation brought about by the
washing. For the sake of consistency of method, washing of precipitates
was included in the technique used in this thesis.
IV. The original formulation (Farr, 1958) of the per cent of antigen
specifically bound by antibody took into consideration the fact that
amount of non-antibody bound radioactivity in the precipitate would be
*
proportional to the amount of non-antibody bound I-BSA in the super-
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natant bound) and not to the total amount of test antigen added. The
formula derived was based on the assumption that the ratio of counts in
the control precipitate to supernatant would equal the ratio ofnon-antibody
bound counts in the experimental precipitate to supernatant. This ratio,
when multiplied by the number of counts in the experimental supernatant,
gave the non-antibody bound counts in the precipitate. This could be
subtracted from the number of counts in the experimental precipitate to
give specifically bound counts. These were expressed as a percentage
of counts added. Subsequently a new method of calculation evolved that
ft
was based on the fact that I-BSA in the experimental supernatant is
directly proportional to the total amount of non-antibody bound *I-B3A in
a given mixture (Minden and Farr, 196?). This method had the advantage
of simplicity and was expressed as:
$ bound » 100 - Experimental supernatant counts
'Control' supernatant counts
This in fact can easily be further simplified to involve precipitate
counts:
a:Sff - lo°*TCA - 'Control'
the formula expressed on p.69
All these formulas give identical results although the last is the easiest
to use and does not require correction for a constant background.
6. Agglutination of sheep red blood cells.
Sera were heat-inactivated (5<>0C for 30 min). 0.05 ml volumes were
used to make doubling dilutions with phosphate buffered saline
(pH 7*2; yu - 0.2) in 'Falcon' microtitre plates. 0.05 ml of saline or
0.02 M 2-mercaptoethanol was added to each well and the plates incubated
overnight at 4°C. O.05 ml of a 0.4$ suspension of washed sheep cells
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was added to each well. The plates were incubated at 37°C for 1 hour
and room temperature for two hours before the end points were established.
7. Bacterial Adjuvants.
a. Corynebacteriua parvua NCTC 10387
C.parvum 10387 was obtained from the Kational Collection of Type
Cultures, Colindale, London. This strain was originally obtained from
Professeur Prevot in Paris by Dr. H. Seeliger, Bonn, Germany in 1954-
The American Type Culture Collection obtained it from Br. Seeliger and
typed it as C. parvum strain ATCC 12930. Colindale accepted it from
them as C.parvum. Correspondence with Professor Raynaud and Professor
Prevot in Paris, however, cast doubts on its identity. These workers
consider it more likely to be a non-lysogenic strain of C.granulosum.
In view of the difficulties inherent in the classification of anaerobic
corynebacteria, for the purposes of this thesis it will still be considered
as C.parvum 10387.
Culture of C.parvuia IO387.
To avoid the problems of contamination of the bacterial suspension
with determinants cross-reacting with BSA, the organism was grown in a
bovine-free media of minced cooked-meat infusion broth.
Minced cooked-meat was prepared with 500 grams of sheep heart,
trimmed free of all connective tissue and finely minced. This was boiled
for 20 min in 500 of distilled water with 1.5 ml IN NaOH added. The
resulting suspension was filtered through muslin and the solids blotted
dry.
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Infusion Broth was prepared from 500 g of lean sheep meat minced
and mixed with 1 litre of distilled water containing 5 B NaCl. This
was kept at 4°C for 24 hr and then boiled for 15 min. The resulting
suspension was filtered through muslin and then filter paper and the
pH of the filtrate adjusted to 7*4 with IN NaOH.
The minced cooked heart was distributed in 100 ml and 500 ml bottles
to a depth of l"-2". The sheep meat infusion broth was added till the
bottles were 80/ full before sealing and autoclaving. Seitz-filtered
glucose was then added (10/ w/v) until the final concentration was l/.
The bottles were loosely sealed and steamed for 20 min.
c
A freeze dried culture of C.parvum was added to the 100 ml bottles
which were then incubated anaerobically for 48 hr at 37°C. Following a
purity check by Gram stain 25 ml of the starter cultures was added to
the 500 ml bottles of media. These were incubated for a further 3 days
at 37°C. The resulting bacterial suspension was tested for purity by
plating on blood agar and Gram staining. The final bacterial suspension
was filtered through eight layers of muslin and spun down at 4,500 g.min
in an MSI? "Major" refrigerated centrifuge (4°C), then resuspended and
washed six times in sterile saline. Before use the bacteria were killed
by heat (70°C/60 min), counted microscopically and dry weights measured
by dessication. They were stored at -20°C until used.
b. SF 16.
The diphtherlod SF 16 was originally isolated from the synovial
membranes and fluid of a patient with rheumatoid arthritis by Drs. Stewart,
Alexander and Prof. Duthie in the Northern General Hospital, Edinburgh.
This strain is typical in its morphological, cultural and biochemical
characteristics of 60/ of diphtheroids isolated from patients with this
disease by these workers (Stewart et al., 1969? Stewart unpublished 1970).
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Culture of SF 16.
The freeze-dried bacteria obtained from Dr. Stewart were grown on
bovine-free infusion broth agar (see above) in 10$ CO,,. After incubation
at 37°C for 72 hours the bacteria were washed off the surface of the
agar with sterile saline, spun at 4,500 g.min (4°C) and washed six times
in sterile 0.85$ saline. The bacteria were killed by heating at 70°C
for 60 min before being counted and weighed dry. They were stored at
—20°C before use.
c. Corynebacterlum anaerobium was a kind gift from Prof. Prevot,
Institut Pasteur, Paris. The suspension was killed and preserved in 1$
formalin. Immediately before use the suspension was washed six times
in sterile 0.85$ saline.
d. Bordetella pertussis, Lot 74432, was obtained from Burroughs Wellcome
& Co., London, in the form of pertussis vaccine B.P. in 0.01$ thiomersal
as preservative. Again the suspension was washed six times in sterile
saline before use.
8. Cellular studies.
a. The preparation of mouse spleen cell suspensions.
Materials.
1) Minimal Ragles Medium (M®), Burroughs Wellcome Co., London.
Made to single strength in distilled water and to contain 5 ml
of a 4.4$ sodium bicarbonate solution per 100 ml.
2) Loose fitting ground glass horaogenisers.
3) Metal sieve 0.5 mm mesh 3ize.
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Method.
The spleens were collected and all subsequent procedures were done
in the cold. Each organ was cut into three pieces and the individual
cells homogenised free, using a loose-fitting horaogeniser containing
sufficient MEM to prevent air bubbles being trapped. The cells and
washings were transferred to universal containers and allowed to stand
for 3 min to allow the separation of large particles. The cell suspen¬
sion was passed through a previously moistened wire sieve. This
procedure leads to a consistently high yield of spleen cells with
viabilities of > 95$ as judged by the trypan blue dye exclusion test
(final concentration 1:2000 w/v). Where necessary sterile procedures
were performed.
b. Column separation of spleen cells.
Many methods have been used in attempts to specifically deplete
leucocyte populations of one or more morphologically, or functionally,
distinct type of cell. The most common method employs the use of glass
bead columns to separate cells that adhere to glass from those that do
not. Although most commonly used for the separation of peripheral white
blood cells, Plots and Talal (1967) and Shortman (1966) have used the
technique for rodent spleen and lymph node cells respectively. The
method to be described is a modification of that of Plots and Talal (1967)
and is based on the observation that the presence of divalent cations
seems important in the attachment of certain cells to glass. The
mechanism is unknown.
This method has been shown to achieve a degree of separation of two
main populations of cells. One depleted of mononuclear cells and
granulocytes and the other enriched in these cell types as well as in
cells actively forming antibody.
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Materials.
1) Hank's tissue culture medium was prepared either:-
a) without divalent cations (H)?
b) with divalent cations Ca++ 0.0018M, Mg++ 0.001M
and 10$ calf serum (HSC).
c) without divalent cations and with 10f calf serum
and 0.01M KDTA (HSV).
2) Glass columns - 15M x - three-quarters full with glass beads
2 mm diameter and washed for 10 min in concentrated nitric acid
followed by 20-30 volumes of distilled water. Air was drawn
through the column overnight to dry it. The capacity of the
column was about 25 ml.
3) Spleen cell suspensions were prepared as described previously
p.75 .
Method:
The column was equilibrated with HSC at 37°C. Cell suspensions from
three spleens were pooled and suspended in 5 ml of H medium. An equal
volume o? HSC was added and the mixture incubated for 20 min at 37°C»
Cells and washings were added to the column with the outflow clamped and
left at room temperature for 10 min. Cells were eluted and colleoted in
40 ml fractions, 90 ml of HSC and 75 ml of HSV being passed through.
The final fraction was collected by passing a further 25 ml of HSV through
after the column had run dry. This was the only time the fluid level
was allowed to drop below the level of the beads. The flow rate through¬
out was approximately 4 ml/min. The cells were centrifuged at 500g for
7 min before resuspending to the required volume. Viable and total cell
counts were performed at this stage. The first and last (5th) fractions
only were used in the experimental work to be described.
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9. Histological techniques
All histological techniques were performed according to standard
methods collated by Humanson (1967)*
Fixation of organs for sectioning was carried out using 10$ formalin
in 0.85$ saline or phosphate buffered saline or employing corrosive sub¬
limate (HgClg). Where autoradiography was to be performed the fixative
of choice was 10$ formalin in 3aline.
After dehydration in alcohols and clearing in toluene the tissues
were infiltrated with paraffin (56-58° grade) and embedded in the 3ame.
Sections 5 y" thick were cut, floated and warmed onto glass slides
lightly smeared with 'Tissue-Tac' (Dode Reagents Inc.).
Staining of sections depended mainly on Harris's Hematoxylin I
(progressive method), counterstained with eosin. Pyronin-methyl green
staining for nucleic acids was found useful where autoradiography was
done. Bacteria were stained for by the Brown and Brenatothod.
Sections were mounted in D.P.X.(BDH).
10. Autoradiographic sections
Materials:
1) Ilford K5 Nuclear Track Emulsion in gel form. Stored at 4°C.
2) ID 19 Developer - Ilford Ltd., used at 20°C in full strength.
3) Ilford 'Hypam' rapid fixer (liquid).
Method!
Sections were taken to water before coating with emulsion. The
emulsion was melted by diluting the shredded gel with 2 parts of water
at 50°C with very gentle stirring. The slides were coated and the
excess emulsion allowed to run off. The slides were air dried in a
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horizontal position before being stored at 4°C. Throughout the process
care was taken to avoid exposure of the emulsion to any light other than
minimal exposure to a brown safety light. After the requisite exposure
IOC 1
time (3-4 weeks for ?I and H) the autoradiographic sections were
developed (5 min with intermittent agitation), fixed and washed. The
slides were stained and mounted in B.P.X.
Buring examination care was taken to take into account the natural
background grains and distinguish this from 'specific* grains. It was
found convenient to study sections serially in order that grains could
be established beyond reasonable doubt as being the result of specific
disintegrations.
11. Carbon clearance?
The clearance of colloidal carbon from the circulation has been long
established as one of the methods of choice for quantitative estimation
of the granulopectic activity of the reticuloendothelial system. Although
the kinetics of phagocytosis have been shown to depend upon a variety of
factors like particle size, type of particle, concentration of particles
as well as other more complex variables, this method is still used widely,
in particular in comparative experiments. The method is that of Biozzi
et al. (1953).
Materials;
l) Carbon - 'Pelikan' shellac-free india ink, Gunther Wagner Ltd.
(Cll/l431a). This is a suspension of particles in fish glue
with a small amount of phenol added as preservative. The particle
size is approximately 250° A.
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2) Calibrated bleeding pipettes.
3) 0.1# Na^COy
4) 2$ gelatin solution in distilled water neutralised with
ammonia.
■Method:
The carbon suspension was spun at 5*000 r.p.m./l5 rain "to remove
large particles. The dry weight of carbon in the suspension was esti¬
mated and a 15 mg/ml suspension was made in 1$ gelatin as stabiliser.
This was kept at 37°C until injected in 5 mg quantities into mice via
the lateral tail vein. Mice were repeatedly bled for 0.05 ml from the
retro-orbital plexus over a period of 30 min and the blood lysed in 4 ml
of 0.1$ Na^CO^. The concentration of carbon was estimated by readings
obtained at 660 nyu in a Unicam SP 500 Spectrophotometer with the red
photocell. Blanks were prepared from blood collected from uninjeoted
animals. The log concentration of carbon, estimated by reference to a
standard curve, was plotted against time. A straight line equation
could thus be derived. The slope of the line was calculated by the
method of least mean squares. This gives the value of K (the phagocytic
index) which is a measure of the rate of clearance of carbon, or the
granulopectlc activity of the reticuloendothelial system. The animals
used in these experiments were within a very narrow weight range and no
correction was necessary for animal and organ weights.
12. Estimation of haemoglobin.
The method was that of Halpern et al. (1964). 0.05 ml of blood
from the retro-orbital plexus was lysed in 4 ral of 0.1$ NagCO^ and
immediately mixed. The released haemoglobin was read spectrophoto-
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metrically at 540 ra/U. Experimental results were expressed as a
percentage of control animals, saline injected and bled contemporane¬
ously.
13. Peripheral white blood cell counts.
0.05 ml of blood was collected into 0.5 ml 1# acetic acid and the
white cells counted in a standard Nauerberg counting chamber until the
standard proportional error was ^ 1$.
14. ^H-thymidine incorporation in jvdvo.
Cells actively synthesising DM were labelled by a 'flash' labelling
procedure. 20yuCi ^H-thymidine TRA 61 (Thymidine-6-T (n) in aqueous
sterile solution 5000 mCi/mM — Radiochemicals Centre, Amersham) was
injected intravenously into the lateral tail vein of mice which were
killed 15 min later by cervical dislocation. The organs were removed
and processed for autoradiography.
15. Acid phosphatase assay.
Materials.
1) acetate buffer pH 5*0, 0.4 M.
2) p-nitrophenylphosphate 5 mM solution
3) absolute ethanol
4) 0.25 a NaOH solution
Method.
Cells were sonicated at 20 kilo cycles/sec for 10 minutes. To
0.35 ml of the sonicate was added 0.1 ml of buffer and 0.05 ml of
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substrate. \fter incubation at 37°C for 30 min the reaction was stopped
by the addition of 2 ml absolute ethanol. 0.2 ml of sodium hydroxide
was added and the released p-nitrophenol read spectrophotometryally
at 410 rn^u against a blank where 0.35 ml of 0.29 M sucrose was U3ed in
place of the enzyme preparation.
16. Splenectomy.
Mice were anaesthetised by Nembutal and ether. The spleens were
removed and the blood vessels to the spleen sealed by cauterisation.
The small incision wound was closed with a 3ingle metal clip. Pull
3terile precautions were used throughout.
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HnSULTS
1. The immune response and the induction of tolerance to BSA in miee.
The initial aim of this work was to investigate the response of mice
to BSA, in particular with regard to the induction of tolerance by low
dC3es of antigen.
Although the response of mice to multiple injections of BSA ia
well characterised ( litchison, l%4)» their response to a 3ingle inject¬
ion is less well known. In 3pite of the inconsistency in the results
of Dietrich and eigle (1964) in their attempts to make mice tolerant
with a single injection of native P3A, it was decided to U3e single
injections of ultracentrifuged BSA to induce tolerance, if possible, as
this would give the simplest experimental system.
Preliminary experiments were performed to examine the relationship
between the dose of soluble ultracentrifuged BSA (c.BSA) and the response
of CBA mice, as judged by their response to a challenge with highly
immunogenic alum-precipitated BSA. Having shown that tolerance could
be induced by microgram doses of antigen, more information concerning
the induction of thi3 state was derived by examining the class and
affinity of antibody produced, the effect of the physical 3tate of the
antigen and the ability of different strains of mice to become tolerant.
The final aim of these experiments was to gain information that, when
taken in conjunction with the studies done with 0.parvus, vrould enable
some of the more important parameters in tolerance induction to be
elucidated as a step towards simulation of the basic mechanisms involved.
Antigen-binding capacities of antisera were routinely measured
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110ragc.BSA 25mgc.BSA 32mgc.BSA 40.05mgc.BSA 5Saline
5mga.BSA 5mga.BSA 5taga.BSA 5mga.BSA 5mga.BSA
c
3.60 5-63 0.30 0.00 0.44
b
(4) (4) (5) (3) (6)
0.69 0.49 0.20 0.00 0.08
(5) (6) (5) (3) (6)
1.09 4.14 2.26 0.06 5.26
(4) (5) (5) (6) (4)
0.98 1.47 0.45 0.04 1.03
(4) (5) (5) (7) (4)
#
aBSAconcentrationaddedit st
bnumberofseratest dp rg oup cgeometricmeanfABCvaluesf rg ouj
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The use of the lower concentration (3.6 z If) of the antigen Is
known to yield the most sensitive reproducible assay for low levels
of antibody (Pinckard et al., 1966a). At this level the minimal binding
capacity of the antisera is in fact being,measured (linden and Fair,
1967) and it might be expected that the high affinity antibody was being
preferentially detected. This problem can be overcome by also measur¬
ing the ABC values of tho antisera at a higher antigen concentration.
Additional information concerning the immune response is gained by this
manoeuver as the effect of antigen dilution on the abc value represents
a measure of the quality of the antibodies being*detected. In fact,
for the experiments performed, the quantity of anti-BSA antibody present
in an antisera wa3 found to be adequately represented by the ABC value
*
measured at O.l^i N or 0.01 y N I-BSA no matter what concentration of
the antigen was used. In many cases only the results achieved with
the latter concentration will be quoted and the effect of dilution of
antigen will be referred to where appropriate.
All injections were given by the intraperitoneal route to CBA mice
unless otherwise stated.
a. The response of mice to varying doses of centrifuged. B3A (c.BSA).
The response of cba mica to varying single doses of c.bsa (day -20)
was tested by their ability to respond to a challenge with 5 mg of a.BSA
given twenty days later (day 0). The antigen-binding capacities of sera
taken at 12 and 20 days after challenge were measured at two antigen
concentrations (Table l).
Results1
Because of the small numbers of mice in this preliminary experiment,
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group 4 receiving 30fxg of c.BSA seem to be rendered hyporesponsive
when compared to control group 5 (P<0.01). In addition, by inspection,
5 mg of c.BSA is shown to be about the optimal priming dose for antigen
given in this form (group 2) as judged by the early high ABC values of
sera in this group.
b. The induction of tolerance to B3A In CBA mice.
A
In order to reaffirm that low zone tolerance was being induced follow¬
ing the injection of yug doses of c.BSA, a further experiment was performed
that was, in addition, designed to examine the effect of potential variables
such as dose of c.BSA» the route of injection, the sex of the animals,
their body weight and the strength of the challenge dose.
Centrifuged B3A was found to induce a similar degree of unresponsive¬
ness in male and female CBA mice, weighing 16-18 or 25-27 g , whether
injected intravenously or intraperitoneally. As these variables were
found to be unimportant the results were pooled and can be seen in Table 2
as a function of the dose injected and time after the challenge. Doses
of 10, 50 and 200^ug of c.BSA (groups 3, 2 and l) were all capable of
inducing a profound hyporesponsive state in CBA irdc© as compared with the
normal responsiveness of the saline treated controls of group 4 (P<0.01).
In addition, it can be seen from the results for groups 5 and. 6 that
challenge with antigen in complete Preund 'a adjuvant resulted in a
general increase in circulating antibody titres in controls but the
degree of tolerance induced was not affected.
Comments:
In the light cf theao results it was possible to adopt a standard
regime for tolerance induction. A profound state of hyporesponsiveness
to BSA could be induced by doses of 10—200 ug of centrifuged antigen
Table3
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given intraperitoneally (day -20) to CM jii.ee of either sex and 16-27 g
body weight. A dose of 50yug c.ESA was chosen for use in the majority
of further experiments. The tolerant 3tate was tested for by a challenge
with 5 a.BSA given twenty days later (day 0). The test sera were
obtained at approximately day +10, +20 and +30 after this challenge.
This schedule was used in future experiments.
c. The effect of the physical state of the antigen upon tolerance
Induction.
Recent evidence has suggested a marked degree of biochemical hetero¬
geneity in albumin preparations (Peeters et al., 1970). Furthermore,
it is recognised that different physical forms of an antigen may vary
in their immunological potential. The following experiments were
performed in order to investigate the effects that the physical state of
the antigen might have upon tolerance induction.
The capacity of different physical forms of soluble BSA in tolerance
induction was tested in the dose range already shown to be optimal for
c.BCA. The results are presented in Table 3.
Results:
Soluble 'native* BSA (BSA) was found to be capable of inducing
tolerance (group l) and although the state was not quite as profound as
that induced by c.BSA (group 2) the difference was not statistically
significant (o.l < P <. 0.3).
Mildly denaturatod heated BOA (group 4) resulted in priming of 5° -
of animals as judged by the response to 200yug soluble BSA. This
challenge by it3elf results in no detectable antibody formation in
normal or tolerant animals (groups 7, 6) B.iA, which had been heated
at low pH and the residual monomer removed (pBSA), primed all mice for




























Included in Table 3 is a study on the effect of routine radio—
iodination upon the capacity of B"A to induce tolerance (groups 8, 9» 10)*
The low levels of substitution routinely used in this thesis did not
affect this biological activity of the molecule, a fact of considerable
importance to later studies.
The .ABC values of sera for group 5 (Table 3) were tested not only
*
with BSA in the Farr test but also against the same concentration of
*
p.BSA. 'The results can be seen in Table 4 for sera taken at day o
(group 1). The ABC vaJues were much higher when the aggregated test
antigen was used. Similar results were obtained whether c.BSA or p.BSA
was used to immunise the mice (groups 2, 3)•
Tina reason why 4 to 5 fold higher ABC values were obtained when
*
p.BSA is used as test antigen are at present under investigation. The
consistency of the increase, irrespective of the ABC value, obtained with
*
p.SSA allows valid conclusions to be drawn from experiments where only
*
B3A is the test antigen. Furthermore, in order to obtain a reproducible
#
assay system with p.BSA it is necessary to lower the concentration of
ammonium sulphate in the Farr test to , with a resulting loss of
precipitation of a proportion of the soluble antigen-antibody complexes.
These considerations, together with the difficulties involved in preparing
* *
a suitable aggregated p.BSA pret.aration, makes the use of p.BSA unsuit-
*
able for routine assay work at present and as a result BSA only was used
routinely in this thesis.
Comments!
The results presented show that the response of mice to ^0of BSA
is dependent upon the physical 3tate of the antigen. The greater the
degree of aggregation the less the degree of tolerance induced and the
greater the degree of priming.
Table5











1 2 3 4 5 6
CBA C57B1 CBAx57B1 KZB NZBxCBA DBA/2
a +
0.35^.11 0.02io.oi 0.40io.18 3.02io.84 1.56io.43 0.04- .02
b
(9) (8) (5) (9) (10) (5)
2.11-0.45(9) 0.04^0.03(8) 1.24-0.18(6) 7.34-1.02(10) 6.86^1.10( ) 0.49-0*20(7)
P<0.001 0.1<P<0.2 P<0.1 P<0.02 P<0.001 P<0.002
1.11 0.03-0.02 0.43^0.32 7.72-2.20 3.28^0.75 0.05^0.08
(?) (4) (4) (9) (9) (3)
3.73-0.21 0.08^0.04 1.86^0.41 12.33^1.70 16.34^4.90 0.83^0.25
(6) (4) (4) (8) (7) (6)
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d. Tolerance Induction In different strains of mica.
^ariced strain differences are known to exist in the immune respons¬
iveness of mice to given antigens and/or antigenic determinants (see p. II 2 ).
Pew synchronous studies, however, have been performed on the strain
requirements for tolerance induction, although on the basis of empirical
reasoning, a common threshold for tolerance induction has been suggested
(Dresser and Kitchison, 1968). It seemed important to examine different
inbred mouse strains with respect to the induction of tolerance and
immunity in order that the relationship between these two effects could
be examined.
It was of particular interest to include New Zealand Black (NZ.B)
mice in this experiment because of their lymphoreticular abnormalities
and their proclivity towards autoimmune phenomena. These features are
shared to a lesser degree by the (NZB x CBA) F^ hybrids also examined.
Other mouse strains included in the study were C57B1, CBA, their
hybrids and DBA/2.
Inter-and intra-strain weight variation were large (up to 6g) although
no correlation was observed between the final ABC values and body weight.
All mice, with the exception of the NZB strain, were 3-5 months old.
NZB mice ranged from 3 to 10 months of age and were either Coomb's
«
negative or Coomb's positive. No external features of severe illness
were apparent in any of the mice.
Results and Comments*
The results in Table 5 show market! strain differences in the response
to 5 rag a.BSA ('control* columns). It is interesting that (CBA x C57B1)
F1 hybrids display responsiveness intermediate between those of their
parents whereas (NZB x CBA) Fj hybrids seem to take on the parental
responsiveness of NZB.
89
In contrast to this marked variation in the 'control* responses,
all strains seemed to become tolerant to a lesser or greater degree
('test' columns). The significance values in certain cases are doubtful
probably because of the low level of normal responsiveness in the
appropriate 'control* mice.
Of particular interest in these results is the observation that NZB
mice, although becoming tolerant to a certain degree, did not seem to
display the same sensitivity to tolerance induction as the equally
responsive (NZB x CBA) hybrids. The response of NZB mice did not
correlate in any way with sex, age or weight nor with the presence of
Coomb's posltivity in the experimental animals.
e. Observations upon the quality of antibodies and tolerance.
It is well established that an immune response is characterised by
a change in the affinity of the antibody formed ('Plisen and Siskind, 1964).
It is often assumed that this occurs by the preferential stimulation of
high affinity antibody producing cells which parallels the decrease in
available antigen. By extrapolation it might be suggested that only
high affinity clones would become tolerant to low doses of antigen.
This hypothesis was tested using as an index the effect of antigen
dilution upon the binding capacity of the sera. The dilution effect
was expressed as the ratio of the values of the sera measured at antigen
concentrations of O.Ol^N and 0.1j>N #B3A added. This fraction is expressed
as a percentage. A low percentage is normally taken as being indicative
of the presence of an antibody population with a high dissociation rats
(Mlnden and Farr, 1967; sse p.65 )•
Table6
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Reiults:
Table 6 shows the effect of antigen dilution upon the antigen-
binding capacities of sera from primed and 'tolerant' CM mice, and
•non-tolerant' control mice treated in the standard manner with Br;A.
ABC values for these groups were significantly different (P<0.001).
Although the error in these calculations is high, it can easily be
seen that there is the expected tendency for higher affinity antibodies
to be formed later in the immune response. 'Tolerant* sera (compare
day 12 and day 20) (groups 2,4), however, show indices insignificantly
different from 'control' sera (groups 3,5) whereas animals that have been
primed display high affinity antibodies soon after challenge (groups 1;
day 12| P <0.01).
Comments:
These experiments suggest, but do not conclusively prove, that
tolerance to BSA in mice is mainly characterised by a decrease in the
quantity of antibodies produced rather than by a change in their affinity.
They also suggest that there is little or no priming effect following
tolerance to low doses of BSA.
f. The class of antibodies produced in the tolerant animals.
Possible changes in the class of antibodies produced following
challenge with a.BSA that might be the result of immune deviation caused
by prior exposure to soluble BSA were investigated. Radioimmunoelectro-
phoresis was performed on 'tolerant' and 'non-tolerant' sera taken 12 and
20 days after challenge. The developing sera were rabbit anti-mouse
gamma globulin (RAWS) and rabbit anti-mouse whole serum (RAMS). Four
immunoelectrophoretic lines developed with RAMG that were known to be
associated with antibody activity (Plate la).
Plate 1:. Immunoelectrophoresis of sera from tolerant mice.
Veil a. - 'non-tolerant' control sera* day 20.
./ell b. - 'tolerant' sera, day 2b.
Trough - rabbit anti-mouse gamma globulin.
125
. late lb. autoradiography showing the binding of I-3dA to the
immunoelectrophoretic lines in Plate la.
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l?1?
Autoradiography after exposure to VI-B3A showed that the anti-BSA
antibody in sera from tolerant and non-tolerant mice was of one class of
immunoglobulin tentatively assigned on the basis of immunoelectro-
t • «
phoretic behaviour. The only differences between tolerant and non-
I
tolerant sera lay in the density of the lines developed following exposure
to 125I-BSA (Flate lb).
Table7





























































2 3 4 5
l.p.8daysbefore i.p.4daysbefore i.v.4daysbefore tolerantcontrol non-tolerantcont ol
100yugc.BSA 100yugc.BSA lOCyUgc.ISA 100yUgc.BSA saline
5mga.BSA 5taga.BSA 5mga.BSA 5mga.BSA 5mga.BSA
notdone- notdone- notdone- notdone- Hotdone-
1.223(8)P<0.001 1.26(8)P<0.001 2.10(5)P<0. 2 0.29(8) 2.67(8)P<0.001
II
6 7 8 9
10
i.p.4daysbefore i.p.1hrbefore i.p.4daysfter tolerantcontrol non-tolerantcontrol
100yUgc.BSA 100yugc.BSA/ 100yUgc.BSA 100yUgc.BSA saline
5taga.ESA 5raga.BSA 5mga.33A 5mga.BSA 5aga.BSA
1.18(6)P<0.01 1.13(6)P<0.01 0.40(6)P<0.05 0.23(6) O.55(6)P<0.05
4.85(6)P<0.001 7.30(6)P<0.0 1 2.32(6)P<0.05 0.Q0(6) 4.34(6)F<0.01
*
aABCt0.01̂NBSA-geome ricmeanofvalu sf rroup.bnu berserate t dpr p,
csignificanceofdifferencesbetweenABCvalu sf rxp rim talgro pa dtol rano trol.
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2. The effect of bacterial adjuvants upon the induction of tolerance
to BSA«
Various adjuvants have been reported to be able to prevent the
tolerance induction to certain antigens in mice. C.parvum (strain 10387)
had already been shown to possess this ability in rabbits (Pinckard
et al.t 1968) and the following experiments were performed in an attempt
to study in detail the action of this adjuvant.
For comparative and aetiological purposes other agents were also
used. These were C.anasrobium obtained from the Institut Pasteur,
Bordetella pertussis - a well documented adjuvant, and SF16- a strain of
diphtheroids isolated by Steward et al. (1969) from the synovial membranes
and fluid of a patient with rheumatoid arthritis.
The standard regime for tolerance induction was used in CBA mice.
a. The effect of C^parvug upon tolerance induction.
Varying doses of C.parvum were given four days (day - 24) before the
tolerance inducing regime in a preliminary experiment to test the ability
of the organism to prevent the induction of tolerance to C.B3A in CBA
•7
mice. The results are expressed in Table 7» A dose of 8 x 10 bacteria
was found to be minimally effective (group 3). When doses greater than
V? bacteria were given there was slight evidence of toxicity with certain
preparations as judged by visible signs of illness in the injected mice.
g
For these reasons, doaea of 3 - 10 x 10 bacteria were chosen for future
experiments.
Table 8 shows the effect of timing and the route of C.pamun adminis¬
tration. There was no difference in the ability of C.parvum to prevent
induction of tolerance to BSA whether the adjuvant was given eight days
(group 1), four days (groups 2,6) or one hour (group 7) before the
tolerance-inducing regime. The effect was less marked if adjuvant was
Table9
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given four days after c.BSA (group 8). When C.parvum was given intra¬
venously the overall effect seemed to be enhanced (group 3) although
the variance of this group was high and therefore significance of the
results was diminished.
Incorporated into the design of these experiments was the effect of
sex of the animals which was found not to be an important variable. In
addition, control experiments showed that C.parvum had no obvious effect
upon the responsiveness of animals to challenge with 5 a.BSA 24 days
after the adjuvant treatment.
Commentsj
C.parvum can prevent the induction oflowzone tolerance to c.23A
in CBA mice of either 3ex if given up to eight days before, or the same
day as c.BSA injection. This effect was not as narked if the adjuvant
was given four days after the antigen.
For convenience and reproducibility of results, the intraperitoneal
8
injection of 3-lo x 10 C.parvum organisms four days before c.BBA treat¬
ment was considered a suitable system for further experiments.
b. The effect of SF16, C.anaerobium and B^pertussis on the induction
of tolerance.
Preliminary experiments showed that C.anaerobium and 3F16 had a
similar effect to C.parvum on the prevention of tolerance induction,
8
with a similar lower threshold of effectiveness (2.0 x 10 organisms).
The results of a comparative experiment upon the effect of these agents
are presented in Table 9« Both agents show similar effects to those
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The effect of B.pertussis upon the induction of tolerance is
summarised in Table 10. The dose chosen had been shown previously to
give an adjuvant effect in other systems. B.pertussis appears to be
more effective if given one hour rather than four days before c.BSA
(groups 4, 2).
Commentsi
SF16, C.anaerobium and B.pertussis have, like C.parvum, been shown
to be capable of preventing the induction of tolerance to c.BSA in CBA
mice. In view of the difficulties inherent in comparing bacteria by
numbers or weight, when the active principle cannot be assessed, it
would be invalid to judge the relative effectiveness of these agents
from the results presented.
c. The effect of C..parvum upon responsiveness to low doses of c.BSA.
The experimental results presented in Table 8 showed a relatively
high early rise in ABC values of sera from C.parvum treated animals
undergoing the tolerance inducing schedule (groups 6,7; day 12). It
has been already shown (section la) that this response is typical of
animals that have been primed. In order to show that priming occurred
following the initial injection of c.BSA, even though no serum antibody
could be detected, the effect of C.parvum upon the response was examined!
1. by the response of animals to challenge with a second sub-
immunogenic dose of B3A,
2. with relation to the quality of anti-BSA antibody formed,
3. with regard to the class of anti-BSA antibody produced.
Table11
























































C.parvun saline saline C.parvura saline saline saline
100yUgc.BSA 100y«gc.BSA saline 100yugc.BSA 100yugc.BSA^, B.pertussis 100Aigc.BSA saline
5aga.BoA 5mga.BOA 5mga.BSA 5-nga.BSA 5raga.BSA 5aig.BSA 5mga.SSA
31.2 20.8 19-5 25.3 25.6 15.5 16.5
P<C.C1 notsignificant P<0.01 P<0.01 notsignificant
34.1 32.7 29.4 28.6 30.2 25.6 28.9
P<0.05 notsignifi¬ cant notsignifi¬ cant notsignifi¬ cant notsignifi¬ cant
a.ABCt0.01-N*B3A// BC.̂Kx1 0/ b.sixerate tedineachgroup 8 c.5x10organismsC.parvurainjectedi p. 9 d.2x10'organismsB.pertus isinj ctedp.hrbefo ec.BSA
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Results:
As can be seen frora Table llt 200yug of B3A given at day 0, which
in itself did not produce an immune response in normal or supposedly
tolerant animals (groups 4»3)» did show that C.parvum and B.pertussis
treated animals undergoing a tolerance induction schedule, became
primed by the tolerance-inducing C.B3A (groups 1,2).
The significantly higher affinity of antibodies produced by
adjuvant treated animals early in the response to challenge with a.BSA
supported the concept that they were primed (Table 12| groups 1,4,5)*
Radioimraunoelectrophoretic patterns of sera from animals treated
C.parvum and undergoing the standard tolerance inducing regime
were compared with those from tolerant and non-tolerant animals. Auto-
1 OC I II
radiography showed binding of -labelled B5A by tolerant and ncn-
I
tolerant sera to a gamma line which was tentatively considered as being
yG ^ Only sera from C.parvum treated animals bound antigen in a y g
line as well as ^ and only then if the sera were taken twenty days but
not twelve days after challenge. According to its position the ^ 0
line was tentatively designed as being ®2b 2).
Comments:
C.parvum pretreatment led to the priming of mice that received a
tolerogenic dose of c.BSA. In addition, the features of the response
to later challenge v?ere altered such that the classes of antibodies
produced were different.
Plate Pa.Iranunoelectrophoresis of sei'a taken 20 days after challenge
with a.BSA. 'Jell a* - aera from mice pretreated with C.parvum
and undergone a tolerance inducing schedule. Well b. - Holerant1
control sera. Trough - rabbit anti-mouse gamma globulin.
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- lato 2b. Autoradiography showing the binding of I-B3A to tine
immunoelectrophorotic lines in Plate 2a.
Table 13









spleen 5 55 35 36 50 76 119
liver 4 51 4 6 19 21
thymus 2 29 30 35
lymph node 1 20 23
a organs weighed 4 days after injection of 4 - 8 x 10 organisms.
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3. The effects of adjuvants upon lyophorsticular tissues.
C.parvua has been shown to be capable of preventing the induction
of tolerance to o.BSA in CBA nice* In order to examine the mechanism
of adjuvant action, it seemed relevant to look at the effects upon the
lymphoreticular tissues brought about by these organisms, in particular
over the first days following injection.
a. The effect of C.parvua upon organ weight.
The weights of various organs four days after C.parvua injection
8
(4-8 x 10 organisms) are given in Table 13. All animals were carefully
matched with respect to body weight which did not change following
adjuvant injection.
A consistent significant Increase in the weight of spleens from
adjuvant injected animals over the saline treated controls was noted.
An Increase in size of the livers also followed C.parvua injection
although this effect was rather variable. Significant increases in
thymus weight and cervical lymph node weight were also found four days
after injection (P<0.01).
b. The effect of C.jgaryua upon peripheral white blood cell counts.
There was an Initial drop in the circulating white oell count
following the injection of standard doses of C.parvum (Fig. l). Hie
level reached a minimum value some hours after injection, however,values
obtained 5 and 8 days after injection were not significantly different
from the controls. The decrease appeared to be mainly due to a fall
in the numbers of circulating lymphocytes.
Days after injection
The effect of C,-. upon peripheral white cell counts.
3
jrlate 3«Tbe incorporation of H-thymidino into 0.0Ha in the spleen
Q? C> parwia - treated aninale5x3IO.
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c. Histological examination of the offsets of C.parvum.
Various organs taken from CBA mice treated four days beforehand
with C.parvum were studied histologically and compared with normal
controls* Animals received 1yuCi/g body weight of ^H-thyaidine
Intravenously 15 minutes before sacrifice. Sections of various organs
were examined for the presence of cells that had taken up the DNA
precursor.
In comparison with the controlet C.parvus treated animals had
intensely active spleens with expanded white and red pulp. A marked
degree of extramedullar? haematopoiesis occurred and numerous megakaryo¬
cyte cells were present. Hie general hyperplastic response was most
marked in the pertfollicular regions and it was (Plate 3) in this area
that the most profound increase in thymidine uptake occurred. An
increase in the number of labelled cells could be seen also In the red
and white pulp.
The livers of C.parvum treated animals had numerous granulomata with
mononuclear cell infiltration* in particular around the portal tracts.
Pew infiltrating cells were found to have incorporated ^H-thymidine.
There was a striking increase in the number of both reticuloendothelial
and parenchymal cells that had incorporated labelled thymidine) although
the former appeared to be mostly involved (Plate 4*1 4b).
Hie most obvious changes in the cervical lymph nodes were connected
with hypercellularity and expansion of the paracortical areas. On
histological evidence this did not appear to be completely due to
proliferation of existing cells although studies on ths uptake of
^H-thymidine were not performed. A very marked medullary plaamaeytosis
was also often found.
a*





A considerable apparent increase in the nuaber of reticular cells
and a general increase in the cellularity of the cortex in the thymuses
of C.partua treated mice was found although the study of ^H-thymidine
uptake was not performed.
The changes following C.parvua administration will be considered
further in connection with the localisation of antigen within these
organs.
© Control CBA y= i. 09-0 0158 x; T\ = 19 6hours.
© C.parvum treated y=/,76-0 0195 x; tV2= 15 ^. hours
B animals in each group.
5 lxlO^c/sec injected
30 60 90 120 150 180 210 210
TIME (hours)
r'1.7-tro . i. .lie clearance of 5~/Ug c. ... free the circulation of
G. aarrutsa treated mice#
© Control CBAy = V411-0013Ax; T If 22 5hrs
© NZB mice y=t 26/.-0-016 x; t]^= 18 8hrs
© Canaerobium treated CBA y=4 248-0-0196x; T ^ =15-thours





i&iiTg lb • a he clearance of 5G/ug c#3J.k from the circulation of
G» anaflroblum treated mice*
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4. The effect of adjuvants upon the localisation and clearance of BSA.
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The clearance of $0/ug of 'I-c.BSA from the circulation and its
localisation within the lymphoid tissues was examined in order to study
the mechanism whereby the C.parvum injection altered the balance between
tolerance induction and immunisation.
a. The clearance of BSA from the circulation.
g
CBA mice were injected with C.parvum or C.anaeroblmn (6 x 10
organisms) and four days later tested for their ability to clear from
the circulation 50of "^I-c.BSA injected intravenously. The mice
were bled every 24 hours. The amount of radioactivity precipitated
from the blood samples by 10^ TCA wa3 plotted on a log scale against
the time after injection. The results are presented in Figures 2a, 2b.
The equations for the best straight lines derived by the method of least
mean squares and the half life of the c.BSA for each treatment are also
given. Adjuvant treated mice showed faster non-immune clearance of the
injected antigen than did the controls. The highly significant differ¬
ences were corroborated by similar experiments done with smaller numbers
of animals. It is of interest that ffZB mice displayed accelerated
clearance when compared to CBA controls (Figure 2b).
By extrapolation to time zero (x ■ 0) it is possible to arrive at
a figure that represents the concentration of c.BSA that would be present
if the antigen was evenly distributed throughout the fluid volume of the
mouse. Having this information, and knowing the exact amount of antigen
injected, it is possible to determine the volume of fluid the antigen
is being distributed in. Although all mice were closely matched with
respect to body weight and all received the same dose of the same

























bmeanvaluesof7animalsp re chgroup •"t-testwithgroup2-P<0.05 00t-tcstwithgroup2-P<0.001.
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in the amount of antigen per ml of blood at zero time. Therefore
C.parvum or C.anaeroblum injection appears to result either in an
increase in the volume throughout which the antigen is being distri¬
buted or in an initial rapid disappearance of antigen from the circul¬
ation soon after its injection.
b. Gross localisation of BSA.
thymus, cervical lymph nodes, kidney and blood 28 hours after injection
taken as a measure of the amount of antigen retained. The pooled
results of these experiments are expressed in Table 14*
Total counts in the spleens and thymuses of C.parvum treated mice
(group l) were significantly increased over the control group 2 but not
if the results were expressed as counts/mg of tissue. No other signif¬
icant differences were found between these two groups.
Heat-aggregated BSA showed statistically significant differences
from c.BSA in its localisation in the spleen, liver and thymus (group 3).
The effect was most marked in the thymus where the total organ counts
were only 36 % of control values. No significant differences in the
organ weights between groups 2 and 3 were found.
12«5
c. Autoradiographic examination of the localisation of ^I-BSA
in tissues.
Tissues examined in section b. were processed for autoradiography.
Centrifuged BSA given to normal mice did not localise in any
particular area within the lymphoid organs, with the exception of a
In two independent experiments the organ distribution of
12*5
"T-c.BSA given intraperitoneally was examined in C.parvum pretreated
and normal control mice. Another group received 50yug of heat-
12*5
aggregated I-BSA. The radioactivity detected in the liver, spleen,
b.
* Late 5> autoradiography on a section of cervical lymph node from
, rouso prctreatcd /itl; C» , ■\jvq:i (a#) and n control ncusc (b.)
,-xi ,:A th 5/u.p, c. ♦
x 50
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slight degree of uptake by medullary macrophages in the lymph node and
125
the red pulp of the spleen. In the C.parvua treated animals I-c.BSA
uptake was increased, in particular in the cervical lymph nodes (?late3
5a, 51") • There was no germinal centre localisation similar to that
found in primed animals.
The distribution of heat-aggregated BSA within the spleen and
lymph node was similar to c.BSA but with a slight increase in the
quantity localised within macrophages (Plate 5c). Mice receiving h.BSA
did not display the expected reduction in grain counts in thymus, but
in no group was any apparent localisation of antigen noted within thymic
cells.
\
Plata 5c• Autoradiography on a section of cervical lymph node from


















bDerivedythm thodofleastmeansquares;=»l gmgc rbon/100lbl od, x=»timeinin(0-30min)
cnumberofmicep rgroup
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5« The effect of C.parvus* upon the localisation and clearance of carbon*
a* The clearance of carbon from the circulation
The clearance of colloidal carbon in C.parvum treated and control
mice was examined in order to study and verify the effect of C.parvum
upon reticuloendothelial activity. Female mice were injected with
5«5 mg of oarbon intravenously four days after C.parvua treatment and
then bled at four minute intervals for 30 minutes. The results of two
such experiments are expressed in Table 15 as the equation for the
straight lines derived from plotting the log of concentration of carbon
(og/lOO ml blood) against time. The method of least squares was used
to derive equations.
Besultes
There are two obvious points. The first is that carbon is
cleared more rapidly from the circulation of C.parvua treated animals
than controls. This was twe for all animals tested. Secondly, in
groups of animals closely matched by weight and sex, by extrapolation
to time zero, it can be seen that the volume of fluid through which
the carbon is distributed appears to be greater in C.parvua treated mice.
Similar results were obtained when the clearance was studied 30 - 120
minutes after injection.
b. Hletological examination of carbon localisation.
Control mice and mice that had received C.parvua 4 days previously
were sacrificed 4 hours after the intravenous injection of 5*5 ot
carbon and their spleens and livers processed for histological examin¬
ation.
2 I 2 5 , *
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In control animals carbon was found localised in the marginal
zone and in the macrophages of the red pulp of the spleen. In
C.paryum treated mice there was a marked increase in the uptake in red
pulp (Plates 6a, 6b).
An increase in the number of histiocytes containing carbon in the
livers of experimental animals was also found (Plates 7'4» 7b). Few
cells in the granulomas found in C.parvmn treated animals had taken
up the carbon.
6. The activity of macrophages treated with C.parvua in vitro.
As C.parvum was found to affect the uptake of o.BSA in vivo,
attempts were made to reproduce this effect in vitro. The assay
system for activity of macrophages was modified from the work of
Threnreich and Cohn (1967)# Hie time course of ^^I-BSA uptake was
studied in this laboratory by Mrs. A. MeCraken. The amount of *B3A
taken up by washed peritoneal macrophages adhering to glass was found
to increase with time over the first 24 hours of culture.
The acidphosphatase level, often taken as a measure of macrophage
activity, was increased in peritoneal macrophages taken from animals
that received C.parvum four days before hand (164$ of control). How¬
ever, no change could be detected in the uptake and retention of *BSA
by these macrophages at any time during the culture period (up to 48 hr).
Similarly normal macrophages incubated in presence of C.parvum (lo^ -10^
organisms per chamber) failed to show any enhanced uptake of
Plate V« The localisation of carbon in the livers of C.parvum
pretieated (a*) and control (b«) micej (xl25)*
Table16
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7. The effeet of C«^arvum treated spleen cell populations upon
tolerance Induction.
The following experiment was designed to test the ability of
spleen cells to transfer the adjuvant effeot of C.parvum. Populations
of cells that adhered to and that did not adhere to glass were distin¬
guished in order that the activities of the two populations could be
examined separately* A modification of the method of Plots and Talal
(1967) was used to separate the cell populations on glass bead columns*
8
Donor mice received either 6 x 10 C.parvua organisms or saline
intravenously four days before sacrlfioe. The spleens were removed,
homogenised and the non-adherent (first) and adherent (fifth) cell
fractions separated. Recipient mice were injected intravenously with
0.8 x 10^ cells from one or other of these fractions 24 hours before
the start of the standard tolerance inducing regime.
Results!
The results of this experiment are presented in Table 16. The
recipients of normal spleen cells (groups 1,2) became almost as
byporesponsive as tolerant control animals (P>0.5). In contrast,
recipients of spleen cells from C.parvum treated donors, irrespective
of whether an adherent or non-adherent cell population was injected,
show a significant lack of tolerant state (P <0.05 J day 12$ groups 3,4).
5
The results of acid phosphatase assays on 2.1 x 10 cells of the
different oell populations injected are in Table 17* Although the
C.parvua treatment caused an increase in acid phosphatase levels of
both adherent and non-adherent cell populations, a more substantial
increase was observed in the fifth oell fraction.
Table 17
5
Acid phosphatase assay on 2»1 x 10 spleen cells.
C.parvum treated spleens Control spleens
Traction 0I>410 myu Traction 0D410 nyu
let non-adherent 0.37 * (4) 1st non-adherent 0.27 (4)
5th adherent 1.01 (4) 5th adherent 0.36 (40
a mean of four assays per group
Table18
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8. Attempts to dsteot the release of lymphoid.ne8 following C.parvua
Recent studies suggested that the Interaction of phytohaemagglutinin
with normal lymphoid cells, or of antigen with specifically sensitised
lymphoid cells, could result in release of biologically active molecules
(see Lawrence and Landy, 1969)* Those reported include a macrophage-
inhibiting factor, mitogenic factor, transfer factor, interferon, an
inhibitor of ENA synthesis and a cytotoxic factor* It was thought
possible that the release of active soluble factors may in part be
responsible for the adjuvant effect of C.parvma.
Salmonella endotoxin has recently been shown capable of stimulating
the incorporation of ^H-thymidine into 'normal* mouse spleen cells
(Peavy et al., 1970)*
My attempts to induce in vitro transformation of both mouse spleen
cells and human peripheral leucocytes with C.parvum were unsuccessful.
Furthermore, cell-free and bacteria-free supematants, taken from cultures
8
of spleen cells incubated with and without C.parvum or B«pertussis (10
organisms per spleen) for 4 or 24 hours at 37°C were unable to prevent
the induction of tolerance of mice to o.BSA injected on# hour later
(Table 18, groups 1,3)* Control animals (groups 2,4) received 1 ml of
supernatant from normal spleen cell cultures to which the appropriate
number of bacteria had been added 10 minutes before the supernatant was
removed. The supernatant was cleared of cells and bacteria by
centrifugation.
1q6
9. The effect of splenectomy upon the adjuvant effect of C.Parana.
These experiments were performed with the aim of studying the
impact of splenectomy upon the adjuvant effect of C .Parana.
The response to SRBC was examined since » in mice* this is known to
be dependant upon the presence of the spleen (Perkins* 197C).
Experimental CPE mice were Injected with C.Parana and four days later
7
with 5 x 10 3KBC • The splenectomy or sham splenectomy was performed one day
before adjuvant Injection* five days before the administration of the srbc •
Besuits:
The results of this experiment are summarised in Table 19* Splenectomy
led to the expected decrease in response to the antigen*(groups 3 and U)»
The adjuvant effect of C.parvum was noticeable*(groups A and 2)« Splenectomy
did not completely abolish the adjuvant effect*(groups 1 and 3)«
Mld2
The effect of splenectomy upon the response to 3RBC and the adjuvant
effect of Qi PflfYWff*
Treatment f'rota day 0 Agglutinatic n titres


















5.2 - 0.3 (6)
1.2 - 0.2 (5)
2.5 - 0.2 (5) '
6.0 «• 0.6 (6)
8.6 - 0.1 (6)
2.3 - 0.7 (5)
4.0 - 0.6 (5)
9
a* 4 x 10 organisms C.Psrvum i.p.
b. mean of log x.
2
c. standard error of the mean*





In this thesis the response of mioe to bovine sejum albumin has
been described with particular emphasis upon the development of a
model system for the induction of tolerance by a single dose of the
antigen. The tolerant state and certain of the factors influencing
its induction have been studied in detail. Considerable attention
was given to the effect of the 'physical* state of the antigen as well
as to the effect of different genetic background of the experimental
animals upon the process of tolerance induction. The effect of
bacterial adjuvants, and C.parvum in particular, upon the induction
of tolerance in the experimental system studied has been described.
The results of each of these studies shall be discussed individually
with reference to the present state of available knowledge.
Bovine serum albumin as an antigen in mice.
The well documented finding that BSA is a poor iramunogen in mice
(Dresser and Mltchison, 1968) has been confirmed in this study. Centrl-
fugsd BSA (c.BSA) Induced a profound degree of low sone tolerance in CBA
and other mouse strains when given in saline in doses of 10 - 200yug.
Higher doses (2-5mg) appeared to result in simultaneous existence of
tolerance and immunity.
Although low sone tolerance to B3A in mice has been reported to
follow multiple injections of the antigen (mtchison, 1964) there are
few reports that the state can be induced by a single injection. The
experiments of Dietrich and Weigle (1964) on mice, using- single doses of
BSA suggested that "tolerance could be induced only in a small proportion
of animals" and that "the degree of tolerance was not clearly related to
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the dose of BSA.M Dietrich (1968) later reported that tolerance, as
judged by immune clearance of antigen, could be induced in C57B1/6 mice
by i.p. injection of 1 or 10 mg BSA but not by 10 or lOOyUg. These
dosage requirements do not agree with those presented in this thesis.
However, doses of 1 - lOOyug of BSA have recently been reported to induoe
tolerance in CPA mice (Thorbecke, 19^9)» a result which is in agreement
with those reported in this thesis. It is possible that the indirect
immune elimination method of antibody assay used by Dietrich (19^8) is
responsible for the conflicting reports.
The single doses of BSA found to induce low zone tolerance in mice are
strikingly similar to those used by Mitohison (1968) for multiple injections.
This supports the assumption of Dresser and Mitchison (1968) that the dose
per one injection rather than the total dose injected should be used to
evaluate the threshold of tolerance induction to serum proteins.
Mitchison (1968) reported that the induction of tolerance with micro¬
gram quantities of BSA required weeks of thrloe weekly injections. Prom
this observation he concluded that the rate of tolerance induction is slow
in comparison with the rate of elimination of the antigen from the circul¬
ation (T^19hr). The results expressed in this thesis do not fully
support this hypothesis for the following reasons•
A similar degree of partial tolerance to BSA can be induced in the
absence of detectable priming, over a ten fold dose range of single
antigen injections. A second injection of BSA makes the tolerant state
more profound if this is given ten days after the first injection but
not if injected along with or 24 hours after the first injection
(McSridej unpublished). A tentative explanation may be that not all
antigen-sensitive cells are made tolerant by the first injection, possibly
because of their inaccessibility to antigen, and that having, in time,
become accessible they can be made tolerant by a second injeotion of antigen*
Another possibility that also requires investigation is that recovery of a
•virgin* cell population may occur during the time interval before challenge*
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The affect of the physical state of BrA upon tolerance and Immunity.
The response of CBA mice to BSA given in different physical forms,
displayed their capacity to discriminate between •aggregated' and 'non-
aggregated ' materj al •
Bovine serum albumin that was denatured by heat and by low pH (p.BSA)
with non-aggregated material removed, was found to be highly immunogenic
In doses that led to tolerance induction when centrifuged material was
used. In oontraet, h.BSA prepared simply by heating a saline solution
of BSA, was shown to prime only $0% of the animals injected in the sams
dose range. Native BSA was only slightly less tolerogenic than centri¬
fuged BSA (c.BSA).
The removal of aggregated materials from purified serum proteins
has become a standard method for enhancing their ability to produce
tolerance. 'Aggregate-free' preparations of bovine and human gamma
globulins, prepared by ultracentrifugation or in vivo 'filtration', have
been found tolerogenic in mice (Dresser, 1962a; Oolub and Weigle, 1969)*
Similar conclusions have been reported on experiments employing other
species (Battiato and liiller, 1962; Biro and Garoia, 1965; Pinekard
et al., 1968).
Prei et al. (1965; 1968) attempted to relate the presence of phago-
cytosible aggregates in BSA to the antigenicity of the native material.
BSA prepared by passage of native antigen through a rabbit was found to
be capable of inducing tolerance in other rabbits. The native antigen
and also 'dimer' BSA, separated from monomer by gel filtration, induced
immunity.
Tbihanced phagocytosis of antigen that could occur as the number of
the aggregates in the BSA preparations increases, could account for the
results reported in this thesis. Autoradiographic studies on the local¬
isation of c.BSA and h.BSA supported this hypothesis. The gross
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localisation of antigen in tissues 24 hours after i.p. injection also
shoved differences between c.BSA and h.BSA. The finding of slightly
less h.BSA than c.BSA in the spleen and livers of injected mice may be
the result of phagocytosis of aggregates by the macrophages of the
peritoneal cavity. Of particular Interest, however, was the finding
that there was on average 50 to 75^ less h.BSA than c.BSA localised in
the thymus of injected mice.
The role of the thymus, or cells derived from the thymus, in the
induotlon of tolerance has recently received considerable support
(Taylor, 1969? Pierpaoli, 1967)* Aggregated BOG has been shown capable
of inducing tolerance in X-irradiated rats only if it was injected
directly into shielded thymus but not by any other route (Horluehl and
Waksman, 1968). The inability of aggregated B3A to penetrate the thymus
following i.p. injection could result in the escape of this population
of cells, some of which are undoubtedly capable of responding to BSA.
The eentrlfuged (c.BSA) and heated BSA (h.BSA) used in the experi¬
ments described in this thesis have been shown to have different effects
upon a lysosomal enzyme content of mouse spleen cells. The acid phos¬
phatase level was increased 48 hours after an injection of 50yug c.BSA
whereas an injeotion of h.BSA led to a decrease (Jacob and Weir, 1971)*
Fractionation of spleen cells suggested that these changes occurred
within the lymphocyte population (Jacob, 1971)* The early proliferative
response of certain lymphoid cells to thymus-dependant antigens (Daviee
et al.t 1966) suggests that it may be thymus-derlved cell population that
ie reacting differently to the two physical forms of BSA. Aggregated
HOG can stimulate the in vitro transformation of primed rabbit spleen
cells to a significantly higher degree than aggregate-free HOG (Abdou
and Richter, 1970).
Ill
It is therefore possible that differences in the relative abilities
of 'aggregated* and * non-aggregated * BSA to directly stimulate lympho¬
cytes, or to directly rr.ake them tolerant, could account in part for the
results reported here. It is, however, difficult to avoid the con¬
clusion that, in the present model, antigen handling plays a vital role
in determining whether tolerance or immunity is induced. It is at
present not known if steps subsequent to antigen handling are also
involved.
The finding that the aggregated BSA used in these experiments
seems to possess determinants that are not normally found on the native
molecule (McBrlde, unpublished) also requires further examination.
Native BSA is relatively incapable of inhibiting the binding of p.BSA
by anti-BSA antibodies, suggesting the presence of 'denaturation* sites
on the aggregated molecule. Antibodies that bind these sites appear
to follow the injection of native or aggregated BSA. It is possible
that it is the antibody directed against these sites that accounts for
the higher ABC values obtained when aggregated B3A is used as the test
antigen in the Parr assay. Similar finding have been reported by
other workers using different techniques (Peters and Costsi, 19^9)•
The relationship of thsss 'dsnaturation' sites to the immunogenicity
of the molecule is at present not known*
Strain differences in the immune response and induction of tolerance
to BSA.
The induction of tolerance in different strains of mice was under¬
taken in order to investigate whether the low sone threshold for toler¬
ance induction to BSA existed independent of the physiologic and genetic
background of the strain, and independant of the normal response of the
strain to that antigen.
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a. The imaune response to a»B5A.
As expected,differences were found in the normal responses of
six inbred strains of mice to a standard dose of a.BSA. While the
presence of subclinical infections and other environmental influences
can not be disregarded, it seems likely, especially in view of the
responses of the F^^ hybrids tested, that the different levels of
responsiveness of the strains can be attributed to genetic factors.
The immune response to an antigen is a complex process which must
involve genetic control at several levels. The ability to respond to
a specific antigen, however, can be selected for by breeding experiments
(Sobey et _al., 1966} Hardy and Rowley, 1968). Furthermore, immune
responsiveness of mice and guinea pigs to certain synthetic polypeptides
was shown to be under the control of several autosomal genes (McDevitt
and Benacerraf, 1969)* The genetic control of the response to more
complex antigens is less well documented.
Marked differences were shown to exist in the strength of the
responses of five inbred mouse strains to egg albumin adsorbed on alum
(Fink and Quinn, 1953). The production of natural anti-SRBC agglutin¬
ins in two inbred mouse strains, their F^^ hybrids and reciprocal back-
crosses appeared to be under a dominant quantitative control (Stern et al.,
1956). Similar results were obtained in a study of the number of anti-
sheep erythrocyte plaque-forming cells produced in different inbred mouse
strains (Playfair, 1968). By contrast, other reports suggest a lack
of genetic control of the response to complex antigens (McDevitt and Sela,
1965).
The genetically controlled differences in the specificity of anti¬
bodies produced in mice to branch chain aminoacid polymers have been
interpreted as concerning the nature of the antigenic determinant to
which the animal makes its most vigorous response (Mozes et al.» 1969)*
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Furthermore, genetically controlled differences in the fine specificity
of antibodies to one haptanic group ha3 been reported (Paul et _al., 1970a)*
It has been suggested that these fine genetically controlled features
of the response may often be masked when there are a large number of
different antigenic determinants against which the whole response is
directed (KcPevitt and Sela, 1965)* resulting in an apparent lack of
genetic influence.
If, as seems likely, the differences between the responses in the
strains tested, are genetically based, one must ask why the differences
are 30 obvious. McDevitt and Sela (1965) could find ho differences
between the responses of C57B1 and CBA mice to B5A given in complete
Freund's adjuvant. The discrepancy between their results and those
reported in this thesis may be due to a dose or adjuvant effect, but the
following should also be considered. In this work the low antigen
concentrations used to te3t for serum antibodies could be preferentially
detecting high affinity antibodies. These antibodies might be expected
to more readily display the fine differences in specificity for antigen
that other workers have reported show genetically controlled strain
variations. Marked differences were found in the affinity of antibodies
produced by the different strains of mice used in this thesis, as meas¬
ured by the effect of antigen dilution. Although only a few animals
were tested in each group, the results suggested that those strains for
which high ABC were found also produced high affinity antibody (McBride,
unpublished). Further support for this hypothesis comes from recent
experiments that show that the response of mice to ovalbumin adsorbed
on alum appears to be linked to H2 histocompatibility locus, provided
only low doses of ovalbumin are injected (Vaz et al., 1970). Low doses
of antigen preferentially stimulate high affinity antibodies (Eisen and
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Siskind, 1964) and these might be expected more readily to show differ¬
ences between strains because of their high degree of specificity.
By contrast to the differences between strains in their response
to a.BSA, all strains, with the possible exception of NZB mice appeared
results of limited statistical significance were obtained this appeared
to be due to the rather small numbers of animals in the groups and the
low levels of antibodies produced in the control animals.
b. Tolerance induction.
Pew synchronous studies are available on the strain requirements
for tolerance induction. Inbred mouse strains have been shown to
differ in the dose of ultracentrifuged HGG required to produce high
zone tolerance (Golub and Weigle, 1969)* This variation, however,
seems to be dependant upon the presence of trace amounts of aggregates
in the antigen preparations, and hence presumably upon the efficiency
with which the strains process these aggregates. On the basis of
empirical argument it has been suggested that the low zone threshold for
tolerance Induction, in the absence of an immune response, is relatively
constant for different species and strains of animals (Dresser and
••0 -10
Mitchison, 1968), an antigen concentration of 10 M to 10 II being
most efficient. This hypothesis is strongly supported by the data in
-7
this thesis, 10 M c.BSA inducing a degree of tolerance in six inbred
mouse strains. It appears that the actual thresholds of immunisation
are also similar in the strains studied, and that the variation in
antibody titres is the result of events subsequent to those necessary
for the triggering of the response. As a corollary, it could be
inferred that those genetic factors that govern the immune response are
not important in the state of tolerance, and that the pathways of
to become tolerant following a single injection Where
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induction are different for the two processes. It is tempting to
consider the uptake or non-uptake of antigen by reticuloendothelial
cells as being the factor determining the eventual outcome of challenge.
c. The response of NZB mice to B3A.
Of particular interest in this study were the responses of the NZB and
(NZB x CBA) mice to B3A. Mice of NZB strain spontaneously develop
immunopathological disorders of an autoimmune nature. They have a high
incidence* with age, of Coomb's positive haeraolytic anaemia (Bielchowsky
et al.. 1959)• Both NZB mice and their hybrids also show a varying
but high incidence of such generalised disorders as thymic and renal
lesions (Burnet and Eclmes, 1962} Mellors, 1965), serum anti-nuclear
factors (Norins and Holmes, 1964^glomerulonephritis (Howie and Helyer,
1968) and malignant lymphomas. The degree to which these phenomena are
expressed varies markedly with the age of the animal, its sex and the
line studied. Associated phenomena include abnormal plasma cell prolif¬
eration and macroglobulinemia (Past et al., 1965} de Vries and Hijmans,
1967).
No conclusive evidence exists for an initiating mechanism of the
autoimmune processes. Both intrinsic genetic defects involving abnormal
proliferation of autoreactive clones (Burnet, 1962a) or thymic epithelia
(de Vries and Hijmans, 1966), and extrinsic viral-like factors (Past and
da Sousa, 1966) have been implicated as causative agents.
Fundamental to understanding the genesis of the NZB mouse disease
is to know whether the defect in these mice operates speoifioally in
the self-recognition system or if it affects the immunologic performance
of the animal as a whole. It was in order to investigate the latter
of these alternatives that the NZB and (NZB x CBA) P^ mice were included
among the strains undergoing the tolerance inducing schedule.
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NZB mice and their F^ hybrids responded best of all the strains
tested to challenge with a.BSA. The degree of tolerance produced in
NZB mice after prior treatment with c.BSA was markedly less than with
the other strains. In particular,the degree of tolerance produced in
(NZB x CBA) F^ mice was much greater than in the NZB strain alone. In
both 'tolerant' and 'non-tolerant' pooled NZB sera the effect of dilution
of antigen upon the antigen binding capacities was less marked than in
sera from the other strains (licBride, unpublished). This seems to
suggest that the affinity of the antibodies produced in these mice is
high.
Recent reports have suggested that the response of mice to 2, 4, 6 -
trinitrophenyl hapten (Rathburn and Hildemann, 1970) and ovalbumin (Vaz
et al., 1970) are regulated by the products of alleles at the H2 locus
of mice. In this respect it is interesting to compare the poor response
of DBA/2 mice with that of NZB strain, as these are histocompatible at
the main H2 locus.
The characteristics of the response of NZB mice to BSA sure suggest¬
ive of influences which do not appear to be present in the response of
mice from non-autoimmune strsdns. This conclusion has been supported
by work undertaken in other laboratories. Farly development of immune
reactivity in NZB mice has been described using SRBC as a test system
(Playfair, 1968j Fvans et al., 1968), but not when pig or chicken erythro¬
cytes were used (Playfair, 1968). Hyper-reactivity of young adult NZB
mice to SRBC (Reiner, 1966} Morton and Siegel, 1969)» to egg albumin
and bovine gamma globulin (Staples and Talal, 1969) and BSA in complete
Freund's adjuvant (Cerottini et.al., 1969) has been reported. In
contrast, old overtly autoimmune NZB mice showed depressed primary but
not secondary responsiveness to SRBC (Deiner, 1966) and young adult mice
showed no hyper-reactivity when challenged with keyhole limpet
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haemocyanin. In addition to the studies reported in this thesis NZB
mice have recently bean 3hown relatively refractive in their ability
to be made tolerant to BOO (Staples and Talal, 1969).
In the view of the number of studies dealing with responsiveness
of NZB mice it is surprising that there is so little data concerning
the In vivo fate of the antigens used. Very recently Morton and Siegel
(1970) reported that the clearance of colloidal carbon and technetium~99n
sulphur colloid from the circulation of old NZB mice was faster than that
observed in the young animals and Balb/c mioe. The reticuloendothelial
activity correlated with the state of splenomegaly. In this study young
Coombs negative and Coombs positive NZB mice showed an accelerated rats
12*
of clearance of a tolerogenic dose of ■'I-BSA as compared to the CBA
strain. Furthermore, by extrapolation to time zero it was found that
NZB mice had a higher plasma volume as compared to weight-matched CBA
mice or there was a very rapid Initial clearance of antigen from the
circulation. The ability of NZB mice peritoneal macrophages to take
12*
up I—B3A was superior to that of macrophages from CBA animals during
the early stages of tissue oulture (McBride and McCracken, unpublished),
and Balb/c mice (Whyte, unpublished). This finding seems to be related
to the age of the animal from which the macrophages are taken. The
abnormal responsiveness of the NZB mice may therefore be associated with
abnormalities in the reticuloendothelial activity of this strain. These
could be associated with their persistent viral infection (Fast and
de Souza, 1966). Differences in the handling and processing of c.BSA
or trace amounts of aggregates in the antigen preparations may result
in the prevention of tolerance induction. Another possibility, howevsr,
is that tolerance is difficult to induce because of a defect in the
thyraus-derived lymphocyte population that appears to exi3t in the NZB
strain (Chaffer et al., 1970). In any event it seems that the
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immunological performance of these mice is abnormal in aspects of their
response other than the production of autoantibodies.
The quality of antibodies produced in tolerant animals.
Since the antigen binding capacity of an antiserum is known to be
influenced by the relative avidity of the antibody present, the effect
of antigen dilution upon the ABC value was determined using two concen¬
trations of antigen. This provided information upon the quality of the
antibodies being produced by tolerant animals.
The results presented in this thesis show that the quality of
binding of BSA by anti-BSA antibody is similar in both 'tolerant' and
control sera following challenge with a.BSA. Furthermore, the 'effect
of dilution' ratio^increased to the same degree in both tolerant and
control animals with time during the immune response.
An immune response is characterised by a change in the affinity of
the antibody formed, from low, early after immunisation, to high late
in the response (Eisen and Siskind, 19M). This can be interpreted as
the display of a mechanism based on thermodynamically driven selection
of cell populations participating in Immunologic reactions. It is
assumed that as the antigen concentration decreases, only those cells
capable of synthesising antibody of high affinity can capture the
antigen. This results in their preferential stimulation and prolifer¬
ation. By extrapolation it might be suggested that only high affinity
cells would become tolerant to low doses of antigen if direct interaction
of antigen with lymphocytes was necessary also for this process to occur.
This hypothesis has received some degree of experimental support.
Rabbits made partially tolerant by neonatal injection of DN3» and a carrier
gave rise to anti-hapten antibodies of low affinity for T)NP-£ -lysine
after challenge (Theis and Siskind, 1968).
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Tho similarities between the antibody affinities of sera from
tolerant and non-tolerant mice 3hown in this thesis do not support the
simple hypothesis that only high affinity clones are affected during
tolerance induction to B3A. This may be due to the complexity of the
antigenic form where the heterogenous array of anti-BSA antibodies for
the many antigenic determinants on one molecule may mask the effect.
On the other hand the difficulties inherent in considering tolerance
in simple thermodynamic terms should not be minimised. The presence
of only low affinity antibodies in the serum of tolerant animals
following challenge, described by Theis and Siskind (1968), may be
explained as follows. The specificity of much of anti-TNP antibody
is not only associated with the •immunodominant' hapten molecule but
also with the carrier. As a result the affinity of the antibodies
observed may depend upon the test antigen used. Changes in the speci¬
ficity of the antibodies or the clas3 of antibodies produced by tolerant
animals could lead to the observation of low affinity antibodies in
these animals. The same result could also be obtained by the selective
suppression or the removal by antigen of high affinity antibodies that
could be the result of a certain degree of priming during the initial
stages of tolerance induction.
The effect of adjuvants upon tolerance induction.
The effect of bacterial adjuvants upon the response of mice to
B3A was examined at the low antigen doses in order to further elucidate
the factors that govern the induction of tolerance or immunity.
C.parvum, C.anaeroblum, 3F16 and B.pertussis have been shown to be
capable of preventing the induction of low zone tolerance to BSA in CBA
mice. Instead of tolerance a degree of priming is produced that was
detected by the qualitative and quantitative aspects of the response
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after further challenge. The sex of the animals had little effect
upon the results of these experiments though the dose of adjuvant and
the time of its injection were found to be crucial. The importance
of these variables ha3 been reported in other similar systems.
Claman (1963) demonstrated that mice could respond rather than
become tolerant to 1.9 mg BGG if they were injected two hours previously
with 100 mg of S.typhosa endotoxin. Similar results were obtained
using BCG or actinomycin D as adjuvants (Dresser, 1962; Claman and
Bronsky, 1965)*
Adjuvants of this type have often been shown to be effective only
if they are given at a time when they may reasonably be thought of as
influencing the initial stages of a response. The mechanisms by which
they work, however, are obscure.
The fate of a tolerogenic dose of BSA in normal and C.parvum treated
animals has been studied quite extensively in this thesis. The conclus¬
ions as to the effect of C.parvum treatment may be expressed as follows:
a. BSA is catabolised faster during non-immune elimination of
the antigen from the circulation.
b. BSA appears to be distributed throughout a greater plasma
volume in C.parvum treated animals.
c. There is no obvious difference in the gross distribution of
c.BSA In the lymphoid organs.
d. In normal animals the C.B3A was diffusely scattered throughout
the lymphoid organs. In C.parvum pretreated animals antigen
was, in addition, concentrated by the reticuloendothelial cells
in the medulla and marginal zone of the lymph node and spleen.
In addition to altering the distribution of injected antigen,
C.parvum also causes alterations in the circulation of lymphoid cells and
in the haematological picture. Before considering in greater detail the
adjuvant action of this organism it is necessary to evaluate the role of
these other effects.
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Changes in lymphoid organs following C.parvum administration.
Two features of C.parvum administration that have been shown to
occur a few days after injection are lymph node and thymic hyperplasia.
Marked hypercellularlty and expansion of the paracortical regions
of cervioal lymph nodes was found to follow i.p. administration of C.parvua.
The number of blast cells was increased in these areas. These changes
are similar to those observed after an injection of antigenic and non-
antigenie adjuvants (Taub at al., 1970). These workers stressed the
similarity of this response to that following local stimulation of contact
hypersensitivity (Oort and Turk, 1965)* This response is thought to be
thymus dependent (Parrott and de Souza, 1966). Other ohanges in the
lymph node Include a generalised reticuloendothelial hyperplasia and
marked medullary plasmacytosis. The former may be reflected in the
increased uptake of c.BSA already mentioned.
Thymic hyperplasia can be found in animals that received C.parvua
four days before sacrifioe. Histological examination revealed little
alterations in the medulla to cortex ratio and the only consistent finding
was reticulum cell hyperplasia with generalised hypercellularlty. Unfort¬
unately, uptake of ^H-thymidine by dividing cells was not examined.
Results of experiments by other workers, which employed adjuvants
other than C.parvum, should be mentioned. Peripheral blood lymphocytosis
and splenomegaly, accompanied by a profound decrease in the number of
lymphocytes in the thymus and peripheral lymph nodes, followed the i.v.
injection of pertussis organisms into mice (Morse, 19^5)• On the other
hand, Taub et al», (1970) observed that B.pertussis injection led to an
influx of cells into the thymus dependant, paracortical areas of the
lymph node draining the site of injection. The seemingly conflicting
results obtained with C.parvum and B.pertussis warrant a full comparative
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investigation of the effects of these adjuvants although it seems
probable that with both agents, chant-res in the recirculating lymphocyte
pool after adjuvant injection could account for the lymphocytosis,
leucopenia and alterations in thymic, lymph node and splenic cellularity.
Haematological changes following administration of C.parvum.
Although the normal cytokinetics of the RES are little understood,
it is known that its size and filtering ability is increased following
the injection of bacterial endotoxin (Biozzi et al., 1955)» methyl
cellulose (Palmer et al., 19153), zymosan (Gorstein and Benaoerraf, i960)
and many other substances of varying chemical composition. Furthermore,
repeated injections of these substances have, on occasion, been shown to
oauae splenomegaly and anaemia with haematologlcal changes resembling
hypersplenism in man (Motulsky et al., 1958). Similar changes, with the
induction of a transitory state of anaemia, can be shown to follow a
single or a small number of injections of C.parvum. Other workers have
noted decreased haemoglobin levels (Halpern et al., 19&4), lowered circul¬
ating red cell counts {Halpern and Fray, 1969), and reticulocytosis
(Nussenweig, 1967)* These findings have been verified and extended by
published (UcCraken et al., 1971) as well as unpublished work carried
out in this department. A summary of these changes are shown in Fig.3.
Certain of the effects are found only inconsistently and hence a rough
guide is also given a3 to the frequency of their occurance following the
8
injection of 4 - 6 x 10 organisms. The reason for the irregular
expression of some of these effects may lie in the rapid adaptation to
anaemia that rodents appear to be capable of by virtue of their high
capacity for splenic extramedullar haematopoiesis (Schooley, 1970).
Figure 3, [hematological changes 1/»days after C.parvum.
Effect Frequency of occurrence (1 -5)
1. hepatospienomegaly 5
2. lowered total red cell counts 3
3. lowered haemoglobin levels l*
/♦.increased reticulocyte counts /.
5. increased plasma volume I ?) 5
6. leucopenia 5
7 Coombs positivity 2
8. rosettes against self1 red cells I*
9. plague forming cells against self red cells /.
/»-8x10® organisms injected i.p.
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Hypersplenism is a wide spread syndrome which occurs in many dis¬
orders associated with splenomegaly. These include, amongst others,
infectious diseases such as malaria, tuberculosis and leishmaniasis;
the myeloproliferative and lymphoproliferative diseases; the reticulo-
endothelioses; certain haemolytic diseases such as thalassemia, sphero¬
cytic anaemia, and even some instances in which the hypersplenism must
be labelled primary because no specific cause i3 found. The character¬
istics of hypersplenism are enlarged spleen, anaemia, leucopenia or
thrombocytopenia. The mechanism whereby the anaemia occurs often appears
to be related to sequestration of circulating blood cells within an
enlarged splenic pool (Bagshawe, 1970). It is possible that here there
is excessive red cell breakdown and it has been suggested that this may
occur by increased phagocytosis, antibody mediated destruction, changes
in the surface lipids of red cells that increase the tendency to seques¬
tration in the spleen, or an increased glucose consumption that could
lead to a deficit in a necessary metabolic substrate. The mechanism
whereby the leucopenia is brought about is unknown.
The similarities between the haeoatological changes in hypersplenism
and those following administration of C.parvum to mice have not yet been
fully evaluated although they are striking. It is neccessary to consider
the consequences of these changes with respect to the lymphoproliferative
and adjuvant effects of this organism and also with respect to the find¬
ing that lymphoid cells from the spleens of C.parvum treated animals can
form rosettes and produce haemolytic plaques with activity directed
against autologous red cells (McCracken et al., 1971; McBride, unpublished).
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The proliferative response of the spleen and liver to C.parHum
and haemolysis.
There is evidence to suggest that particulate materials can increase
the size and filtering ability of the RES. The reactions which follow
the injection of these materials (Marshall and White, 1950f -tfiasler
et al., 1957? Kelly et al», I960* 1962) have in general also been shown
to follow damage to autogenous red cells (Jandl et al., 1965). A
marked increase in the number of dividing cells in the liver was demon¬
strated four days after C.parvum injection by 'flash* labelling of DNA
with ^H-thymidine. Both parenchymal and reticuloendothelial cells were
involved although the increased mitotic activity was most striking in
the latter population. Kelly and her co-workers (1960$ 1962) noted
that foreign particles can stimulate division of hepatic reticuloendo¬
thelial cells and C.parvum can be found to be present within these cells
four days after injection (McEride, unpublished). The nature of the
stimulus for parenchymal cell division is obscure though it is likely
that it contributes to the hepatomegaly often found in treated animals.
One possible explanation is that it is a *work' hypertrophy. The liver
has been shown to be the main source of purine supply for bone marrow
cells and possibly also cells in the periphery (Lajtha and Vane, 1958).
The liver may expand to fulfil increased requirements of these cells.
Most of DNA synthesis in the spleen of normal mice seems to be associated
with the medium to large mononuclear cells in the marginal zone and in
the red pulp, with light but frequently labelled cells also in germinal
centres. This is in a good agreement with the findings of other workers
(Jandl et al., I965). Four days after administration of C.parvum there
is a marked increase in the number of labelled cells in the perifollicular
areas and the red pulp.
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The importance of colls in the marginal zone of the spleen with
respect to the uptake of antigens and the subsequent immune response
has often been inferred. Snook (1964) showed that carbon and sacchar-
eated iron oxide first appear localised in the marginal zone before
moving outwards, to be found a few hours after injection mainly in the
macrophages of the red pulp. A similar location of carbon has been
shown in this study to be present four hours after injection. In
C.parvum treated animals carbon wa3 found to localise less in the cells
of the perifollicular region and more in the red pulp. This altered
distribution may be due to an increase in number and also activity of
the cells in these regions but may also be contributed to by alterations
in the flow of blood through the spleen.
The proliferative response in the perifollicular areas presumably
occurs as a response to the lodgement of C.parvum within reticuloendo¬
thelial cells. On the other hand it may also be contributed to by the
uptake of damaged autologous cells. Jandl et al. (1965) demonstrated
that chronic haemolysis could give rise to a very similar picture of
reticuloendothelial hyperplasia without any toxic, foreign or immuno¬
logical mechanisms being apparently involved.
Anti-self reactivity in C.parvum treated animals.
C.parvum treated animals have been shown to possess many haema-
tological disorders (see Fig.3). The anaemic state is transitory, first
being in evidence several days after injection of the organism and
disappearing 2-3 week3 later. It is accompanied by an increase in the
number of rosette and direct plaque-forming cells with reactivity directed
against autologous or syngeneic red cells (Holton and McBride, unpublished;
L'cCraken eit al., 1971)* It is of interest that C.parvum injected into
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NZB mice gives rise to an exceptionally large increase in the number of
cells forming rosettes with autologous red cells (Holton and McBride,
unpublished), and that several injections of the adjuvant can result in
the early onset of Coomb's positivity in these mice (Halpern and Fray,
1969)* It was also of interest to observe that SF16, could give rise
to anti-self reactivity similar to that found with C.parvum in C3A mice
(McCraken et al«, 1971). SF16 is a strain of diphtheroid-like organisms
isolated from the synovial fluid of a patient with rheumatoid arthritis
(Stewart et al., 1969)* This condition is often associated with an
unexplained state of anaemia that has the characteristics of the anaemia
associated with chronic infection (Alexander and Duthie, l$62). At
present, however, it is a matter of speculation whether this type of
autoimmune response is of pathogenic significance.
The diversity of possible autoimmune mechanisms has recently become
clear. Alteration in antigenic structure i.e. the conversion of a given
cell or unit from 'self* to 'non-self' with resultant autoantigenlcity,
can be considered as one possible basic mechanism. Another mechanism
could be centered around alterations in some or all cells comprising
the immunocyte complex.
Attempts to show that C.parvum and SF16 share common determinants
with, or attach to, or destroy mouse red cells, have so far proved
negative (McCraken et al., 1971). As a result the hypothesis that the
anti-self reactivity has its basis in the abnormal lymphoid proliferation
induced by C.parvum has been strengthened, although proof is difficult
to obtain.
Preliminary results suggest that splenomegaly following C.parvum
injection cannot per ae result in increased anti-self red cell activity,
even if anaemia is detectable. Methyl cellulose, B.pertussis.
Mycoplasma and BCG give rise to negligible alterations in the numbers of
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spleen cells with reactivity directed against self (McCraken, unpublished}
Young and McBride, unpublished). It would be of interest to examine
the effect of phenylhydrazine which ia known to be capable of experi¬
mentally inducing autoimmune haernolytic anaemia in mice (Morton and
Siegel, 1970). At present, however, it seems that the trigger for this
reaction may not be sequestration of red c611s in an enlarged splenic
pool, nor enhanced phagocytosis of these cells but may lie at the lymphoid
cell level.
There are many clinical examples where an intimate relationship has
been found between autoimmune disease and leukaemic lymphoproliferative
processes e.g. macroglobulinemia, cold haemagglutinin disease and chronic
lymphocytic leukemia. Furthermore, the induction of experimental auto¬
immune disease in animals almost invariably involves the use of Freund's
complete adjuvant, a powerful lymphoproliferative agent.
The destruction of lymphoid cells capable of reacting against self
antigens has been postulated to occur during foetal life (Burnet, 1959)•
By extrapolation escape of cells from this process has been suggested
as a mechanism whereby *abnormal' clones might persist arkl give rise to
autoimmune phenomena. It also seems possible that loss of tolerance
to self might be the result of alterations in the immune reactivity of
normal lymphoid cells. In the same way that C.parvum altera the threshold
for the induction of immunity to low doses of BSA, it might also alter
the threshold of immunity to 'self antigens that are normally tolerated.
Many 'self' antigens must exist in quantities that are not sufficient to
normally induce tolerance or immunity. An example is the idiotypic
determinants on the antibody molecules. Anti-idiotyplc antibody can be
induced in mice by the provision of a 'helper' thymu3-derived population
(Iverson, 1970} Iverson and Dresser, 1970). It, also seems possible
that lymphoid cell3 could exist that produce anti-'self' antibodies,
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perhaps of restricted biological activity, but which can be stimulated
to induce transient autoimmune phenomena. Bussard and Hannoun (1962)
reported that lymph node cells from rabbits primed with 3RJBC produced
j sospecific and autospecific red cell antibodies as well as the expeoted
artti-SKBC antibodies. A background level of anti-liver mitochondrial
antibodies of the IgM class exists in rats and other species. They are
normally present in a steady state and give rise to no autoimmune disease
but they can be stimulated following damage caused by CCl^ (7,'eir 1961,
1963).
There is now a considerable body of opinion that stresses the
involvement of the thymus in immunological diseases and in view of the
thymic changes that result from C.parvum administration this aspect of
the subject cannot be ignored.
NZB mice show thymic lesions characterised by expansion of the
medulla with germinal centre formation (Burnet and Holmes, 1962). These
observations, combined with the knowledge of the thymic influence on
Immune responses in general, led other workers to search for such lesions
in other autoimmune phenomena. In humans germinal or 'reaction* centres
in the thymus have been reported in rheumatoid arthritis, endocrlnopathies,
hypogammaglobulinemia and aplastic anaemia (Miller, 1963) and has long
been known for myasthenia gravis (Castlemann and Norris, 1949)* These
findings led to the concept that the occurence of germinal centres in
the thymus represented a characteristic reaction found in autoimmune
states and, in other words, the anatomic evidence of "forbidden clones"
(Burnet, 1962). There is, however, little evidence to show that these
changes are of primary Importance to the disease states and not part of
a generalised hyperplasia. Do Vries and Hijmans (1967) considered them
to be of the latter nature and drew attention tc other changes in the
thymus of NZB and related autoimmune mouse strains. These changes
Involved hyperplasia of the large epithelial cells that seem to be
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involved in the formation of Hassal's corpuscles, followed by their
hypoplasia and subsequent deletion. The relationship of these phenomena
to the disease processes is uncertain.
Fxperimental studies suggest that the presence of the thymus in NZB
mice is not necessary for the onset of a positive Coomb's test (Howie
and Helyer, 1966). Furthermore, the presence of a thymus graft from a
normal strain did not prevent the subsequent disease state although this
graft, in turn, developed lesions similar to those developed in the NZB
thymus (Holmes and Burnet, 1964).
It seems likely that the thymus is not directly concerned with the
initiation of an autoimmune disease at least in NZB mice. A normal
controlling function which is disturbed in autoimmune states may, however,
be present. Neonatal thymectomy results in an increased incidence of
Coomb's positivity (de Vries _et ad., 1964, Sutherland _et al., 19^5)»
anti-nuclear factor (Brezin et al., 1965) and anti-self reactivity of
lymphoid tissues in a GVII reaction (de Vries et al., 1964).
In addition to controlling immune responses the thymus may also play
a role in the control of haeraatopoiesis. Neonatal thymectomy in the
opposura resulted in an abnormal persistence and increase in myeloid
cells, particularly erythroblasts Qiiller et al., 1965)* Thymic
explants have a beneficial effect upon the growth of all cell elements
of the spleen (Auerbach, 1963? Metcalf, 1964). Thymus cells have been
shown to work synergistically with bone marrow cells in the recovery of
erytUropoiesis in heavily X-irradiated recipients (Goodman and
Shinpock, 1968).
Alterations in myeloid tissues are also often found associated with
immunological disorders and, like the thymic changes, may be characteris¬
tic of autoimmune reactions although the inter-relationship of these
phenomena has received little attention. It has recently been suggested
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that the defect in NZB mice might be associated with an abnormally
large stem cell pool, allowing reactivity against self to be expressed
by virtue of the relative lack of competition by foreign antigens and
haematopoietic requirements for precursor cells (Morton and Siegel,
1969)* Furthermore it was postulated that mycobacterial adjuvants
might increase the size of this pool (Siegel and Morton, 19&7)* The
results obtained in this thesis suggest that further examination of the
phenomena at the stem level may be of value.
The adjuvant effect of C.parvum.
There appears to be many possible modes of action by which C.parvum
could exhibit its adjuvanticity. Which of these effects are crucial
may depend upon the system under investigation.
From a teleological point of view, optimal stimulation of an immune
response oould be facilitated by the trapping of an antigen-reactive
population of cells within a site, or close to site where there is
already enhanced localisation of antigen (Balfour and Humphrey, 19^71
Goldschneider and McGregor, 1968). Increased trapping of c.BSA by
reticuloendothelial cells might be considered as being responsible for
altering the threshold of immunity to this antigen and preventing
tolerance induction. However, there is an increasing amount of evidence
that the initial stages of an immune response are characterised by an
altered distribution of reactive cells (Abdou and Richter, 19^9)» and
C.parvum might facilitate this process. While the experimental obser¬
vations in this thesis are consistent with the occurrence of both these
processes, it has not been possible to conclusively prove that one or
both effects are responsible for the adjuvant action with BSA.
In spite of the differences in in vivo localisation of c.BSA between
C.parvum treated and control mice, no enhanced in vitro uptake of 125I-BSA
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by macrophages from C.parvum treated animals was found, nor by macro¬
phages incubated with the organisms. Unanue et al. (1969) showed that
the retention and catabolism of haeraocyanin ('iSH) by macrophages in vitro
was similar whether or not B.pertussis was present. They did however
show that macrophages incubated with the adjuvant could transfer the
adjuvant effect, whether the antigen was or was not associated with the
same macrophage population. Lymph node cells treated with the adjuvant
In vitro were ineffective in transferring adjuvanticity. These workers
postulated that the adjuvant effect of B.pertussis was, at least in part,
brought about by its ability to labilise lysosomal membranes, a capacity
shared by many adjuvants (Spitznagel and Allison, 1970).
The explanation for the redistribution of circulating reactive cells
that appears to follow adjuvant injection, is not clear. Attempts to
show a direct effect of C.parvum upon lymphoid cells in vitro by inducing
transformation or the release of biologically active substances, proved
negative. However, the hypothesis that mechanisms such as these are in
fact operative in trapping and perhaps stimulating lymphoid cells remains
attractive.
In this thesis attempts to transfer the adjuvant effeot of C.parvum
demonstrated that the induction of tolerance to BSA could be prevented
by the transfer of populations of spleen cells from adjuvant treated
animals whether or not the cells adhere to glass and independant of their
acid phosphatase content. Transfer of bacteria is unlikely to have
accounted for this effect. This experiment suggests that the adjuvant
effeot of C.parvum may not be solely attributable to increased reticulo¬
endothelial activity and the system deserves further investigation from
this viewpoint.
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Little information is available to support or deny association
between the haematological changes induced by C.parvum and the adjuvant
effects. Splenectomy, which is known to cure many of the haematological
defects associated with hypersplenism (Tumen, 1970), did not completely
abolish the adjuvant effect of C.parvum found following the intraperi¬
toneal injection of SRBC. However, the effect of splenectomy upon the
haematological changes induced by C.parvum remains at present unexamined.
It is not yet known whether or not the autoimmune reactivity found
in C.parvum treated animals is also a manifestation of its adjuvant
effect. The presence of anaemia itself does not seem sufficient for
this reactivity to develop as methyl cellulose injection which caused
splenomegaly and anaemia, did not lead to an increase in the number of
rosette-forming cells against syngeneic red cells. Neither is reticulo¬
endothelial stimulation apparently sufficient, as a few other known
reticuloendothelial stimulating agents were relatively ineffective.
However, it still remains to be shown that the disturbances are primarily
at the lymphocyte level. There is a good evidence for suggestion that
there is a relationship between the myeloid and lymphoid cell systems
(Yoffey, 1964; Wu st al., 1968). One of the modes of action of myco¬
bacterial adjuvant (Siegel and Morton, 1967)* and perhaps also C.parvum,
might be to increase the size of the plurlpotential stem oell pool.
Although Albright and Makinodan (1965) and Doria (1968) have reported
that erythropoiesis is generally associated with a decreased level of
antibody formation, it would be of interest to consider the haemato¬




The main findings of this thesis are as follows.
1. Ultracentrifuged native BSA (c.BSA) is a poor immunogen in CBA mice.
2. Single low doses (10 - 150^g) of centrifuged B3A can readily induce
a state of hyporesponsiveness in CBA mice as judged by their impaired
response to challenge with alum-precipitated B3A (a.BSA).
3. The class and quality of the antibodies formed in tolerant mice
following challenge is similar to those found in non-tolerant controls.
4. Pour different inbred strains and two hybrid mouse populations
differ quantitatively in their response to immunogenic alum-
precipitated BSA.
5. In contrast, these different populations of mice, with the possible
excej tion of NZB strain, become all tolerant if given 50^ig of
centrifuged B3A.
6. Of the groups of mice tested, NZB and (NZB x CBA) mice respond
beat to alum-precipitated BS,\. In addition, NZB mice are relatively
refractory to tolerance induction.
7. The use of aggregated BSA in the place of tolerogenic centrifuged
BSA switches the response of CBA strain from tolerance towards
immunity.
8. A tolerogenic dose of centrifuged BSA is not localised to any extent
by the reticuloendothelial system.
9. The same dose of aggregated BSA (h.BSA) is found localised to a
greater extent than centrifuged BSA within macrophages.
10. Treatment with C.parvum, C.anaerobium, SF 16 or B.pertussis is
capable of preventing the induction of tolerance to centrifuged BSA
in CBA mice. This affect depends upon the dose and timing of adjuv¬
ant administration.
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11* C«parvua pre-treated ados show an accelerated rata of non-immune
elaaranoa of oentrlfuged BSA and an enhanced localisation of the
antigen within the cells of the reticuloendothelial system.
Those main conclusions, along with the results of other experiments,
are discussed with respect to proposed mechanisms of tolerance Induction
and immunity and their control. The adjuvant action of C.parvum is
discussed with relation to the effects of the bacteria upon various
cell populations and in regard to the haematological changes that follow
injection, including the increase in the number of spleen cells with
reactivity directed against autologous red cells.
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LIST OP ABBREVIATIONS.
ABC antigen binding capacity
AgAdd antigen added
BCG Bacille-Calmette-Guerin vaccine
BGG bovine gamma globulin
BSA bovine serum albumin
a.BSA alum-precipitated bovine serum albumin
c.BSA centrifuged bovine serum albumin
h.BSA heated bovine serum albumin
p.BSA bovine serum albumin heated at low pH
X) dextrorotary
DNP dinitrophenyl
EDTA ethylenediamine tetracetic acid
P^ first hybrid generation
FCA Freund's complete adjuvant
GVH graft-versus-host
H-2 histocompatibility locus No.2
HOG human gamma globulin
HSA human serum albumin
KLH keyhole limpet haemocyanin
L levorotary



























w/v weight per volume
*BSA radioactive preparation




Of j/M etc. symbol of gammaglobulins
*ve positive
et al. et alii (and collaborators)
i.e. id est (that is)
i.p. intraperitoneally)
i.v. int ravenous (ly)
P. page
Appendix 1.
Flow Diagram for Farr results»
ABC = number of sets of data for each serum - 1 or 2.
TCA » TCA 'control1 counts.
CONT » 'control' counts
sets = number of sets of dilutions for each sera.
D (lsdil) = dilutions.
Bin 1 and Bin 3 ■ origional 'experimental' counts, sets 1 and 2.
Bin 2 and Bin 4 ■ 1° binding.
ABC 1 a ABC - 33 values for first set.
ABC 2 = direct ABC values for first set.
ABC 3 = ABC - 33 values for second set. ^































The interpretation of the program for obtaining percent bindings, ABC - 33
and direct ABC values, written for the 360/50 Edinburgh University computer
(IMP compiler), is included in the pocket at the back of this thesis.
•
•








6 SINTEGERFN ELAPSED TIME
7 ^RESULT = 1
•
0 8 ^END •
9 ^INTEGER ABC ,TCA 1 ,TCA 2 , CON T1 ,CON T2 ,S ETS , DIL , I , Z
0 10 £REAL Y
11 99: READ (ABC)
12 |N0 OF SETS OF RESULTS
•
0 13 NEWPAGE
14 5gIF ABC = 1 5KTHFN -> 2 •
15 READ ( SETS ) 5READ (D IL ) ;READ ( TCA1 ) ;READ( TCA2 ) ;R EA D (C 0NT1 ) ; REA D(C 0NT2 )







0 22 igPRINTTEXT 'CONT •
•
23 PRINT(C0NT1,4,0)
24 PRINT(C0NT2 ,4 ,0)
f - *
W rdF r----r : ~-£-=xE.
0 25 NEWLINES (3)
26 gPRINTTEXT'
27 '
0 28' DIL COUNTS BIN ABC1 ABC2 COUNTS'





33 2: READ (SETS ) *,READ (DIL ) ;READ( TCA1 ) ;READ(C0NT1 )













_ ■ . . . . •, ?>.. • ' . ;




4| 46 1: 5SBEGIN
47 ^REALARRAY D(1 :DIL),BINI,BIN2,BIN3,BIN4,ABC1,ABC
C (1 :SFTS*D II )
0
2,ABC3,ABC4 %C
0 48 1 BIN 1 AND 3 REFER TO SET 1: 1 CONTAINING ORIGINAL COUNT %C 0
C 3 CONTAINING % BINDING : 2 +4 TO 2*ND SET OF DAjTA .
49 3CYCLE I = 1,1,DIL
0 50 RF AD inm 1 J*
51 ^REPEAT
52 5gCYCLE I = 1,1, SETS*DIL
0 53 READ(BIN1(I))
54 %IF ABC = 1 5gTHEN -> 3
•
55 READ ( B~IN"2 ( I ) )
0 56 3: ^REPEAT
57 5gCYCLE I = 1,1,SETS*DIL
58 EIF BIN 1 (I ) =0 %THEN ->4
. . . _ .. ,ps - - —
4| 59 BIJSI3 (I ) = ( (BIN1 ( I J-C0NT1 )/( TCA1-C0NT1 ) )*100
60 4: %1F BIN1 ( I ) <=0 SgOR BIN3(I)<=0 ?THEN B I N 3 ( I)
•
=0
61 %IF ABC = 1 gTHEN ->6
0 62 %1F BIN2(I)=0 ^THEN ->5
63 BIN4(I)=((BIN2(IJ-C0NT2)/(TCA2-CONT2))*100
64 5: %1F BIN2(I )<=0 gOR BIN4(I)<=0 % TH EN BIN4(I)
a
=0
# 65 6: ^REPEAT
66 Z = 0
•
67 %CYCLE I = 1,1,SETS*DIL
0 68 Z = Z +1 A
69 %1F Z =DIL 1THEN ->12
70 %1F B IN 3 ( I ) =0 S5AND BIN3(I+1)=0 3? TH EN ->12
n
# 71 Y={LOG(D(Z + l))- LOG(D(Z) ))*(BIN3(I)— 33)/ (BIN3(I)
72 ?IF Y>7 %THEN ->888
- BIN3(I+l)) 0
73 |*V R
0 74 ABC1(I)=EXP(Y XD(Z)*0.066
75 %IF ABC1 (I XO .00 1 SgTHEN A BC1 (I ) =0
76 ->13
PP




0 80 13: ABC2(I)=BIN3(I)*D(Z)*0.002
81 8: %IF ABC= 1 HEN ->10
82 %IF DIL=Z gTHEN ->14
a
pp.
*— V * ■ ^ Ui 1— U 1 1 1 I— IV ' JL i
0 83 %IF B IN4 ( I ) =0 £AND BIN4(I+1)=0 % THEN ->14
84 Y=(LOG(D(Z+l))—LOG(D(Z)))*(BIN4(I)-33)/(BIN4(I)-
85 SglF Y >7 HEN ->887
0 86 I*VR
87 ABC3(I)= EXP(Y)*D(Z)*0.0066 ^




0 92 14: ABC3(I)=0
93 15: ABC4 (I ) =B IN4 ( I )*D (Z XO .0002
94 10 : PRINT(D(Z ) ,4 ,1 )
0 95 PRINT(BIN1 ( I ) ,5 ,0 )
96 PRINT(B IN3 ( I ) ,3,2 )
97 PRINT(ABC1(I ) ,6 ,3 )
0 98 PRINT(ABC2 ( I ) ,3 ,3 )
99 %IF ABC=1 2THEN -> 11
100 PRINT(B IN2 ( I ) ,5,0 )
0 101 PRINT(BIN4(I ) ,3,2)
102 PRINT(ABC3(I ) ,6,1)
103 PRINT(ABC4(I),3,3)
0 104 11: SIF D IL =Z ? TH EN NEWLINE




0 109 READ (ABC)
110 SIF ABC=-1 3THEN ->99 ;| NEXT SET C
111 ?ENDOFPROGRAM
•
128 STATEMENTS COMPILED SUCCESSFULLY
CODE OCCUPIES 5264 BYTES GLAP 380 + 0 BYTES DIAG TAB L ES
a
•












164 BYTES TOTAL 5880 BYTES
0V
OBJECT PROGRAM FILE COMPLETE
•
